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Summary
An investigation of the two major stress pathways, the 
sympathomedullary system, and the hypothalamic-pituitary-adrenal (HPA) 
axis and their role in the mediation of the physiological response to acute 
stress was undertaken in the sheep. Particular emphasis was given to the 
metabolic regulation initiated by these two stress pathways. In addition, the 
specific role of each pathway was assessed. This was achieved by using 
two different approaches. Firstly, by the active immunisation against ACTH 
1-24, which acts to immunoneutralise the glucocorticoid response. 
Secondly, a pharmacological approach using non-selective adrenergic 
receptor antagonists. Propranolol HCI, a /^-adrenergic antagonist and 
phentolamine methane-sulfonate, a or-adrenergic antagonist were used. To 
determine the contribution of the sympathetic nervous system tyramine 
HCI, a potent sympathomimeteic agonist compound was infused into 
sheep.
The stress response to dynamic exercise (2.5 km/h and 5 km/h) was 
examined in both ACTH-immune and non-immune sheep (a? = 3 per group). 
During the experiments the adrenergic antagonists were infused into both 
groups of animals.
in the non-immune sheep, exercise activated both stress pathways and 
the degree of stimulation was proportional to the exercise intensity. In the 
ACTH-immune sheep, only the sympathomedullary system was activated. 
Exercise stimulated the level of plasma glucose and lactate in both groups, 
while maintaining plasma insulin concentrations at or near basal levels. In 
addition, there was little difference in the cardiovascular response in either 
group.
The importance of the hypothalamic-pituitary-adrenal axis during exercise 
particularly in relation to energy substrate metabolism was highlighted by
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the failure of the ACTH-immune group to mobilise plasma free fatty acids 
(FFA's). The increase in FFA's was shown to be mediated by the /?- 
adrenergic receptor. Inhibition of insulin section and the stimulation of 
glucose release was shown to be mediated by the a-adrenergic receptor.
The contribution of the sympathetic nervous system to an acute stress 
response was examined by infusion of tyramine HCL into non-immune 
sheep. In addition, the receptor type responsible for the mediation of 
metabolic and haemodynamic changes was also assessed. Tyramine HCI 
infusion into non-immune sheep (/? = 4) stimulated the release of 
endogenous noradrenaline. Neither plasma adrenaline or cortisol levels 
increased. Tyramine HCI infusion increased plasma FFA's, plasma glucose 
and plasma insulin levels as well as increasing arterial blood pressure. 
Plasma insulin levels were unaffected by the increased plasma 
noradrenaline levels, suggesting that the inhibition of insulin secretion in the 
sheep is mediated by adrenaline and not noradrenaline.
Surgical procedures under general anaesthesia and anaesthesia alone were 
used as "unnatural" acute stressors to assess the stress response in both 
ACTH-immune and non-immune sheep (/? = 3 per group). The carotid artery 
from both the ACTH-immune and non-immune groups was catheterised 
under general anaesthesia. Only the non-immune sheep were subjected to 
the anaesthesia only treatment. The stress responses were quite distinct 
with anaesthesia exerting less influence on the endocrine function than the 
combined stress of surgery and anaesthesia. The sympathomedullary 
pathway was suppressed in both groups in response to anaesthesia only or 
surgery. Activation of the HPA axis during surgery in the non-immune group 
was associated with increased plasma glucose, FFA's and reduced 
circulating insulin levels. In contrast, the ACTH-immune sheep were unable 
to modulate these metabolic and endocrine changes.
It is concluded, that the nature of the stressor itself dictates the response
vi
from the two stress pathways. The sympathomedullary pathway appears to 
be the most important axis during exercise and the hypothalamic pituitary 
adrenal pathway to be the dominant axis during surgery. Exercise as a 
stress stimulates catecholamine release which in turn mobilises stored 
energy substrates while inhibiting peripheral insulin. The HPA-axis plays an 
important role during exercise in energy substrate mobilisation especially 
the lipolytic response. Suppression of the sympathomedullary pathway 
results in a more dynamic role for the HPA-axis whereby it initiates 
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"Stress Is a dangerous and useless word. It may seem useful because it is a 
unifying word, but it unifies our ignorance rather than our knowledge" 
(Zanchetti 1972).
This notion was further elaborated by Harvey and co-workers (1984) and 
they characterised stress as being "an ill-defined concept, that attempts to 
describe the interaction of an organism with environmental stimuli 
perceived as imposing a threat, real, or anticipated, on its survival or 
wellbeing".
Exposure to a variety of environmental events can evoke a wide range of 
physiological changes. Historically, these physiological adaptations were 
divided into two distinct phases "the emergency reaction" and the "general 
adaptation syndrome". The "emergency reaction" as described by Cannon 
(1935) involves actions which are mediated via the stimulation of the 
sympathetic nervous system and the release of hormones from the adrenal 
medulla. Cannon delineated this reaction as an acute response and involved 
the release of humoral factors (catecholamines) that mobilised the 
organisms physiological resources for "flight or fight".
Hans Seyle (1936) described the overall physiological response to "diverse 
noxious agents", which encompassed both an acute as well as a chronic 
phase. This latter phase Seyle termed the "general adaptation syndrome" in 
which the organism adapts to a given stressor over time with a standard 
physiological response irrespective of the nature of the stressor. This long­
term reaction is characterised by the activation of the hypothalamic- 
pituitary-adrenal (HPA) axis. It involves the release of adrenocorticotropic 
hormone (ACTH) from the pituitary gland, which in turn stimulates the
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synthesis and the secretion of corticosteroids from the adrenal cortex. 
These corticosteroids then modulate the non-specific physiological 
adaptation of peripheral tissues.
The activation of the sympathomedullary system and the HPA axis in 
response to various potential hostile stressors and the animals responses to 
their release enables the cells of an organism to be maintained within 
closely defined physiological limits. Thus the maintenance of a constant 
interior milieu, recognised by the 19th century physiologist Claude Bernard 
(1878) can be maintained by physiological and behavioural homeostatic 
adaptations.
Judge and co-workers (1966) claimed that farm animals were prone to the 
unfavourable consequences of stress because their genetic selection results 
in metabolic processes which are anabolic in nature, whereas mechanisms 
aimed at survival are, on the whole, catabolic in nature. This reduced 
homeostatic capacity of farm animals to respond to stress is manifested by 
ongoing farm practices in which animals are helped to cope with stress by 
the farmer. For example domestic animals are provided with a variety of 
anti-stress drugs, to repress their reactions to environmental stressors; 
antibiotics to control microbial growth and hormones and vitamins to 
compensate for a deficiencies in their physiological defence mechanisms 
(Dantzer and Mormede, 1979).
Most of the past research into the effects of stress on farm animals has 
focused on chronic stress conditions whereby animals are exposed to the 
same stressors or to repeated stressors for a long period of time, rather 
than acute stress. This may be an important consideration in animal 
practice as chronic stressors are not uncommon in animal husbandry. 
However, acute stressors undoubtedly have wide ramifications for the well 
being of farm animals and therefore animal product quality especially when 
stressors are novel.
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In this thesis, I explore the physiological responses of sheep following 
exposure to acute stress. Particular emphasis was given to processes 
involving metabolic regulation. These studies were aimed at achieving a 
better understanding of the interaction between the two major stress 
pathways, the adrenomedullary system and the HPA axis when sheep are 




The Sympathetic Nervous System and the Hypothalamic-Pituitary-Adrenal 
Axis
2.1. Introduction
The catecholamines and adrenocorticosteroids are both important 
physiological responses to stress. They are also, in themselves important 
endocrine regulators which act to maintain homeostasis in many species, 
including the sheep. Adrenaline and noradrenaline play a major role in the 
short term regulation of energy substrate availability and have significant 
effects on the metabolism of carbohydrate, fat, and protein (McDowell and 
Annison, 1991). These two catecholamines, along with dopamine, are the 
active neurotransmitters of the adrenal medulla and sympathetic nervous 
system. This sympathomedullary system is basically the alarm system for 
"fight or flight".
The hypothalamic-pituitary-adrenal axis also plays a major role in 
facilitating other physiological systems to maintain homeostasis during 
exposure to stress. Stimulation of this axis by acute stressors has profound 
metabolic effects. These involve the promotion of carbohydrate metabolism 
and lipolysis, with the subsequent release of free fatty acids (Odio and 
Brodish, 1988; Widmaier, 1992). However, it is in their role as co­
ordinators of the long term adaptations to chronic stress that the 
glucocorticoids exert their most important effects.
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2.2 Catecholamines
2.2.1 Biosynthesis of Catecholamines
The principal catecholamines are noradrenaline, adrenaline and dopamine. 
Both adrenaline and noradrenaline occur in high concentrations in the 
adrenal medulla, with dopamine present in only small amounts. The 
catecholamines are stored in the chromaffin granules which are analogous 
to the secretory granules found in many other endocrine tissues (Blaschko 
and Welch, 1953). Chromaffin granules also contain ATP, chromogranin, 
lipids, and RNA (Hillarp eta/. ,1955; Philippu and Schümann, 1963).
Catecholamines are formed by the hydroxylation and decarboxylation of 
precursor amino acids, phenylalanine and tyrosine. Some important steps in 
the pathway are the formation of DOPA (Imaizumi, 1938), and conversion 
of DOPA to dopamine by DOPA decarboxylase (Holtz, 1939). From these 
and other studies the following biosynthetic pathway was derived, tyrosine 
-> DOPA dopamine noradrenaline -* adrenaline.
The presence of dopamine in the adrenal gland was first reported by 
Goodall (1950). In vivo experiments using dopamine-C14 demonstrated that 
it was converted to adrenaline within the adrenal medulla deeper and 
Udenfriend, 1956) and similar experiments by Masuoka et a/. (1956) 
demonstrated that noradrenaline-C14 was also converted to adrenaline. The 
presence of these products within the adrenal gland has lent support to the 
existence of a catecholamine biosynthetic pathway within the adrenal gland 
which had been postulated by Blaschko (1939). The same pathway for 
catecholamine synthesis has also been confirmed in organs other than the 
adrenal gland, including the brain (Carlsson et aL, 1958) and the splenic 
nerve (Schümann, 1956).
Dietary tyrosine is the normal precursor of catecholamine biosynthesis but
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dietary phenylalanine can be converted to tyrosine by phenylalanine 
hydroxylase in the liver, and the tyrosine formed in this way can also act as 
the precursor. Tyrosine is transported to the adrenal medulla, adrenergic 
nerve endings, brain, and sympathetically innervated tissues where it is 
converted to dopa and then to catecholamines. The conversion occurs in 
the cytoplasm and is activated by tyrosine hydroxylase which can be 
inhibited by the subsequent products, dopamine and noradrenaline. The 
conversion of tyrosine to DOPA is the rate limiting step in the biosynthetic 
pathway. Phenylanaline hydroxylase is exclusively localised in the liver and 
this contrasts to tyrosine hydroxylase which is localised within the 
catecholamine containing organs. Upon formation, dopamine enters the 
granulated vesicles of the adrenal medulla and the neuronal cells where 
conversion to (and the storage of) catecholamines occurs. Noradrenaline is 
synthesised within the adrenergic nerve endings; however, some of the 
noradrenaline is also manufactured elsewhere and is taken up from the 
blood stream. Circulating adrenaline is also taken up in small amounts by 
the noradrenergic nerve endings. Catecholamines cannot pass through the 
blood brain barrier (Jesova et at., 1990). Therefore, brain catecholamines 
are synthesised de novo from precursor amino acids which are taken up 
from the circulation across the blood brain barrier.
Dopamine represents only a small percentage of the total adrenal 
catecholamines; most of the adrenal dopamine is beta-hydroxylated to 
noradrenaline and then to adrenaline (Carlsson et at., 1973). While its 
synthesis in the adrenal medulla and the adrenergic nerve endings is similar, 
some of the medullary cells contain the cytoplasmic enzyme 
phenylethanolamine-N-methyltransferase (PNMT). This enzyme catalyses 
the conversion of noradrenaline to adrenaline and is found in high 
concentrations only in the adrenal medulla. For this reason it is only the 
adrenal medulla that produces substantial quantities of adrenaline.
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2.2 .2 . Metabolism of Catecholamines
As with all neurotransmitters and hormones, the released agent must be 
rapidly dissipated when the response it induced is no longer necessary 
(Mersmann, 1989). Catecholamines, when released, may re-enter the nerve 
endings via specific uptake transport mechanisms (Iverson, 1974; 
Trendelenburg, 1979) or dissipate from the effector site. This latter action is 
the major source of circulating noradrenaline and dopamine (Mersmann,
1989). The catecholamines are converted to biologically inactive products 
under the influence of catechol-o-methyltransferase, (COMT), and 
monoamine oxidase, (MAO). Catechol-o-methyltransferase promotes the 
methylation of the hydroxyl group at position 3 on the aromatic ring to 
produce the inactive metabolites methoxytyramine, normetanephrine, and 
metanephrine from dopamine, noradrenaline, and adrenaline, respectively 
(Goldberg and Marsden, 1975). Monoamine oxidase acts to remove the 
amine group from the side chain of the catecholamines (Mersmann, 1989). 
As most noradrenaline is released directly into individual tissues from the 
sympathetic nerve endings, considerable metabolism may occur before it 
reaches the circulation. Degradation of adrenaline in the circulation is via o- 
methylation by COMT in the liver.
2.3. The Autonomic Nervous System
The autonomic nervous system is also termed the visceral, vegetative, or 
involuntary nervous system. It's peripheral representation consists of 
nerves, ganglia and plexuses that provide the innervation to the heart, 
blood vessels, glands, viscera and smooth muscles. In general, this system 
regulates the activities of structures that are not under voluntary control. 
Respiration, circulation, digestion, thermoregulation, metabolism, and the 
secretions of certain endocrine glands are regulated, in part or whole by the 
autonomic nervous system. This system is divided into two subdivisions, 
these are the parasympathetic (or craniosacral outflow) and the
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sympathetic (or thoracolumbar outflow) nervous systems.
The sympathetic system is distributed to effectors throughout the body, 
whereas the parasympathetic distribution is more limited. The sympathetic 
nerve fibres form branches which may traverse a considerable distance 
along the sympathetic chain passing through several ganglia before it finally 
synapses with a post ganglionic neuron. The parasympathetic system has 
its terminal ganglia near to the innervated organs and therefore is more 
discrete and limited in its discharge of impulses. The sympathetic and 
parasympathetic systems are considered to be physiological antagonists; if 
one system inhibits a certain function, the other often augments that 
function. The sympathetic system and the parasympathetic system are 
normally active at all times, with the level of activity varying from moment 
to moment and organ to organ. This enables fine adjustments to a 
constantly changing environment. The sympathomedullary system, 
consisting of the sympathetic nervous system and the adrenal medulla, 
together act as a single unit, especially during rage and fright when all 
sympathetically innervated structures are affected simultaneously. This 
prepares the organism for "fight or flight". The parasympathetic system is 
organised mainly for discrete and localised discharge and not for mass 
responses. It is concerned primarily with the functions of conservation and 
restoration of energy reserves rather than with the expenditure of energy 
(Grollman, 1978).
Transmission of impulses through the synapses of the autonomic nervous 
system is mediated by two neurotransmitters, acetylcholine and 
noradrenaline. In the parasympathetic system, transmission at the synapses 
of both the ganglion and the neuroeffector junctions is mediated by the 
production of acetylcholine; this is termed cholinergic transmission. The 
sympathetic system is considered to be adrenergic as transmission through 
the synapses involves both acetylcholine and noradrenaline, the former at 
the presynaptic, the latter at the neuroeffector junction although, in some
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animals acetylcholine is released at post-synaptic sites (Koelle, 1975).
2.4. Adrenergic Transmission
Von Euler (1954) found a sympathomimetic like substance in highly 
purified extracts of sympathetic nerves and effector organs, and determined 
that the substance bore a strong resemblance to noradrenaline. He 
proposed that the sympathetic transmitter was noradrenaline and that 
during sympathetic nerve stimulation small quantities of adrenaline may 
also be liberated. Other workers (see review by Hillarp et a!., 1966), 
confirmed that noradrenaline is the predominant sympathomimetic 
substance in postganglionic sympathetic nerves and is the adrenergic 
mediator liberated after their stimulation.
The adrenal medulla is considered to be part of the sympathetic nervous 
system; however, physiologically the adrenal medullary cells differ from 
sympathetic neurones. The adrenal medulla secretes a mixture of both 
adrenaline and noradrenaline, whereas the sympathetic neurones secrete 
mainly noradrenaline. The medulla releases these hormones into the 
peripheral circulation and its physiological action is at distant sites. In 
contrast, the sympathetic neurones secrete noradrenaline from the 
terminals of their axons in intimate association with the tissue to be 
influenced.
2.5. Catecholaminergic Receptors
Adrenaline and noradrenaline regulate physiological processes through 
their interaction with specific cell surface receptors. These 
catecholaminegic receptors were initially classified as a- and /?-adrenergic 
based on their relative pharmacological properties (Alquist, 1948). The 
classification is based on the relative abilities of adrenaline, noradrenaline 
and isopropylnoradrenaline to produce a particular response from these
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receptors.
Noradrena l ine s t imula tes  pr inc ipa l ly  the a - receptors ;  
isopropylnoradrenaline stimulates principally /7-receptors and adrenaline 
stimulates both, (Himms-Hagen, 1967). Later studies by Lands et a!., 
(1967) described two classes of ^-adrenergic receptors, termed /?1 and /?2 
and two classes of or-adrenergic receptors, termed o1 and a2. Ariens et a!. 
(1979) suggested that the /?1 -receptors are stimulated by noradrenaline 
released from the sympathetic nerves and that the /72-receptors are 
stimulated by adrenaline released from the adrenal medulla. Evidence of 
three /7-receptor types was suggested to account for the non-/?1- and non- 
/?2-adrenergic responses of rat brown and white adipose tissue. The 
characterisation of a gene coding for a third /?-adrenergic receptor was 
reported in humans (Emorine et a!., 1989) and rodents (Nahmias et a!., 
1991). Recent studies have confirmed the existence of three distinct /?- 
adrenergic receptors (Caron and Lefkowitz, 1993).
Separate intracellular events characterise ar1- and the a2-receptor 
stimulation as they are linked to different intracellular second messenger 
pathways (Fain and Garcia-Sainz, 1983). The a1-adrenergic receptor affects 
involve the turnover of phosphatidylinositol and the elevation of cytosol 
Ca2+ while the a2-adrenergic receptor affects involve the inhibition of 
adenylate cyclase (Wikberg, 1979). Stimulation of the a1- receptors is by 
noradrenaline released from the sympathetic nerve endings and stimulation 
of the o2- receptors is by adrenaline released from the adrenal gland. 
Recent studies have found three distinct a1- and three distinct a2- 
adrenergic receptors (Caron and Lefkowitz, 1993). These receptors are all 
encoded by different genes and are all pharmacologically distinguishable.
Both a- and ^-adrenergic receptors bind ligands with different 
pharmacological profiles and are coupled to different signal transduction 
mechanisms (i.e. stimulation or inhibition of adenyl cyclase or stimulation of
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phosphatidylinositol hydrolysis (Caron and Lefkowitz, 1993). Adrenergic 
receptors mediate a series of complex transmembrane signalling events or 
intracellular processes that often lead to gene activation. This signalling 
system is composed of three functional components, the receptor with its 
seven hydrophobic transmembrane segments, a guanine nucleotide 
regulatory protein, (G protein), that mediates the interactions of the 
receptor, and an effector component that can be either adenyl cyclase or an 
ion channel, (K+ or Ca2+) (Lefkowitz and Caron, 1988; Casey and Gillman,
1988). Activation of the receptor leads to the subsequent interaction of the 
receptor with it's appropriate G protein which in turn promotes nucleotide 
exchange and activation of the G protein. This results in the modulation of 
the activity of an effector system. Activation of the adrenergic receptor, 
which increases cyclic AMP levels due to activation of adenyl cyclase, 
results in phosphorylation of protein kinase A (Alberts et al., 1989).
2.6. Catecholamine Release in Response to Stress
Stimuli from the internal and external environment are transformed into 
neural information and integrated within the central nervous system where 
they may be perceived as being stressful (Ramade and Bayle, 1982). 
Stressors known to activate the sympathetic nervous system in the intact 
animal include exposure to cold or heat, emotional stress, trauma, tilting, 
hypotension, exercise, birth, hypoxia, hypercapnia, arousal from hibernation 
and surgery (Graham, 1975).
Stress results in the stimulation of the sympathetic nervous system and 
the rapid release of the catecholamines from the adrenal chromaffin cells 
and the sympathetic nerve terminals into the peripheral circulation. The 
catecholamines may be released in proportion to their adrenal 
concentration, however, adrenaline can be preferentially released following 
methylation of noradrenaline by phenylethanolamine-N-methyltransferase 
(PNMT) (Harvey et a!., 1984). The release of catecholamines during stress
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can therefore deplete adrenal catecholamine stores, especially the 
noradrenaline content (Rees et a/., 1984). The maintenance of elevated 
plasma adrenaline concentrations during stress or the replenishment of 
adrenaline stores is ensured by increased levels of adrenal PNMT activity 
(Jurani et aL, 1978).
2.7. Metabolic Effects of Adrenaline and Noradrenaline
2.7.1. Carbohydrate Metabolism
Both noradrenaline and adrenaline promote hyperglycaemia. Associated 
with this are increased glycogenolysis, increased gluconeogenesis and 
decreased peripheral glucose utilisation. In this regard adrenaline is far more 
effective than noradrenaline. For example in the sheep it has been reported 
that noradrenaline is only 20% as effective as adrenaline with respect to 
the glycaemic rise (Bassett, 1970). Both hepatic and muscular 
glycogenolysis rates are increased via activation of the /?2-adrenergic 
receptors (McDowell and Annison, 1991). Infusion of adrenaline into sheep 
(Bassett, 1970) increased muscle glycogenolysis as evidenced by the 
increased circulating lactate levels. When catecholamines bind to the ß- 
adrenergic receptors on the plasma membrane of hepatocytes, this 
activates adenylate cyclase which, in turn, catalyses the formation cyclic 
AMP (cAMP). This cAMP activates a protein kinase which phosphorylâtes 
both phosphorylase kinase and glycogen synthetase. Phosphorylated 
phosphorylase kinase enhances glycogen breakdown while phosphorylation 
of glycogen synthetase inhibits its action.
Adrenaline stimulates gluconeogenesis in the liver by increasing the 
availability of the gluconeogenic substrates, lactate and glycerol which are 
generated during lipolysis. Increases in gluconeogenesis have been 
demonstrated in the dog following administration of adrenaline (Stevenson 
et aL, 1991). This increase was suggested to result from firstly, the
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stimulation of precursor release from peripheral stores which initiated 
substrate movement into the hepatocytes and, secondly, by increased 
intrahepatic gluconeogenic efficiency. In his studies on sheep, Bassett
(1970) demonstrated that the infusion of noradrenaline had no stimulatory 
effect on either blood glucose or lactate levels. Infusion of catecholamines 
is also associated with a decrease in the metabolic clearance rates of 
glucose (Himms-Hagen, 1967). This effect could be due to an increase in 
muscle cell glucose-6-phosphate levels formed during glycogenolysis. This 
intermediary in glucose metabolism is a potent inhibitor of glucose uptake 
(Brockman and Laarveld, 1986).
Glucagon, which is secreted by the pancreatic a-cells, plays an important 
role in stimulation of hepatic glycogenolysis and hepatic gluconeogenesis. 
In both cases increases in cyclic AMP have been shown to coincide with 
increases in glucose output after glucagon stimulation (Sutherland et a!., 
1968). Both adrenaline and noradrenaline have been shown to stimulate 
glucagon levels, (Steffens and Strubbe, 1983).
The catecholamines have indirect actions on carbohydrate metabolism by 
affecting insulin secretion in sheep (Bassett, 1970) and man (Clutter et a!., 
1988). Inhibition of insulin secretion is mediated via the a2-adrenergic 
receptors of the /?- pancreatic cells (Clutter et aL, 1980). This or2-adrenergic 
action inhibits insulin secretion independently of the blood glucose 
concentration. Activation of /?2-adrenergic receptors stimulates insulin 
release (Remie et a!., 1989). When the sympathetic nerves to the islets of 
Langerhans are activated, noradrenaline is released as well as the peptide 
galanin which is present, colocalised with noradrenaline (Dunning et a!.,
1990). Suppression of insulin secretion and the increase in both plasma 
adrenaline and noradrenaline through activation of the sympathetic nervous 
system is highly coordinated. This occurs firstly by the release of both 
noradrenaline and galanin and secondly, by the stimulation of the ¡32- 
adrenergic receptor by adrenaline resulting in the release of noradrenaline
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and galanin from the sympathetic nerve endings (Scheurink et aL, 1992).
Because catecholamines have effects on both insulin and glucagon, the 
molar ratio between these two pancreatic hormones can be altered. A 
decrease in the insulin to glucagon ratio results in the mobilisation of 
metabolic fuels such as glucose and free fatty acids (FFA's) into 
extracellular fluids. Increased glucagon levels decrease glucose uptake by 
cells and also decrease the capacity of the liver to synthesise glycogen. A 
fall in the insulin : glucagon ratio was observed by Boettger et aL, (1972) 
when dogs were exercised on a treadmill to the point of collapse. This is 
related to the animals requirement for increased glucose utilisation, rather 
than to a state of hypoglycaemia, which was not evident in this study.
2.7.2. Lipid Metabolism
The sympathetic nervous system is the main regulator of lipolysis in man 
(Webber and Macdonald, 1993) and sheep (Bassett, 1970). In ruminants, 
catecholamines are more potent stimulators of lipolysis than glucagon 
(Vernon, 1980). Adipocytes possess both stimulatory ^-adrenergic 
receptors and inhibitory a2-adrenergic receptors with /7-receptors being the 
more abundant. Both /?1- and /?2-adrenergic receptors have been identified 
in human subcutaneous adipose tissue and more recently the /?3-adrenergic 
receptor has been shown to be active in adipose tissue although less active 
in superficial tissues (Emorine et aL, 1994). Catecholaminergic stimulation 
of the ^-adrenergic receptor causes dissociation and activation of the GTP- 
binding protein (Gs, stimulatory), which interacts with and activates 
adenylate cyclase. Adenylate cyclase catalyses the formation of cyclic AMP 
which activates protein kinase-A which in turn acts to phosphorylate 
hormone-sensitive lipase. The end result is the release of fatty acids and 
glycerol into the peripheral circulation. The rate-limiting step in lipolysis is 
the initial hydrolysis of stored triglycerides by hormone-sensitive lipase. 
There are other hormones which will also activate the /7-adrenergic
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receptor, including growth hormone and the glucocorticoids. It has been 
suggested that growth hormone may enhance the transduction of the /?- 
adrenergic signal by increasing the number of /?-adrenergic receptors 
(Vernon, 1992). Other studies have failed to reveal an effect of growth 
hormone on the a2-adrenergic receptor (Vernon, 1992). Glucocorticoids will 
increase the ^-adrenergic receptor number in rats, (Giudicelli et aL, 1989), 
however, associated with this is a decrease in maximum adenylate cyclase 
activity.
In ruminants, catecholamines inhibit lipogenesis (Vernon, 1980) and this is 
associated with a decrease in the activity of acetyl CoA carboxylase, an 
enzyme essential for lipogenesis. Changes in the phosphorylation state 
have been shown to play a major role in the acute control of acetyl CoA 
carboxylase (Vernon, 1992), but the mechanism by which the 
catecholamines induce these changes remains to be determined.
Mobilisation of lipid stores requires a close interaction between adrenergic 
actions on adipose tissue blood flow and those on lipolysis. The 
sympathetic innervation of white adipose tissue is mainly of the vasculature 
rather than the adipocytes (Fredholm, 1985). Stimulation of a-adrenergic 
receptors results in vasoconstriction and activation of ^-adrenergic 
receptors results in vasodilation. It is considered that catecholamines act 
mainly on the adipocytes while neuronal effects on lipolysis are indirect and 
due to changes in blood flow to adipose tissue (Webber and Macdonald,
1993). Lands et aL, (1967), reported that lipolysis was mediated by 
stimulation of the £1 -adrenergic receptor and that vasodilation was 
mediated by stimulation of the /?2-adrenergic receptors. They also reported 
that noradrenaline preferentially activates the /?1 -adrenergic receptor while 
adrenaline is a potent agonist for the /?2-adrenergic receptor. This suggests 
that direct effects on lipolysis are largely due to noradrenaline and effects 
on vasodilation are largely due to adrenaline.
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2.7.3. Protein Metabolism
Catecholamine effects on protein metabolism are not as well documented 
as those on carbohydrate and lipid metabolism. Infusion of adrenaline into 
humans decreased plasma amino acid levels, and this was especially so for 
the branch chained amino acids (Shamoon et a!., 1980). The response to 
adrenaline was thought to be mediated via the ^-adrenergic receptor 
because the decrease in amino acid levels was prevented by the 
administration of propranolol, a nonselective ^-antagonist. The effect on 
protein metabolism was similar to that of insulin. This was observed by 
Miles et al. (1984), who demonstrated a decreased rate of proteolysis 
during adrenaline infusion in humans which is similar to the response 
induced by insulin. However, unlike insulin there was no stimulation of 
protein synthesis (Castellino et a!., 1990; Mathews et a!., 1990). 
Adrenaline acts to increase the splanchnic uptake of gluconeogenic amino 
acids and also to increase the production of alanine from muscle. Branched 
chain amino acid levels within the muscle decreased after adrenaline 
treatment, indicating reduced protein synthesis (Del Prato et a!., 1990).
Adrenaline infusion for 8 days has been reported to have anabolic effects 
in rats (Racotta et al., 1986). In this experiment, growth rate was 
suppressed for 8 days during the infusion and then anabolic processes 
returned to normal once the infusion was stopped. The infusion of 
noradrenaline also depressed growth rate in these rats but returned to 
normal after the end of the infusion.
Little is known of the effects of catecholamines on growth in ruminants. 
Oddy et al. (1987) showed no change in proteolysis in the hindlimb muscle 
of lambs during the infusion of adrenaline, but the rate of protein synthesis 
was reduced.
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2.8. Activation of the Sympathetic Nervous System and Adrenergic 
Antagonists
Adrenergic blocking agents, have been used in many studies to determine 
the metabolic responses mediated by the activation of the sympathetic 
nervous system. These molecules bind to the receptors without eliciting a 
response and prevent binding of the endogenous ligand. Early studies were 
chiefly concerned with the metabolic action of adrenaline and 
noradrenaline. The aim of these studies was to determine the metabolic 
responses elicited by activation of the a-adrenergic receptors and those 
elicited by activation of the ^-adrenergic receptors.
2.8.1. Catecholamine Infusions
A classical study by Bassett (1970) in sheep demonstrated increased 
plasma levels of glucose, lactate, and free fatty acids (FFA) after a 30 
minute intravenous adrenaline infusion. Intravenous infusion of 
noradrenaline for 60 min increased plasma FFA levels only, but had only a 
small effect on plasma glucose and lactic acid concentrations. Similar 
effects on plasma glucose, lactate, and free fatty acid levels have been 
reported in sheep after a 3 hour intravenous infusion of adrenaline 
(Halmagyi et a!., 1967). These workers also observed increases in pyruvic 
acid, systemic arterial pressure, cardiac output and oxygen consumption. In 
sheep, an intravenous adrenaline infusion for 3 hours increased heart rate, 
and progressively lowered arterial blood pressure during the infusion period 
(Wood et a\., 1979).
These physiological and endocrine changes have also been reported in 
other species. Both adrenaline and noradrenaline infusions increased plasma 
FFA's and glycerol levels in fed and fasted cattle (Blum et al., 1982). 
Adrenaline infusion also increased glucose and lactic acid concentrations in 
both groups. A lower energy balance in the fasted group altered the
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metabolic response to the adrenaline infusion; FFA levels were more 
pronounced in the starved group compared to the control, while the rise in 
both glucose and lactic acid were blunted. In a more recent study, 
adrenaline infusion increased FFA levels and glucose concentrations in 
steers (Frohli and Blum, 1988). Noradrenaline infused into steers increased 
glucose levels but not FFA concentrations and this was in conflict with the 
observation made by Bassett (1970) in sheep. Similar to the studies in 
sheep and cattle, adrenaline increased plasma glucose, free fatty acids and 
glucagon in the rabbit (Knudtzon, 1984). In humans, adrenaline infusion 
resulted in increased systolic and diastolic blood pressure and heart rate 
(Hjemdahl et a!., 1983). In the same study, noradrenaline infusion increased 
systolic and diastolic blood pressure, but decreased heart rate. Infusions of 
both catecholamines blunted the insulin response to increased energy 
availability in sheep (Bassett, 1970) and steers (Frohli and Blum, 1988). In 
sheep there was no change in insulin concentrations during the 
catecholamine infusion (Bassett, 1970), while insulin concentrations 
decreased in steers during the infusion (Frohli and Blum, 1988). A decrease 
in circulating insulin levels has also been reported for rabbits following 
adrenaline infusion (Knudtzon, 1984).
2.8.2. cr-Adrenergic Receptor Antagonism During Catecholamine Infusion
Propranolol HCI, a non-selective /^-adrenergic receptor antagonist, and 
phentolamine methane-sulfonate, a non-selective a-adrenergic receptor 
antagonist, have been used to investigate the metabolic changes associated 
with adrenergic receptor blockade (Bassett, 1970; Frohli and Blum, 1988; 
and Blum et a!., 1982).
Phentolamine infusion followed by either adrenaline infusion (Bassett, 
1970; Frohli and Blum, 1988) or noradrenaline infusion, (Frohli and Blum, 
1988) increased plasma insulin levels. As a result, there was no rise in 
plasma glucose levels following either the adrenaline or noradrenaline
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infusion. Bassett (1970), reported a decrease in plasma FFA levels 
following phentolamine infusion whereas levels increased in the studies of 
Blum et al. (1982) and Frohli and Blum, (1988). An increase in FFA levels 
following adrenaline stimulation in animals having only the a-adrenergic 
receptors blocked, has also been reported for the rabbit (Knudtzon, 1984). 
Pre-treatment of rabbits with either prazosin, an a1-receptor antagonist or 
yohimbine, an a2-receptor antagonist, failed to prevent an increase in either 
FFA or insulin following adrenaline infusion (Knudtzon, 1984). However, 
blockade of either the a1- or a2-receptors prevented the adrenaline induced 
rise in plasma glucose and glucagon. The a-adrenergic receptors of sheep 
can be blocked with the non specific a-antagonist phenoxybenzamine. In 
sheep, adrenaline infusion increased plasma glucose, oxygen consumption, 
and cardiac output and these effects were not prevented by pre-infusion 
with phenoxybenzamine, however, the increase in the systemic blood 
pressure following adrenaline infusion was prevented (Halmagyi et aL, 
1967). A decrease in arterial pressure following pre-infusion with 
phenoxybenzamine has also been reported in the sheep by Wood et al. 
(1979), although in their study, arterial pressure was more marked after the 
start of the adrenaline infusion.
2.8.3. /?-Adrenergic Receptor Antagonism During Catecholamine Infusion
Pre-infusion with the non-selective ^-receptor antagonist propranolol HCI 
prevented the adrenaline induced rise in plasma lactic acid and FFA's but 
failed to prevent the rise in plasma glucose in sheep (Bassett, 1970) and 
steers (Blum et a!., 1982; Frohli and Blum, 1988). When phentolamine and 
propranolol were infused into steers followed by adrenaline (Frohli and 
Blum, 1988) plasma glucose levels decreased and FFA levels remained 
constant. A combined infusion of phenoxybenzamine or yohimbine (a- 
antagonists) and propranolol, followed by adrenaline, prevented the rise in 
plasma FFA's, and plasma glucose in the sheep (Halmagyi et a!., 1967) and 
rabbit, Knudtzon (1984). In the study of Halmagyi et al. (1967) the pre­
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infusion of the same antagonists also prevented the adrenaline induced 
increase in cardiac output, systemic blood pressure, oxygen consumption, 
plasma lactic acid and plasma pyruvic acid. In these studies selective or 
non selective ^-adrenergic blockade failed to affect the insulin response to 
adrenaline infusion. In humans, the -selective antagonist metoprolol has 
been shown to partially block the adrenaline-induced rise in blood pressure 
and heart rate, while propranolol, the non-selective ^-antagonist has been 
shown to reduce both blood pressure and heart rate (Hjemdahl, et a!.,
1983).
2.8.4. Summary of Sections 2.8.1 to 2.8.3
Intravenous infusion with catecholamines has pronounced physiological 
effects on energy substrate mobilisation, cardiovascular function and 
haemodynamics. The infusion of adrenaline results in increased circulating 
levels of glucose, lactate, FFA's glycerol and glucagon, while increasing 
blood pressure, heart rate, cardiac output and oxygen consumption. 
Infusion of noradrenaline results in increased circulating levels of glucose, 
FFA's and glycerol while increasing blood pressure but decreasing heart 
rate. When both catecholamines are infused the insulin response is blunted 
in respect to an increase in energy availability. The a-adrenergic receptor 
mediates glucose and glycogen release while inhibiting insulin secretion. In 
addition the a-adrenergic receptor inhibits systolic blood pressure. The /?- 
adrenergic receptors mediate FFA and lactic acid release as well as 
modulating blood pressure and cardiac output
2.8.5. Problems Associated with Exogenous Catecholamine Infusion
Webber and Macdonald (1993), have made reference to one of the major 
problems involved with intravenous infusions of catecholamines; that is the 
failure to mimic the normal route of delivery. This is especially so for 
noradrenaline which mainly functions as a neurotransmitter within the
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sympathetic nervous system and whose effects are at the local tissue level. 
This is important when interpreting data from infusion studies, especially in 
relation to metabolism.
Himms-Hagen (1967) in his extensive review on sympathetic regulation of 
metabolism in various species has also cast doubt upon the interpretation 
of some aspects of infusion studies using catecholamines. He states, "that 
different effects from the intravenous infusion of catecholamines may be 
produced by large and small doses of adrenaline and noradrenaline, the 
same dose given by different routes, or the same dose in animals of 
different species, different ages, or different environmental experience".
Other difficulties which he proposed from his review were the use of 
adrenergic antagonists. These agents block the actions of exogenous 
noradrenaline but they may not always block the actions of endogenous 
noradrenaline liberated from the nerve endings.
2.8.6. Stimulation of the Sympathetic Nervous System by the 
Sympathomimetic amine Tyramine Hydrochloride
Tyramine hydrochloride (HCI) can indirectly act as a sympathomimetic 
amine because it results in displacement of noradrenaline from it's storage 
vesicles, (Poch and Kopin, 1966). Tyramine is actively transported into the 
sympathetic nerve endings and acts as a competitive inhibitor of 
noradrenaline uptake, (Burgen and Iverson, 1965). Active uptake of 
tyramine HCI into the noradrenaline storage vesicles displaces noradrenaline 
into the cytosol. Noradrenaline accumulates in the presence of tyramine 
HCI, and because it is not degraded by monoamine oxidase, it remains 
physiologically active, and in turn, it stimulates the noradrenergic receptors, 
(Usdin and Snyder, 1973). Thus tyramine HCI is therefore used in 
experimental studies to stimulate the sympathetic nervous system by 
increasing endogenous release of noradrenaline from the neurones.
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Tyramine HCI and l-tyramine infused into humans resulted in decreased 
heart rate and increased systolic blood pressure (Scriven et aL, 1983). The 
physiological responses to both treatments were similar but plasma 
noradrenaline concentrations were significantly lower in the tyramine 
infused subjects. Interestingly, the lower peripheral noradrenaline levels, 
and the associated increase in blood pressure in the tyramine HCI infused 
subjects were similar to both the endogenous noradrenaline levels and the 
increase in blood pressure stimulated by cigarette smoking (Cryer et a!., 
1976). Tyramine HCI infusion or injection will increase blood pressure in 
foetal sheep (Walker and Schuijers, 1989) and newborn lambs (Lumbers et 
a!., 1980). When tyramine HCI was perfused into the isolated rat pancreas 
the insulin secretion rate declined and the glucagon secretion rate increased 
(Hirose et aL, 1994), The secretion rates of both hormones were similar to 
that when noradrenaline was used to perfuse the pancreas.
2.8.7. Sympathomedullary Response To Exercise
Plasma catecholamine concentrations have been reported to increase in 
response to physical exercise in man (Christensen and Galbo, 1983; Kjaer 
et aL, 1987), calves (Blum and Eichinger, 1988), sheep (Palmer et aL,
1984), and rats (Scheurink et aL, 1989a). This increase is the result of an 
increased rate of release of the hormones rather than a reduced uptake rate 
into the tissue, (Christensen and Galbo, 1983). The concentration of 
catecholamines released is dependent upon both the intensity and duration 
of the exercise, (Christensen and Galbo, 1983; Kjaer et a!., 1987; Palmer et 
aL, 1984). Both static (isometric) and dynamic exercise stimulate the 
release of noradrenaline and adrenaline, (Kjaer et aL, 1987). The quantity 
of adrenaline released during static exercise is greater than the quantity of 
noradrenaline released while the reverse is true during dynamic exercise, 
(Kjaer et aL, 1987).
In man, intensive exercise results in increased sympathetic nervous
22
activity which increases blood flow and oxygen supply to the working 
muscles and away from areas of less need, such as resting skeletal 
muscles, kidneys, and the splanchnic bed (Christensen and Galbo, 1983). 
In the sheep, the blood flow away from the splanchnic tissues is not as 
great as in man and it has been suggested that this is an adaptation by the 
sheep to maintain gut function, thereby allowing normal rates of nutrient 
absorption (Pethick eta!., 1991).
During intensive exercise, activation of the sympathetic nerves supplying 
the islets of Langerhans inhibits insulin release from the pancreas (man; 
Christensen and Galbo, 1983, cattle; Blum and Eichinger, 1988, rats; 
Scheurink et a/., 1989 (b), sheep Brockman and Halvorson, 1981). Such 
declines in plasma insulin can be prevented if phentolamine is infused prior 
to a period of exercise (Brockman and Halvorson, 1981). These 
observations suggest, that in sheep, the exercise-induced decline in plasma 
insulin is mediated via a-adrenergic activity. The decline in plasma insulin 
concentrations in man following the initiation of intensive exercise, 
promotes the mobilisation of energy stores and this results in the 
subsequent release of glucose and FFA's, (Christensen and Galbo, 1983). 
Increases in both glucose levels and FFA's during exercise have also been 
shown for the rat, (Scheurink et al., 1989b), cattle, (Blum and Eichinger, 
1988), dogs, (Issekutz, 1978) and sheep, (Brockman and Halvorson, 1981, 
and Palmer et a!., 1984).
2.8.8. a-Adrenergic Receptor Antagonism During Exercise
Blockade of the a-adrenergic receptors increases the rate of insulin release 
from the pancreas, (man: Kjaer, et aL, 1987; sheep: Brockman and 
Halvorson, 1981). In a study by Scheurink et aL, (1989b), a single dose of 
yohimbine, (an a2-adrenergic receptor selective antagonist), given before 
exercise elevated plasma insulin in the rat. In the same study, the exercise 
induced rise in plasma glucose was inhibited using yohimbine, but there
23
was no effect on plasma FFA's, as the levels remained elevated in response 
to exercise. Phentolamine infused into sheep throughout an exercise period 
reduced both plasma glucose and glycogen levels (Brockman and 
Halvorson, 1981).
2.8.9. /^-Adrenergic Receptor Antagonism During Exercise
Exercise-induced increases in energy availability following the release of 
catecholamines can be blocked or inhibited by adrenergic receptor 
antagonists. In man, blocking ^-adrenergic receptors will prevent the 
increase in fat catabolism, turnover rate of plasma FFA's and the increases 
in plasma FFA's and glycerol concentrations, (Christensen and Galbo, 
1983). In the rat, the /?2-antagonist, ICI 118551 given as a single dose 
before the onset of an exercise period reduces the rise in both plasma 
glucose and FFA's (Scheurink et a/., 1989b). Similar effects were reported 
for the sheep by Brockman and Halvorson (1981). In their study propranolol 
HCI infused prior to an exercise period prevented the rise in plasma glucose 
and plasma glucagon. Propranolol HCI similarly administered to dogs 
prevented the rises in FFA's, glucose and lactate (Issekutz, 1978). In all 
these studies /7-adrenergic receptor blockade prevented any rise in plasma 
insulin. Insulin levels remained either constant or declined during the period 
of exercise.
2.8.10. Summary of Sections 2.8.7. to 2.8.9.
Exercise stimulates the release of adrenaline and noradrenaline which, 
inturn stimulates plasma glucose and FFA release. In addition, exercise 
increases blood flow and oxygen supply to the working muscle. During 
exercise the cr-adrenergic receptor mediates glucose and glycogen release 
and inhibits insulin secretion. Whereas the /^-adrenergic receptor mediates 
FFA and glycerol release as well as stimulating plasma glucose, glucagon 
and lactate levels.
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2.8.11. Sympathomedullary Response to Surgery
Stimulation of noradrenaline and adrenaline release during and following 
surgery and anaesthesia has been demonstrated conclusively by a number 
of investigators (humans: Felländer et aL, 1994; Bickel et al., 1991; 
Tonnesen et a!., 1984; Halter and Pflug 1980; and Halter et a!., 1977; rat: 
(Roizen et aL, 1974). For the rat, the total plasma catecholamine 
concentration decreases as the quantity of anaesthetic agent administered 
increases (Roizen et al., 1974). In their study, plasma adrenaline levels 
decreased at the time of anaesthesia induction and then rose towards the 
end of anaesthesia and surgery, and remained elevated during the recovery 
period following surgery. In similar studies plasma noradrenaline either 
declined (Bickel et a!., 1991; Roizen et a!., 1974) or remained constant 
after the induction of anaesthesia (Tonnesen et al., 1984; Halter and Pflug, 
1980; and Halter et a!., 1977) and then increased during the surgical 
procedure and into the recovery period. In contrast, Felländer et al., (1994) 
found that plasma levels of noradrenaline and adrenaline increased 
throughout the surgical procedure but did not decline following induction of 
general anaesthesia. This difference is likely due to the anaesthetic agent 
used. Fellander et al., (1994) maintained patients under general anaesthesia 
with nitrous oxide in oxygen whereas in the other studies, the general 
anaesthetic agent used was halothane.
Hormone and metabolic responses to anaesthesia and surgery have also 
been extensively studied in man, (Felländer et a!., 1994; Bickel et a!., 1991; 
Hagen et a!., 1980; Halter and Pflug, 1980, and Clarke, 1970) and the 
horse (Robertson et a!., 1990). Regardless of which anaesthetic agent was 
used to induce anaesthesia, plasma glucose concentrations increased. The 
rise in glucose is related to the severity of the surgical procedure. Clarke 
(1970) reported higher glucose levels during intra-abdominal surgery when 
compared to body surface surgery while anaesthesia alone produced no 
significant change in glucose concentrations. In humans, insulin levels have
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been reported to be either suppressed by anaesthesia followed by a slow 
increase during surgery (Halter and Pflug, 1980) or to remain constant 
throughout anaesthesia and surgery (Felländer et a/., 1994). A significant 
rise in plasma insulin 10 minutes after induction of anaesthesia followed by 
a decline was reported by Robertson et al., (1990) for the horse.
Lipolytic activity has been shown to increase continuously from the start 
of anaesthetic induction until the end of surgery in humans (Felländer et a!.,
1994). In contrast, plasma FFA levels in the horse declined during surgery 
and remained suppressed until the recovery period (Robertson et a!., 1990). 
Prolactin levels increased before skin incision (Bickel et a!., 1991), or after 
induction with general anaesthesia (Hagen et al., 1980). In both these 
studies prolactin levels remained high until the recovery period. Growth 
hormone has been reported to increase during surgery and recovery in 
humans (Hagen et a!., 1980, Noel et a!., 1972 and Ichikawa et a!., 1971). 
Noel et al. (1972) reported that the rise in growth hormone during surgery 
occurred later than did the rise in prolactin and these findings are in 
agreement with those of Ichikawa and co-workers (1971) who found that 
the peak in growth hormone concentration occurred 30 minutes after skin 
incision. Human studies have shown that vasopressin levels and diastolic 
blood pressure increase during surgery but systolic blood pressure and 
heart rate remain unchanged (Bickel et a!., 1991). In the study of Halter et 
al. (1977), arterial pressure increased as catecholamine concentrations 
increased. There was a positive relationship between catecholamine levels 
and blood pressure during surgery (Halter et al.f 1977A
Epidural analgesia administered to humans with or without general 
anaesthesia alters the neuroendocrine, endocrine and metabolic responses 
to surgery when compared to general anaesthesia alone (Tonnesen et al., 
1984; Halter and Pflug, 1980; and Hagen et a!., 1980). Plasma adrenaline 
and noradrenaline concentrations remained at pre-operative levels 
throughout the surgery and the period immediately post-surgery (Tonnesen
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et al. 1984; Halter and Pflug 1980). Halter and Pflug (1980) observed no 
changes in glucose and insulin concentrations during surgery. Under general 
anaesthesia Hagen et al. (1980) reported no increase in plasma prolactin 
concentrations but, when patients were administered both epidural 
analgesia and general anaesthetic (Tonnesen et a!., 1984), prolactin levels 
increased during both anaesthesia induction and surgery. Growth hormone 
concentrations were significantly lower during surgery in the patients given 
epidural anaesthesia Hagen et al. (1980), however, during the post 
operative period growth hormone levels increased.
2.8.12. Summary of Section 2.8.11.
General anaesthesia and surgery stimulates the release of adrenaline and 
noradrenaline as well as increasing plasma glucose and FFA levels and 
blood pressure. In addition, general anaesthesia and surgery stimulate the 
release of prolactin, growth hormone, and vasopressin while either 
stimulating or inhibiting insulin secretion. In contrast epidural blockade 
prevents the rise in adrenaline and noradrenaline as well as preventing the 
rise in plasma glucose and circulating growth hormone levels.
2.9. The Hypothalamic-Pituitary-Adrenal Axis
The components of this axis are the hypothalamus, the pituitary gland and 
the adrenal gland and together they function as a hierarchically-integrated 
feedback system (Seeman and Robbins, 1994). Stimulation of the axis 
results in the rapid release of the glucocorticoids from the adrenal cortex 
into the peripheral circulation (Munk et a!.f 1984). Glucocorticoids, as their 
name implies, affect carbohydrate metabolism and many other physiological 
functions; these include stimulation of hepatic gluconeogenesis, inhibition 
of glucose uptake by peripheral tissues, suppression of inflammation, 
enhanced secretion of a water load, as well as inhibition of the release of 
some hormones and neuropeptides (Munk et at., 1984). The major
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glucocorticoid for some mammal species including the sheep is cortisol, but 
cortisone and corticosterone are also present (Baxter and Rousseau, 1979) 
while corticosterone is the major glucocorticoid in rodents and birds 
(Buttemer et a!., 1991).
2.9.1. Biosynthesis of Adrenocortical Hormones
The adrenal cortex is the site of cortisol synthesis. Aldosterone is also 
synthesised in the adrenal cortex and is referred to as a mineralocorticoid 
because it affects mainly salt and water metabolism (Seyle, 1946). The 
adrenal cortex is anatomically divided into three zones; the glomerulosa 
(outer zone), the fasciculata (central zone) and the reticularis (inner zone). 
The glucocorticoids are synthesised in the zona fasciculata and the 
mineralocorticoids in the zona glomerulosa (Dallman et a!., 1987). These 
hormones are structurally related to each other and are derived from 
cholesterol. They have a steroid nucleus consisting of three cyclohexane 
rings designated A, B and C and a cyclopentane ring designated as D. A 
system of nomenculture that numbers the positions on the rings identifying 
modifications at specific positions is widely used. Two structural types of 
steroids are formed in the cortex, these are termed C21 or C19 steroids 
depending upon the total number of carbon atoms in the molecule. C21 
steroids have a 2-carbon side chain attached at position 17 of the D ring 
while C19 steroids have a keto- or hydroxyl group at position 17. The C21 
steroids which also have a hydroxyl group at position 17, in addition to the 
side chain, are called 17-hydroxycorticoids or 17-hydroxycorticosteroids. 
Both the mineralocorticoids and the glucocorticoids are C21 steroids.
Acetate is the major precursor for the synthesis of cholesterol. Preformed 
cholesterol is converted to pregnenolone which is the precursor from which 
other steroid hormones are synthesised. Progesterone formed from 
pregnenolone is the precursor for the adrenocorticoids. Different 
biosynthetic pathways lead to the formation of both glucocorticoids and
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mineralocorticoids and while there are similarities in the pathways there are 
also different steps (Baxter and Rousseau, 1979). The rate limiting step in 
the synthesis of the glucocorticoids is the conversion of cholesterol to 
pregnenolone (Baxter and Rousseau, 1979).
Adrenocorticotropic hormone (ACTH) released from the pituitary 
stimulates both the synthesis and secretion of adrenocorticoids by 
catalysing a step in the conversion of cholesterol to pregnenolone (Ganong, 
1971). Continued exposure to high levels of ACTH levels enhances the 
secretion of the glucocorticoids, but depresses the secretion of the 
mineralocorticoids. While ACTH may be the only secretagogue that drives 
the fasciulata cells, there are other substances which synergise with ACTH 
to potentiate the rate of steroidogenesis (Dallman et al., 1987).
2.9.2. Glucocorticoid Metabolism
Ninety percent of the circulating cortisol is normally bound to a specific 
plasma alpha globulin called corticosteroid-binding globulin (CBG) or 
transcortin and binds to a lesser degree to serum albumin. Binding to CBG 
does not appear to be necessary for glucocorticoid action as low 
concentrations of hormone dissolve in plasma and are physiologically 
effective (Baxter and Rousseau, 1979). Hormone bound to CBG is 
essentially inactivated. While CBG does not appear to be necessary for 
glucocorticoid action, it probably influences the plasma kinetics of the 
glucocorticoid response or steroid metabolism (Baxter and Rousseau, 
1979). During "non activated" periods most of the plasma cortisol is 
bound to the CBG. When secretion of cortisol is increased, the rise in 
plasma cortisol is due to an increase in the amount of unbound cortisol 
(Ganong, 1971).
Free cortisol is rapidly removed from the circulation (Cope, 1972). 
Estimates of the biological half life vary from four hours (Grodsky, 1983) to
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one hour (Cope, 1972). Cope (1972) reported that cortisol is extensively 
metabolised in a number of tissues. Estimates of the amount secreted into 
urine range from 2% (Cope, 1972) to 70% (Grodsky, 1983). The variation 
could be due to the amount of cortisol bound to CBG during different 
physiological states as protein binding reduces the amount of free cortisol 
in urine (Ganong, 1971).
The liver is the principal site of glucocorticoid catabolism (Cope, 1972; 
Ganong, 1971). Degradation of cortisol takes place by ring reduction of the 
3-ketone group by NADPH-requiring hydrogenases (Grodsky, 1983). Some 
cortisol is converted to cortisone in the liver. Little of this cortisone enters 
the circulation as it is reduced and then conjugated (Ganong, 1971). These 
conjugates enters the circulation and are then excreted in the urine. 
Cortisone, however, is not secreted by the adrenal cortex.
2.10. Glucocorticoid Receptors
The glucocorticoid hormone receptors are ubiquitous throughout the body 
i.e. they are found in every mammalian tissue (Ballard et aL, 1974). The 
glucocorticoid receptors are a member of the superfamily of steroid/thyroid 
hormone nuclear receptors which control differential gene expression by 
acting as an enhancer of specific gene transcription (Evans, 1988; Beato,
1989). The steroid is thought to cross the plasma membrane and to 
penetrate the cell by simple diffusion but this is not considered to be rate 
limiting (Baxter and Rousseau, 1979). The steroid binds reversibly with high 
affinity to complementary intracellular receptor proteins. The steroid 
receptor is a polypeptide chain and is folded into 3 distinct domains: the 
carboxyl-terminal domain which binds the hormone, the middle domain 
which binds to DNA and an amino terminal domain which activates gene 
transcription. Receptor binding initiates a conformational change of the 
receptor and this process is dependent on both temperature and ionic 
strength (Baxter and Rousseau, 1979). These conformational changes
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following steroid binding to the receptor increase the affinity of the complex 
for deoxyribonucleic acid (DNA), result in binding to specific genes and 
regulates their transcription. A small number of genes are activated or 
occasionally suppressed by the glucocorticoids and other steroids. Most of 
the activated steroid receptors bind to sites which do not initiate 
transcription. In a study using cultured rat hepatic cells which were 
exposed to cortisol the rate of synthesis of only 6 out of 1000 
distinguishable proteins increased, while the rate of synthesis of one protein 
decreased (Alberts et aL, 1989). Selectivity of gene expression is achieved 
by restricting the expression of the different receptors in specific cells and 
tissues. The chromatin structure of each cell type is uniquely organised and 
different sets of genes in different cells will be accessible to the hormone 
receptor complex (Evans, 1988). Steroid hormone receptors can bind to an 
inhibitor protein, heat-shock protein hsp90. Binding of hsp90 blocks the 
DNA binding domain of the receptor. When the hormone binds to the 
receptor the inhibitor protein dissociates and this leads to receptor 
activation.
Modulation of gene expression results in transcription of specific mRNAs 
(Sarker et al.f 1976). The proteins that these mRNAs encode are 
responsible for eliciting the cellular effects attributed to the glucocorticoids. 
The glucocorticoid regulated proteins are frequently enzymes that catalyse 
reactions responsible for the observed metabolic changes. Because the 
hormone-initiated events involve transcription and translation, there can be 
a lag-time before physiological effects are detected (Christy, 1971). 
Therefore, some glucocorticoid actions may persist for long periods of time. 
The rate of degradation of the components in the process following 
receptor stimulation can vary substantially, and this can in turn influence 
the duration of the glucocorticoid effects. Thus the physiological 
consequences can continue for some time after the steroid stimulus is 
removed (Baxter and Rousseau, 1979).
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2.11. Metabolic Effects of the Glucocorticoids
Ingle (1952) recognised the involvement of the glucocorticoids in a wide 
variety of metabolic processes. From these observations he postulated that 
the glucocorticoids act as hormones which permit key metabolic processes 
to achieve maximal rates but by themselves have little effect. Some of the 
metabolic processes in which the glucocorticoids have a "permissive" role 
include glycogenolysis, gluconeogenesis, lipolysis and glycogenesis.
The effects of glucocorticoids on intermediary metabolism have been 
demonstrated for a number of tissues including the liver, muscle, skin, 
adipose and lymphoid tissues. Effects on glucose and protein metabolism 
result in hyperglycaemia and nitrogen wasting, respectively (Baxter and 
Rousseau, 1979).
2.11.1. Effects on Carbohydrate Metabolism
The glucocorticoids act permissively to influence the actions of glucagon 
and adrenaline in inducing gluconeogenic enzymes in the liver. 
Glucocorticoids act to increase the availability of amino acid substrates for 
liver gluconeogenesis (Baxter and Rousseau, 1979). This was demonstrated 
in rats by Long et a/. (1940) who found that the glucocorticoids influence 
gluconeogenesis by stimulating the release of amino acids from peripheral 
tissues. This was confirmed in the study of Caldwell et al. (1977) when 
they reported that adrenalectomy reduced the amount of glucogenic and 
branched chain amino acids released from skeletal muscle and that 
glucocorticoids could reverse this effect. The increase in the rate of 
gluconeogenesis observed after administration of cortisol to sheep (Reilly 
and Black, 1973) was associated with an increase in utilisation of amino 
acids.
Hormones such as adrenaline which act to influence lipolysis and
/
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glycogenolysis and act via cyclic AMP have a reduced effectiveness in 
adrenalectomised rats (Exton, et aL, 1972). This decrease in 
responsiveness is a result of a decreased responsiveness to cyclic AMP 
rather than a reduction in cyclic AMP production (Exton et aL, 1972). In 
adrenalectomised rats which are adequately fed, the basal rate of 
gluconeogenesis is not impaired but the response to both glucagon and 
catecholamines is diminished (Exton et al.f 1972). However, in fasted 
adrenalectomised rats there is a significant reduction in the basal rate of 
hepatic gluconeogenesis but the administration of glucocorticoids will 
reverse this effect (Exton et aL, 1973). Cortisol will accentuate the state of 
hyperglycaemia produced by both glucagon and adrenaline (dogs; Eigler et 
aL, 1979; sheep Brockman and Laarveld, 1986). The glucocorticoids have 
been shown to increase glucose concentrations in both fed (Reilly and Ford, 
1971) and fasted (Bassett, 1968) sheep, and this is associated with a 
reduction in glucose production and peripheral tissue glucose utilisation.
Changes in the gluconeogenic flux which occur following steroid depletion 
and replenishment in the rat have been shown to involve two enzymes, 
these being phosphoenolpyruvate carboxylase (Exton et aL, 1973) and 
glucose-6-phosphatase (Ashmore and Weber, 1959). Glucocorticoids affect 
the rate of synthesis of phosphoenolpyruvate carboxylase (which is 
involved in the formation of glucose from pyruvate) at the level of 
transcription (Wicks and McKibbin, 1972).
The rate of gluconeogenesis can also be modulated by the glucocorticoids 
acting to decrease the sensitivity of peripheral tissues to insulin. Barseghian 
and Levine (1980) reported that corticosterone inhibited the secretion of 
insulin in the rat following both glucose and alanine administration and 
enhanced the secretion of glucagon. In the same study phentolamine, a 
non-selective a-adrenergic receptor antagonist, diminished the ability of 
corticosterone to inhibit insulin secretion. These observations led the 
authors to suggest that the inhibition of insulin secretion was related to
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activation of the a-adrenergic receptors. Cortisol administration will also 
reduce the insulin response in sheep (Bassett and Wallace, 1967) and man 
(Simmons eta!., 1984).
Some glucocorticoids have been reported to influence liver glycogen 
deposition in both fed and fasted rats (Long et al.f 1940). Hornbrook et al., 
(1966) reported that for rats, cortisol increased the conversion of glycogen 
synthetase from it's inactive form to its catalytically active form. When rats 
and mice were exposed to stress that increased plasma corticosterone the 
rate of glycogen accumulation in the liver increased as did the conversion 
of hepatic glycogen synthase from it's inactive to it's active state (Oyama 
and Platt, 1964; Oyama et al., 1966; and Oyama and Daligcon, 1967). 
Hornbrook et al. (1966) reported a lower level of hepatic glycogen synthase 
in it's active form and a reduced capacity for hepatic glycogen storage in 
the adrenalectomised fed rat compared to normal rats.
2.11.2. Effects on Lipid Metabolism
The glucocorticoids stimulate lipolysis and promote the lipolytic action of 
adrenaline in adipose tissue (Baxter and Rousseau, 1979). However, the 
role of the glucocorticoids in lipid metabolism appears to be ambiguous. In 
patients with Cushings syndrome the hypersecretion of glucocorticoids 
results in obesity but the adipose deposition sites are selective (e.g. Buffalo 
hump on neck) (Cushing, 1932). Humans given large amounts of 
glucocorticoids have increased fat deposition (Ingle, 1943). In contrast, the 
studies of Dreiling et al. (1962) and Nayak et al. (1962) show increased 
FFA release 1-2 hours after glucocorticoid administration to humans.
In vivo and in vitro studies in the rat have shown modulation of lipolysis 
by the glucocorticoids (Leboeuf et al., 1962). In the studies of Fain (1962), 
starvation induced FFA release which was impaired by adrenalectomy and 
restored by treatment with glucocorticoids. In the same study,
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adrenalectomy also diminished the lipolytic action of both the 
catecholamines and growth hormone as FFA release was reduced and 
glucose utilisation increased in the adipose tissue of the adrenalectomised 
rats (Fain, 1962). Significant increases in FFA release were also reported 
when growth hormone and dexamethasone, a synthetic glucocorticoid, 
were administered together to cultures of adipose tissue from control rats 
compared to treatment with growth hormone alone. in vivo dexamethasone 
treatment of sheep adipose tissue increased the response and sensitivity to 
isoproterenol, a synthetic adrenergic agonist (Finley et aL, 1990).
As with the effects on glycogenolysis, lipolytic glucocorticoid potentiation 
may not be mediated through changes in cAMP accumulation (Fain, 1979). 
Glucocorticoids increase the ^-adrenergic receptor numbers in rat adipose 
tissue but decrease adenylate cyclase activity (Giudicelli et al.r 1989; Ross 
et aL, 1989). A decrease in adenylate cyclase activity in adipose tissue 
following dexamethasone administration and followed by isoproterenol 
treatment has also been reported for the sheep (Finley et aL, 1990).
Munk et aL (1984), suggested that the prime metabolic role of the 
glucocorticoids is the antagonistic action on insulin secretion. As previously 
discussed, the glucocorticoids have been shown to reduce insulin secretion 
in the rat (Barseghian and Levine, 1980), sheep (Bassett and Wallace, 
1967) and man (Simmons et aL, 1984). Dexamethasone will inhibit 
lipogenesis in the presence of low concentrations of insulin, however, at 
high concentrations of insulin, dexamethasone synergises with insulin and 
thereby increases the rate of lipogenesis (Walton et aL, 1986). In 
ruminants, insulin influences lipid metabolism altering the release of FFA's 
(Brockman and Laarveld, 1986). A reduced rate of lipolysis decreases the 
amount of FFA's available to the liver for oxidation to ketone bodies. In 
vivo studies in sheep (West and Passey, 1967) demonstrated the anti­
lipolytic nature of insulin. Adipose tissue of ruminants has been shown to 
be well supplied with insulin receptors and they have similar properties to
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those of other species (Vernon and Sasaki, 1991).
2.11.3. Protein Metabolism
The most profound effect that the glucocorticoids have on protein 
metabolism is the influence they exert on nitrogen wasting (Baxter and 
Rousseau, 1979). They induce muscle wasting and this process acts as a 
major source of plasma amino acids (Goldberg, 1969; Odera and Millward, 
1982). Glucocorticoids also act to break down nucleic acids as well as 
decreasing protein synthesis within muscle tissue (Baxter and Rousseau, 
1979). Amino acid catabolism is one of the few metabolic process which 
are sensitive to levels of glucocorticoids within the normal physiological 
range (Reeds and Davis, 1992). In vivo studies with rats have 
demonstrated a reduced rate of protein synthesis after dexamethasone and 
corticosterone treatment (Garlick et at., 1987; Southern et al., 1990). A 
reduced rate of protein synthesis also occurs when muscle tissue from rats 
or rabbits is incubated with either glucocorticoids or dexamethasone 
(McGrath and Goldspink, 1982; Reeds and Palmer, 1984). In 
adrenalectomised rats there is no change in either protein synthesis or RNA 
synthesis, however, when they are treated with corticosterone, both 
protein synthesis and RNA synthesis are significantly depressed (Odera et 
al., 1982). These effects are attributed to an inhibition of translational 
efficiency (Reeds and Davis, 1992). The mechanism which produces the 
above effects remains to be determined, however, Reeds and Davis (1992) 
have suggested that the glucocorticoid effects on protein metabolism are 
mediated through the cytoplasmic receptor binding to a specific promoter 
sequence on DNA which in turn influences the transcription of mRNA. 
Prolonged treatment periods with glucocorticoids have been shown to be 
associated with a reduction in the RNA/protein ratio (Kelly and Goldspink, 
1982; Odera ef a/.,1983).
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2.12. Activation of the Hypothalamic-Pituitary-Adrenal Axis
Stimulation of this axis involves a cascade of events initiated by the 
release of corticotropin-releasing factor(s) (CRF's) by hypothalamic 
neurosecretory neurones. When released into the hypophyseal-portal blood 
these factors stimulate the secretion of pituitary adrenocorticotrophic 
hormone (ACTH) which is released into the systemic circulation. The ACTH 
initiates the release of the glucocorticoids from the adrenal cortex (Baxter 
and Rousseau, 1979).
Corticotropin-releasing hormone (CRH) also referred to as corticotropin­
releasing factor (CRF) has been reported to be the only physiological 
regulator of ACTH release from the anterior pituitary, in man, rats, goats, 
and cattle (Rivier and Plotsky, 1986). Vale et a!. (1981) identified and 
characterised in vitro a 41-amino acid sequence of CRH from ovine 
hypothalami which stimulated ACTH release from the pituitary. 
Corticotropin-releasing hormone is synthesised by the parvocellular 
neurosecretory neurones which are localised within the paraventricular 
nucleus of the hypothalamus. It is released into the portal circulation from 
nerve endings found in the external zone of the median eminence (Antoni, 
1986). The synthesis and secretion of CRH is influenced by a number of 
stimulatory and inhibitory factors and these include the catecholamines, 
serotonin, acetylcholine, angiotensin II, interleukins, y-aminobutyric acid 
(GABA) and the glucocorticoids (Assenmacher et ai., 1987, Tsagarakis et 
ai., 1989). Activation of the pituitary corticotrophs (ACTH releasing cells) 
by CRH is through an interaction with specific plasma membrane receptors 
(Abou-Samra et ai., 1987), and these undergo marked regulatory changes 
during stimulation of the HPA axis (Aguilera et ai., 1987).
Oxytocin and vasopressin play an important role in the pituitary-adrenal 
response to stress. Both peptides have been reported to interact with CRH 
to promote ACTH secretion (Plotsky, 1985). in vivo studies have shown
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vasopressin to be more potent than CRH in stimulating ACTH release in the 
sheep (Smith and Funder, 1989). However, in a recent study by Liu (1994) 
there was a greater release of ACTH in ovine anterior pituitary cells 
incubated with CRH than those incubated with vasopressin. Studies in 
ewes have demonstrated the release of both CRH and vasopressin in 
response to an audiovisual stimulus (a barking dog) and hypoglycaemia 
(Engler et al., 1988). Vasopressin and oxytocin are secreted from the 
magnocellular neurosecretory system located within both the 
paraventricular nucleus and in the supraoptic nucleus of the hypothalamus 
(Sawchenko et al., 1992).
2.12.1. Processing of the Pro-opiomelanocortin Precursor Molecule
Pro-opiomelanocortin (POMC) the precursor for ACTH is derived from the 
cells of the anterior and intermediate lobes of the pituitary gland. Both /?- 
lipotrophin and ^-endorphin are also proteolytically processed from the 
POMC molecule in the anterior lobe (rats: Eipper and Mains, 1981; sheep: 
Smith and Funder, 1988; man: Grossman, 1988). In the intermediate lobe, 
a-melanocyte-stimulating hormone formation occurs from the additional 
processing of ACTH. This lobe also secretes the corticotropin-like 
intermediate peptide (CLIP).
The POMC molecule is also translated and transcribed in extra-pituitary 
tissues. The mRNA for POMC has been identified in the placenta, ovary, 
testis, pancreas, gastrointestinal tract, immune cells (Smith and Funder, 
1988) and the skin (Slominski et a!., 1992). The physiological roles of the 
peptides derived from the POMC molecule are well established; they are 
both disparate and numerous. While ACTH controls adrenocortical 
regulation it also stimulates muscle cell glucose uptake (Levin et a!., 1990) 
and has been reported to act as a specific mitogen for mammalian 
myogenic cells (Cossu et al., 1989). Beta-endorphin acts as an analgesic 
and has a major role in the regulation of eating, drinking, cardiovascular
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responses, respiration and a range of behavioural responses (Olson et a/.,
1991). Alpha-melanocyte-stimulating hormone has a major role in skin 
pigmentation.
2.12.2. Circadian Rhythms within the Adrenocortical System
ACTH production has a circadian pattern which follows the sleep cycle. 
Levels are highest during the night in diurnally active animals with a peak in 
the early morning whereas in nocturnal animals, the peak in ACTH occurs 
late in the afternoon. A circadian rhythm for the POMC peptides and 
corticosteroids have been reported for many species, (man and rats: 
Fischman eta/., 1988; deer: Newman eta/., 1991; sheep: Jones, 1990). 
This pattern is thought to be controlled by direct inputs from the 
suprachiasmatic nuclei within the hypothalamus to the paraventricular 
nucleus (Fischman et a/., 1988) because the rhythm is abolished when the 
suprachiasmatic nuclei is no longer functional (Krieger et a/., 1979).
There is a negative feedback control of the HPA axis where hormones 
secreted from the adrenals in response to ACTH act to inhibit further 
activation of components higher in the axis, (the pituitary, hypothalamus 
and other higher brain centres). In adrenalectomised rats, hypersecretion of 
ACTH and an increase in POMC mRNA in the anterior pituitary have been 
reported (Jingami, et a/., 1985). Plotsky and Sawchenko (1987)
demonstrated increased CRH and vasopressin release into the hypophysial 
portal blood following pharmacological adrenalectomy of rats. Other studies 
have also demonstrated increased levels of mRNA for CRH (Jingami, et a/.,
1985) and vasopressin (Wolfson, et a/., 1985) in the paraventricular 
nucleus after adrenalectomy. These effects were reversed by the 
administration of exogenous steroids. When dexamethasone was implanted 
into the brain of adrenalectomised rats, CRH mRNA decreased (Kovacs and 
Mezey, 1987). Circulating CRH and vasopressin levels were also reported 
to be lower in adrenalectomised rats when dexamethasone implants were
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placed directly over the paraventricular nucleus (Sawchenko, 1987; Kovacs 
and Mezey, 1987). The dexamethasone implants placed into other areas of 
the brain had no effect on CRH or vasopressin levels (Sawchenko, 1987; 
Kovacs and Mezey, 1987).
2.12.3. Hypothalamic-Pituitary-Adrenal Axis Response To Exercise
Physical exercise will activate the hypothalamic-pituitary-adrenal axis in 
man, (Petrides et aL, 1994; Grossman et aL, 1984) rats, (Chin and 
Evonuk, 1971) and sheep, (Apple et a!., 1994). Stimulation of this axis has 
been shown to elicit both neuroendocrine and metabolic responses 
proportional to the relative intensity and duration of the exercise (Deuster et 
aL, 1989).
Increases in plasma ACTH and plasma cortisol, which is the major 
glucocorticoid in man and sheep, were reported from the onset of exercise, 
in man (Petrides et aL, 1994; Grossman et aL, 1984) and in sheep (Apple 
et aL, 1994). Increased circulating cortisol levels act to mobilise fuel stores 
with a consequent increase in blood glucose and FFA levels (Deuster et aL, 
1989). Increased levels of circulating lactate and glucose have also been 
reported from the onset of exercise, in man (Petrides et aL, 1994; 
Grossman et aL, 1984) and sheep (Apple et aL, 1994). This is a response 
which allows metabolic homeostasis to be maintained during physical 
exercise (Galbo, 1983). In contrast, plasma corticosterone (the major 
glucocorticoid in the rat) levels decreased in rats in response to exercise 
(Chin and Evonuk, 1971). This difference in glucocorticoid responses to 
those conducted in sheep and man may be the result of different 
experimental procedures employed. Chin and Evonuk (1971) subjected rats 
to chronic exercise over a six week period whereas in the other studies 
(Petrides et aL, 1994, Grossman et aL, 1984 and Apple et aL, 1994) acute 
exercise was applied for only minutes.
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Of interest are the recent studies by Wittert et al. (1994) and Inder et al. 
(1994) who report elevated basal ACTH levels in highly trained male 
ultramarathon athletes compared to non-sedentary control subjects. The 
early morning surge in plasma cortisol levels, associated with the diurnal 
rhythm, occurred earlier in trained athletes compared to control subjects 
(Wittert eta/., 1994).
2.12.4. Summary of Section 2.12.3.
Exercise stimulates ACTH and cortisol release, in addition to plasma 
glucose, lactate, and FFA levels.
2.12.5. Hypothalamic-Pituitary-Adrenal Axis Response To Surgery
Stimulation of the HPA axis in response to surgical procedures is 
supported by the increased levels of circulating ACTH and cortisol observed 
during surgery, (man: Felländer et a!., 1994; Bickel et al., 1991; 
Lacoumenta et a!., 1987; Tonnesen et a!., 1984; Madsen et al., 1976; 
Gordon et al., 1973; and Clarke et a!., 1970; sheep; Jones, 1990; Shutt et 
a!., 1987; horse: Robertson et a!., 1990). Blood cortisol levels increase 
immediately following the time of incision and continue to increase 
throughout the period of surgery and into the recovery period, (man; 
Lacoumenta et a!., 1987; Clarke et a!., 1970; Madsen et a!., 1976; and 
Tonnesen et a!., 1984; sheep: Jones, 1990). However, in the studies of 
Felländer et a!., (1994), cortisol levels did not begin to increase until 10 min 
to 15 min after the time of incision. This delayed response in cortisol levels 
may be a function of the anaesthetic agent used. In the study of Felländer 
et al. (1994) nitrous oxide in 0 2 plus fentanyl and pancuronium were used 
for the maintenance of anaesthesia as opposed to the other studies where 
halothane and oxygen were used.
The cortisol response in man depends upon the severity of the surgical
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operation, with higher levels occurring with the more invasive procedures 
(Clarke et aL, 1970; Madsen et a!., 1976). The increase in cortisol has been 
shown to coincide with an increase in glucose levels (Clarke et aL, 1970; 
Madsen et aL, 1976). This association between glucose production and 
cortisol levels was also reported by Lacoumenta et aL, (1987). In their 
study, either cortisol or saline was infused into women during surgery. The 
cortisol infusion resulted in a greater increase in glucose levels during the 
operation compared to the women receiving saline alone. Epidural blockade 
in women undergoing surgery will either prevent (Hagen et al.f 1980) or 
suppress the rise in circulating cortisol (Gordon et aL, 1973) when 
compared to patients under general anaesthesia alone.
In the sheep, increased levels of the POMC peptides, ACTH, jff-endorphin 
and a-melanocyte-stimulating hormone, were observed during surgery 
(Jones, 1990). Levels increased at the time of skin incision and remained 
elevated throughout the period of the operation and then declined at the 
cessation of the surgical procedure. Shutt et at. (1987) reported increased 
levels of cortisol and ^-endorphin following routine surgical procedures in 
lambs without administration of anaesthetic. In the horse, /?-endorphin 
levels have also been reported to increase during surgery (Robertson et aL,
1990). However, in the study of Jones (1990), the initial increase in 
endorphin levels in response to surgery was followed by a period (30 min) 
in which levels declined prior to cessation of the operation.
2.12.6. Summary of Section 2.12.5
General anaesthesia and surgery stimulate circulating levels of ACTH, 
cortisol, ^-endorphin, and ar-melanocyte-stimulating hormone as well as 
Increasing plasma glucose levels. In contrast, epidural blockade prevents 
the rise in circulating cortisol levels.
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2.13. Modulation of the Secretion of Corticotropin Releasing Factor and 
Adrenocorticotropin Hormone by the Catecholamines
Any stimulus which perturbs an animal's homeostasis involves activation 
of both the HPA and the sympathomedullary system (Smelik, 1981; Levine, 
1985). Long (1952) and Axelrod and Reisine (1984) both hypothesised that 
the activation of the HPA is evoked by sympathomedullary activation. This 
hypothesis was based on the close interrelationship between these two 
axes.
Both medullary noradrenergic and adrenergic inputs have been shown to 
innervate the parvicellular and the magnocellular systems localised within 
the parventricular nucleus of the hypothalamus (review: Plotsky et a!., 
1989). In addition, noradrenergic inputs innervate the supraoptic nucleus of 
the hypothalamus (review: Plotsky et a!., 1989). Both dendrites and somata 
of paraviceilular and magnocellular neurosecretory cells have been shown 
to receive noradrenergic input (Silverman et a!., 1985). Adrenergic 
synapses have also been described on dendrites and somata of parvicellular 
neurosecretory cells in the paraventricular nucleus as well as CRH 
containing cells (Liposits et al. , 1988).
An intra-paraventricular infusion of adrenaline leads to CRH release in rats 
and this is followed by a prolonged period of ACTH hypersecretion 
(Barbanel et a/. 1991). In a more recent study, Itoi et a/. (1994) reported 
increased levels of POMC and CRH mRNA, and increased plasma ACTH 
levels following microinjection of noradrenaline into the paraventricular 
nucleus. These components increased in a dose dependent manner 
following noradrenaline microinjection.
Ganong (1984) suggested that the catecholaminergic innervation of the 
hypothalamus had a predominately inhibitory role on the corticotropic 
response to stressors. More recent studies suggest that the major
43
catecholaminergic pathways innervating the paraventricular nucleus convey 
the most potent stimulatory signals to the CRH neurones (Assenmacher et 
a!., 1992). Studies conducted with rats involving the destruction of the 
major catecholaminergic pathways to the paraventricular nucleus have 
shown a significant decrease in plasma concentrations of CRH which in 
turn caused a significant fall in plasma ACTH, (Guillaume et a!., 1987) and 
prevention of the ACTH surge following ether stress, (Szafarczyk et al., 
1985). These effects were subsequently reversed by hypothalamic 
infusions of noradrenaline or adrenaline (Szafarczyk et a!., 1985).
Pharmacological studies show that the main catecholaminergic pathways to 
CRH neurones act as a stimulator of the CRH-ACTH axis across 
postsynaptic ar1, a l,  and ft adrenergic receptors (Assenmacher et aL,
1992). These adrenergic receptors located within the paraventricular 
nucleus and the median eminence of the hypothalamus are unevenly 
distributed with the relative density of these binding sites being present in 
the paraventricular nucleus in the order of a l, a*\ and /?1 and 01, the latter 
two being present at the lowest but equal concentrations (Plotsky et al., 
1989). The adrenergic receptor subtypes can be differentially regulated by a 
variety of factors, including, photoperiod, nutritional state (glucose 
availability), afferent tone, and glucocorticoid hormone levels (Plotsky et al., 
1989). The a l  adrenergic receptor number has been shown to be the most 
responsive to these factors while the 0  receptor number is the least 
sensitive (Plotsky et al., 1989). In their review, Plotsky et a!., (1989) 
suggest from the pharmacological and physiological studies reported that 
the catecholaminergic regulation of CRH is mediated via adrenergic 
subtypes. This group have proposed that:
1: the stimulation of CRH release is mediated via the a1 adrenergic 
receptors.
2: unlike noradrenaline, adrenaline can facilitate CRH release through a 
mixed population of both a1 and 0  adrenergic receptors.
3: the a l  adrenergic receptor subtype may inhibit activity of the HPA axis.
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2.14 Aims of this Thesis
The main aim of this thesis was to further understand what physiological 
actions the sympathomedullary axis and the HPA axis initiate in response to 
an acute stress. Stimulation of both pathways and the subsequent effects 
on an animals physiology in preparation for the "flight fight" response has 
been extensively reported in the literature. Review of the literature shows 
that little is known of the role each pathway plays in altering homeostasis 
and also whether the physiological response initiated by either pathway is a 
function of a close interrelationship between the two axes or an 
independent one.
A means of isolating the effects of one axis from the other is necessary in 
determining the contribution each axis has to the maintenance of 
homeostasis. Active immunisation against ACTH has been shown to 
significantly reduce cortisol levels in the sheep (Wynn et al. 1994). Using 
this immunological approach the physiological action of cortisol on energy 
substrate mobilisation can be negated. In addition, the use of non-selective 
adrenergic receptor antagonists enables the identification of the receptor 
type responsible for eliciting the response for each parameter measured. To 
determine the contribution of the sympathetic nervous system to the 
alteration in the physiological response, tyramine HCI, a potent 
sympathomimetic agonist compound was used.
Dynamic exercise, a "natural" stressor and surgery an "unnatural" 
stressor have been shown to stimulate both the sympathomedullary axis 
and the HPA axis. These two stressors were chosen for studies in this 
thesis because they have been shown to have pronounced effects on 




The experiment reported in chapter 4 describes the cardiovascular and 
metabolic effects of aerobic and anaerobic exercise for ewes in which:
1) the HPA axis has been modified by ACTH immunisation.
2) the sympathomedullary axis has been modified by adrenergic receptor 
blockade.
2.14.2. Objective 2
The experiment in chapter 5 was designed to determine the 
haemodynamic and metabolic responses associated:
1) with the stimulation of endogenous noradrenaline release using tyramine 
HCI infusion.
2) the blockade of a- and ^-adrenergic receptors using non-selective 
adrenergic receptor antagonists.
2.14.3. Objective 3
The experiment reported in chapter 6 describes the metabolic response to 





3.1. Protein Assays 
Reagents
All chemicals used in buffer preparations were of analytical grade and 
were dissolved in reverse osmosis water unless specified otherwise.
3.1 .1 . Stripped Ovine Plasma
Hormone free plasma was used in the preparation of standards for all 
hormone assays. It was prepared by adding Norit A charcoal (AJAX 
Chemicals, Auburn Australia) to pooled ovine plasma at a concentration of 
10mg/ml. The mixture was incubated at room temperature and stirred 
constantly for 5 h This procedure was repeated 3 times. The solution was 
then centrifuged (Beckman USA Model J2-21M) at 5,000 g, 4°C for 15 
min, the plasma was then removed and stored frozen until required.
3.1 .2 . Normal Rabbit Serum (NRS)
Normal rabbit serum was obtained from the ear vein of mature New 
Zealand White rabbits by withdrawing 5ml of whole blood using a 25g 
needle (0.50x19mm, Terumo Pty Ltd, Melbourne Australia). Blood was 
allowed to clot at room temperature then held at 4°C for 10 hrs. The serum 
was collected and then centrifuged (Beckman USA Model J2-21M) at 
5,000 g, 4°C for 30 min. The supernatant was removed and stored frozen 
until required.
3.1 .3 . Normal Guinea Pig Serum (NGPS)
Normal guinea pig serum was obtained from mature guinea pigs by 
withdrawing 5 ml of whole blood from the heart using a 21 g needle 0.8x38
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mm. Prior to heart puncture animals were anaesthetised with Anaesthetic 
Ether (Hoechst Limited Victoria Australia). The whole blood was processed 
and stored in a similar manner to that for the NRS.
3.1.4. Donkey Anti-Rabbit Serum (DARS) or Donkey Anti-Guinea Pig Serum 
(DAG PS)
To obtain the DARS or DAGPS a primary immunisation of 1 mg of rabbit 
gamma globulin or guinea pig gamma globulin was dissolved in 2.5 ml 
saline and this emulsified with 2.5 ml Freunds Complete Adjuvant (Sigma 
Chemical Co. USA). At 4 weeks post primary the donkeys were given a 
booster immunisation using a similar regime, however, the Freunds 
Complete Adjuvant was replaced with Freunds Incomplete Adjuvant. One 
week after this boost blood was withdrawn from the jugular vein of the 
treated donkeys using a 13G needle (Solila Pty Ltd. Melbourne, Australia). 
Blood was allowed to clot at room temperature and then kept at 4°C 
overnight before serum was harvested. Serum was centrifuged (Beckman 
USA Model J2-21M) at 5000 g, 4°C for 30 min and the supernatant 
collected and stored at 4°C until required.
3.2. Protein lodination
Buffers
3.2.1. Stock: 0.5 M P04
This buffer was made up by dissolving 78 g of NaH2P042H20 and 16 g of 
NaOH into 1 litre of distilled water. The pH of the buffer was adjusted to
7.4 by using 4M NaOH.
3.2.2. Buffer A
A 0.25M P04 buffer was prepared by taking 100 ml of the stock buffer 
and diluting it with distilled water to give a final volume of 200 ml.
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3.2.3. Buffer B
A 0.05M P04 buffer was prepared by taking 10 ml of the stock buffer 
and diluting it with distilled water to give a final volume of 100 ml.
3.2.4. Buffer C
A 0.05M P04 buffer was prepared by taking 100 ml of the stock buffer 
and diluting it with distilled water to give a final volume of 1 litre. To this 
solution BSA# Fraction V (Sigma Chemical Co. USA) was added to give a 
concentration of 0.25% weight/volume.
3.2.5. Preparation of Sephadex Column for Protein and Free Label 
Separation
Five g of Sephadex (Amrad Pharmacia, Melbourne, Aust. ) was rehydrated 
in 100 ml of distilled water. The Sephadex solution was heated in a boiling 
water bath for 6 h and then allowed to cool to room temperature. The 
Sephadex solution was de-gassed before loading onto a glass column, (1.5 
cm x30 cm) and then was left to stand for 2 days to allow column to "bed 
down". The column was equilibrated by gravity flow with 0.05M P04, 
(Buffer C) before use. A column containing Sephadex G 50 was used to 
separate labelled growth hormone from free radioactive iodine and 
Sephadex G 100 was used to separate labelled insulin from free 
radioactive iodine.
3.2.6. Reagent Preparation
Protein for iodination was dissolved in Buffer A to give a concentration of 
'\pg/p\. Chloramine T was used as an oxidising agent at a concentration of 
1mg/ml of Buffer B. Sodium Metabisulphide was used to stop the reaction 
and was used at a concentration of 0.2 mg/ml of Buffer B. Potassium 
Iodide was used as the eluent at a concentration of 1 mg/ml of Buffer C.
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3.2.7. Reaction Procedure
The lodination procedure was based on that reported by Greenwood et aL 
(1963) and was carried out in accordance with the CSIRO Division of 
Animal Production's health and safety guidelines.
To a glass reaction vial, containing 5 //g of protein was added 5//I I125 
containing approximately 18 MBq. To this was added 5 //I of Chloramine T 
and then allowed to react for 30-45 sec's. To stop the reaction, 10 //I of 
Sodium Metabisulphide solution was added and this was followed by the 
addition of 0.2ml Potassium Iodide solution. The mixture was then 
transferred onto the separation column and then eluted with Buffer C. The 
eluent was collected as fractions the sizes of which were determined by 
following the separation of labelled protein on a radiometric pen recorder. 
The desired fractions were then stoppered and kept frozen at -2 0 °C  until 
required.
3.3. Insulin RIA
Plasma concentrations of insulin were determined in duplicate using the 
double-antibody RIA method of Downing et ai. (1995). The sensitivity of 




3.3.1. Stock :2M P04
This buffer was made up by dissolving 15.6 g of NaH2P042H20 and 3.2 g 
NaOH in 200 ml of distilled water.
3.3.2. Buffer 1
A 0.04M P04 buffer was prepared by taking 20 ml of stock buffer and
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diluting it to 1 litre with distilled water. To this solution was added 8.77 g 
of NaCI and 0.1% weight/volume of BSA, Fraction V. (Sigma Chemical Co., 
St. Louis, USA).
3.3 .3 . Buffer 2
A 0.04M P04 buffer was prepared as for Buffer 1. To this buffer 18.6 g 
EDTA was added and the pH adjusted to 7.4 using a 4M NaOH solution.
3.3 .4 . Primary Antibody:
The insulin antibody used in this assay was raised in guinea pigs at the 
CSIRO Division of Animal Production, Prospect, NSW Australia. A primary 
immunisation of 1 mg crystalline bovine insulin (Burroughs Wellcome, Batch 
No 2189) was dissolved in 1 ml sterile saline and emulsified with 1 ml of 
Freund's Complete Adjuvant. Guinea pigs were injected subcutaneously at 
multiple sites using a 21 g needle. Six weeks later the guinea pigs were 
boosted with bovine insulin, emulsified in Freund's Incomplete Adjuvant 
and injected as for the primary vaccination. The guinea pigs were given 4 
subsequent boosts at 3 weekly intervals before blood collection. Blood was 
withdrawn from the guinea pigs as described previously (section 3.1.3.). 
The antiserum was divided into 0.1 ml aliquots and stored frozen at 
— 20°C. The primary antibody used for assays described in this thesis was 




















3.3 .5 . Insulin Standard
The insulin standards were prepared from purified porcine insulin (Elli Lilly 
Pty Ltd). Initially this was made up to a concentration of 100ng/ml in Buffer 
1 and stored in aliquots at -20°C . When needed, sufficient of the stock 
was serially diluted in buffer 1 down to a concentration of 0.078 ng/ml 
using Buffer 1.
3.3 .6 . Assay Procedure
All samples were assayed in 10 mm x 75 mm, P4 (John Morris Ltd., 
Sydney, NSW) plastic tubes. The samples and the quality controls were 
assayed in duplicate and the insulin standards were assayed in triplicate.
On day 1, 100//I of sample was diluted with 500//I of Buffer 1. The 
standard curve was prepared by adding 100//I of the insulin standard, 100//I 
of the hormone stripped plasma and then diluting this with 400//I of Buffer 
1. The insulin antisera was made up to a working dilution of 1:100,000 in 
Buffer 1 which contained NGPS (1:500). A 100//I volume of antisera 
solution was added to each assay tube and then the tubes were vortexed 
and left to incubate at 4°C for 24 h. On the third day the insulin tracer was 
diluted in Buffer 2 and 100//I containing 14,000 cpm was added to each 
tube before being vortexed. The assay tubes were then incubated at 4°C 
for 48 hr. On the fifth day DAGPS was diluted to a working dilution of 1:4 
with Buffer 1. A volume of 100//I of this mixture was added to each tube 
before being vortexed and then left 4°C for 18 h. On the following day the 
assay tubes were centrifuged (Sorvall RC3C, Sorvall Instruments DuPont, 
USA) at 1,500 g for 45 min. The supernatant from each tube was removed 
and the pellet was then counted on a gamma counter (Gammamaster, LKB
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Wallac, Turku, Finland). The insulin concentration was determined using a 
specific RiaCalc (Wallac Oy, Pharmacia, Finland) computer program.
To determine the inter- and intra-assay variation, quality controls, plasma 
containing a known low, medium and high insulin concentration were 
repeatedly spaced throughout each assay.
3.4. Growth Hormone RIA
Plasma concentrations of growth hormone (GH) were determined by the 
double-antibody RIA assay method of Downing et ai. (1995). The 
sensitivity of the assay was 0.45 ng/ml and the inter- and intra-assay 
coefficients of variation were 8.1% and 8.4% respectively.
Assay Reagents
3.4.1. Primary Antibody
The antisera was obtained as a gift from NIADDK (OGH2). For the assay 
the antisera was diluted in Buffer 1 to give a working dilution of 1:20,000.
3.4.2. GH Standard
The standard was obtained as a gift from NIADDK, (oGH-1-4 code no 
AFP8758C). The GH standards were made up in Buffer 1 to give a range 
from 0.50 ng/ml to 80.03 ng/ml.
3.4.3. Assay Procedure
The GH RIA protocol was essentially the same as for that of the Insulin 
RIA, with some differences in the reagents used. Normal rabbit serum was 
used in place of NGPS and DARS was used in place of DAGPS.
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3.5. ^-Endorphin RIA
The /?-Endorphin assay was kindly performed by A. Shaneh, University of 
Sydney, Camden NSW. Plasma ^-Endorphin concentrations were 
determined in duplicate using the unextracted radioimmunoassay technique 
developed by Lim et al. (1982). The inter- and the intra-assay coefficients 
of variation were 13.8% and 16.5% respectively. The sensitivity of the 
assay ranged from 2 to 5 pg/ml. The antisera used in the assay was raised 
in a rabbit and was the gift of Dr D. Shutt, NSW Dept Agriculture.





Porcine acetyl e-endorphin (1-31) 45
Porcine e-endorphin (1-31) 36
e-lipotropin (1-92) 35
Ovine e-endorphin (1-27) 30
Ovine ACTH (1-31) 2












Plasma concentrations of Cortisol were determined in duplicate using the 
modified technique of Foster and Dunn (1974). Sensitivity of the assay was 




3.6 .1 . Buffer 3
This buffer was prepared by dissolving 2.48 g of H3BO and 2.0 g gelatin 
(porcine skin, approx 300 bloom. Sigma Chemical Co, USA) to 1900 ml 
distilled water. The solution was then heated to dissolve the gelatin and 
then following this 1 g of NaN3 added. The pH of the solution was adjusted 
to 7.6 with 4M NaOH and the final volume was then made to 2000 ml.
3.6 .2 . Dextran Coated Charcoal
The dextran coated charcoal was prepared by dissolving 6.25 g of Norit A 
charcoal and 625 mg Dextran T70 (Amrad Pharmacia, Melbourne, Aust.) in 
250 ml of distilled water. This solution was stored at 4°C and was freshly 
prepared every three weeks.
3.6 .3 . Primary Antibody
The cortisol antibody used in this assay was raised in rabbits at the 
CSIRO, Division of Animal Production, Prospect, NSW. A primary 
immunisation of 1 mg Hydrocortisone 3-(o-Carboxymethyl)0xime:BSA 
(Sigma Chemical Co.), was dissolved in 1 ml sterile saline and emulsified 
with 1 ml of Freund's Complete Adjuvant. New Zealand White rabbits were
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given a 1 ml intra-muscular injection into each hind leg. Six weeks later the 
same rabbits were given a booster injection consisting of 1 mg of the 
cortisol antigen dissolved in 1 ml sterile saline and this was injected into the 
ear vein. One week post-boost the rabbits were bled as described in section
3.1.2. and the serum processed accordingly and stored frozen at -20°C . 
The primary antibody used for assays described in this thesis was Tig Pen' 
and this was sampled on the 12/10/92.
The antiserum was found to have the following cross-reactivities;
Steroid Percentage Cross-reactivity 
(%)









3.6 .4 . Cortisol Standard
A stock standard solution was prepared by dissolving 12.8 g 
Hydrocortisone 3-(o-Carboxymethyl)Oxime:BSA (Sigma Chemical Co.) in 
100 ml AR Ethanol (Ajax Chemicals, Sydney) to give a concentration of 
128//g/ml. The stock standard solution was kept at 4°C until required. 
When needed, 50//I of the stock standard was made up in 10ml of Buffer 3 
to give a concentration of 640 ng/ml. The assay standards were prepared 




All assays were carried out in 12mmx75mm 'Borex' glass tubes (Crown 
Scientific, NSW, Australia). The samples and the internal standards were 
assayed in duplicate and the standards for the standard curve were assayed 
in triplicate.
On day one, 20//I of sample was diluted with 680//I of Buffer 3. The 
standard curve was prepared by adding 20//I of the cortisol standard with 
20//I of the hormone stripped plasma and 660//I of Buffer 3. The samples 
and the standards were then heat extracted by placing them in a 60 °C 
water bath for 60 min at which time they were removed and stored at 4°C 
for 24h. On day two the cortisol antisera was diluted with Buffer 3 to give 
an initial dilution of 1:25,000. A volume of 100//I was added to the assay 
tubes which were then vortexed. The cortisol tracer (Amersham Pty Ltd. 
Aust.) was diluted with Buffer 3 to give a concentration of 6,000 CPM in 
100//I. A 100//I tracer was added to all the tubes before being vortexed. 
The tubes were then incubated at room temperature for 60 min. A 100//I of 
the dextran coated charcoal was added to each tube before vortexing 
again. The tubes were then incubated at 4°C for 15 min before they were 
centrifuged at 1,500 g for 45 min. The supernatant was removed and the 
pellet counted on a gamma counter and a specific RiaCalc programme was 
used to determine the cortisol concentrations.
To determine the inter- and intra-assay variation, internal standards of a 
known cortisol concentration (low, medium and high) were repeatedly 
spaced throughout each assay.
3.7. Catecholamine Assay
Plasma catecholamine samples were absorbed onto alumina using the 
extraction procedure of Henry et a/. (1975) and then quantified by HPLC 
with electrochemical detection (ECD). These analysis were kindly carried
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out by Nerille Willis, of the Dept of Renal Medicine, Royal Prince Henry 
Hospital, Sydney, NSW.
3.7.1. HPLC Conditions
The column used for the adrenaline and the noradrenaline analysis was a 
Waters //Bondapak C18 3.9mm x 30 cm stainless steel column (Cat No 
27324) with a 10 ¡j particle size. An electro chemical detector was used 
with a potential of +0.6 - 0.75V oxidation. The full scale deflection was 1 
nA, the pump flow rate was 1.0 ml/min and the injection volume used was 
100//I.
3.7.2. Mobile Phase (isocratic Conditions)
The buffer used for the mobile phase was 0.15M P04 and contained in 1 
litre of distilled water 20.7 g NaH2P042H20, 500 mg EDTA, and 50 mi of 
MeOH.
The sensitivity of the assay was 0.1 nm/Litre and the inter-assay and 
intra-assay coefficients of variation were: noradrenaline 7.5% and 8.2%, 
adrenaline 7.6% and 7.5%.
Metabolite Assays
3.8. Plasma Free Fatty Acid Analysis
Plasma FFA's were measured by enzymic analysis using a kit supplied by 
Boehringer Mannheim Ltd (Germany). The assay is based on the action of 
acetyl-CoA synthetase in the presence of coenzyme A and adenosine-5'- 
triphosphate. The analysis uses the modified method of Dunshea et al. 
(1989) in which reagents were further diluted with 0.1M P04 at pH 7.8 to 
increase the number of samples assayed per kit. The inter- and intra-assay 
coefficients of variation were 10.6% and 8.1% respectively.
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3.9. Plasma Glucose Analysis
For the samples assayed in chapter 4 the plasma glucose levels were 
determined by the glucose oxidase method of Huggett and Nixon (1957).
Reagents
3.9 .1 . 0.5M  Phosphate Buffer
This buffer was prepared by dissolving 78 g of NaH2P042H20 in 1 litre of 
distilled water. The pH of the buffer was adjusted to 7.0 using 10 N 
NaOH.
3.9 .2 . Colour Reagent
The colour reagent was prepared by dissolving 12.5 mg of type 2 glucose 
oxidase (from Aspergillus niger, Sigma Chemical Co.), 0.7 mg of peroxidase 
type 2 (from horseradish, Sigma Chemical Co.) and 100 mg of 2,2'-Azino- 
bis(3-ethylbenzthiazoline-6-sulfonic acid) (Sigma Chemical Co.) in 100 ml of 
0.5M P04.
3.9 .3 . Glucose Standard
A stock glucose standard solution of 1 mg / 100//I was prepared by 
dissolving 1 g of D-( + )-Glucose (Sigma Chemical Co.) in 100 ml of a 
0.25% benzoic acid solution (Ajax Chemicals, Sydney Australia). From the 
stock solution a range of standards, (10 mg to 300 mg), was made up in 
0.25% benzoic acid.
3.9 .4 . Assay Procedure
To a glass test tube, 100 p\ of sample or glucose standard was diluted 
with 0.5 ml of a 6% perchloric acid solution and the contents then 
vortexed. The solution was left to stand for 10 min before centrifuging for 
20 min at 1,500 g. From these tubes 100 p\ of the supernatant was 
removed and then diluted with 5 ml of the colour reagent before vortexing.
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The assay tubes were then incubated in a water bath at 37°C for 15 min 
in the dark. Following the incubation the optical densities for the samples 
and the standards were read at 436 nm using a Varian DMS 100 
spectrophotometer.
For the samples assayed in chapters 5 and 6 the plasma glucose 
concentrations were determined by the autoanalyser using the method of 
Bergmeyer and Bernt (1963). The inter- and intra-assay coefficients of 
variation were 1.0% and 1.1% respectively.
3.10. Plasma Lactate Analysis
Plasma lactate was determined by autoanalyser using the method of Mann 
and Shute (1970), the inter- and intra-assay coefficients of variation were 
2.3% and 2.3% respectively.
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Chapter 4
Sympathetic Nervous Activity and Glucocorticoid Regulation During 
Exercise in the Ewe.
4 .1 . introduction
An animals physiological regulation of homeostasis when exposed to any 
perceived stress is achieved by a series of complex endocrine interactions, 
these include hormones from the adrenal glands (Harvey et al., 1984). 
Physical exercise has been shown to stimulate both the sympathetic 
nervous system (SNS) (Christensen and Galbo, 1983) and the 
hypothalamic-pituitary-adrenal axis (HPA) (Petrides et al.r 1994). Exercise- 
induced activation of the SNS results in release of catecholamines, 
principally adrenaline from the chromaffin cells of the adrenal medulla and 
noradrenaline from the sympathetic nerve endings. Similarly, exercise- 
induced activation of the HPA axis results in the release of glucocorticoids 
from the adrenal cortex. Both catecholamines (Webber and Macdonald,
1993) and glucocorticoids (Odio and Brodish, 1988) promote lipolysis, with 
the subsequent release of free fatty acids (FFA), and an increase in blood 
glucose levels. These energy substrates are readily available to the working 
muscle during exercise. Their effects are facilitated by the inhibition of the 
secretion of insulin (Viru, 1985). Oxygen consumption (V02) also increases 
during exercise and is associated with the high metabolic requirements 
dictated by the enhanced demand for energy by the skeletal and heart 
muscles (Blum and Eichinger, 1988). There is little published information as 
to the contribution that both these "stress" axes play during exercise; not 
only their involvement in the regulation of energy substrate availability and 
release of other hormones but also their contribution to the cardiovascular 
and respiratory response to stress.
Of all the changes during exercise, an increase in the sympathomedullary
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activity becomes the most important autonomic neuroendocrine response 
(Kjaer et aL, 1987). The increase in sympathetic tone influences many 
physiological processes including cardiovascular adaptation, 
thermoregulation, and water and electrolyte balance (Galbo 1981, 1983). 
These physiological changes as well as changes in carbohydrate and lipid 
metabolism are mediated by specific adrenergic receptors (Himms-Hagen, 
1967). The use of a- and /?- adrenergic antagonists for in vivo studies has 
been shown to facilitate the understanding the physiological processes that 
are mediated by the catecholamines. In sheep, the /?-adrenergic antagonist, 
propranolol HCI, and the a-adrenergic antagonist, phentolamine methane- 
sulfonate, effectively block activation of these receptors during exercise 
(Brockman and Halvorson, 1981).
4.2. Aims of the studies described in this chapter were;
1: To determine the cardiovascular, metabolic and endocrine changes in the 
sheep during aerobic and anaerobic exercise.
2: To measure the physiological changes prior to, during and after exercise 
in sheep that have been pre-treated with the adrenergic antagonists, 
propranolol HCL or phentolamine methane-sulfonate .
The comparisons in these studies were between sheep given a control 
immunisation or immunised against ACTH 1-24.
4.3. Materials and Methods 
Animals
Six Border Leicester x Merino ewes were housed at the University of 
Sydney farms Camden (latitude 34°S). Ewes were maintained at pasture 
before being acclimatised to individual metabolic cages (Till and Downs,
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1967) and housed in a thermoneutral environment under a photoperiod 
regime of 12 L : 12 D. All ewes had full access to water at all times and 
were fed ad libitum a pelleted ration consisting of 60% hammermilled 
lucerne and 40% crushed oats. It was estimated that the diet supplied 10.4 
MJ of metabolisable energy/Kg liveweight/day.
Three of the ewes were actively immunised against ACTH 1 -24-ovalbumin 
conjugate (1mg) in Freund's Complete Adjuvant (2ml). A primary 
immunisation was given in mid December 1993 and two booster 
immunisations prepared in incomplete adjuvant, were given at six weeks 
and ten weeks after this primary vaccination. The three remaining ewes 
acted as controls and were injected with the adjuvant alone.
Assimilation to Treadmill
All sheep were accustomed to walking on a motorised treadmill (Treadmill 
Austredex, Emmans and Sons Pty. Ltd., Preston, Victoria, Aust.) prior to 
the commencement of the experiment. Initial training was for a period of 
less than 10 minutes at a speed of 1.5 km/h on a 0° incline. Once the 
sheep were accustomed to these settings the exercise speed was increased 
to 2.5 km/h and the time extended to 30 minutes. The speed was then 
increased to 5 km/h for 30 minutes by the end of the training period. The 
training was carried out in the presence of technical staff.
Surgical Procedures
Positioning of Blood Flow Probe around the Pulmonary Artery.
Ewes were fasted for 24 hours and denied water for 12 hours prior to the 
surgical procedure. To allow insertion of the endotracheal tube, the short 
acting anaesthetic agent thiopentone sodium (Boehringer) was administered 
intravenously at a rate of 15-20 mg/kg body weight. Ewes were then 
induced with 2-4% Fluothane (ICI) in oxygen to maintain general
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anaesthesia. After anaesthetic induction, wool around the surgical area was 
clipped, and the area was then washed, and sterilised with 70% ethanol 
prior to the surgical incision. The thoracic surgical procedure was based on 
the technique described by Sawyer and Stone (1966) and modified by Giles 
and co-workers (1995). A 20 cm dorso-ventral incision was made on the 
left side of each ewe beginning adjacent to the posterior edge of the 
scapula and continuing into the pleural cavity via the third intercostal 
space. Manual ventilation was used using a Autohand ventilator, set at 20 
respirations per minute. The lung was displaced, then moved towards the 
dorsal side of the pleural cavity to enable access to the pulmonary artery. A 
5 cm incision was made through the pericardium in the direction of the 
pulmonary artery, followed by both blunt and sharp dissection to separate 
the connective tissue between the aorta and the pulmonary artery. A sterile 
blood flow probe (16 mm diameter, S-series, Transonic Systems Inc, 
Ithaca, USA) was secured around the pulmonary artery using the monitors 
own reflector bracket. The probe was located so that the blood vessel was 
positioned within the acoustic window of the probe (Gooden and Giles,
1991). The pericardium was sutured loosely over the probe body using 
chromic gut suture and the probe lead excised near the ventral edge of the 
incision to allow unrestricted movement of the lead during exercise. The 
third and fourth ribs were tied together and the intercostal muscle layers 
closed. Prior to the closing of the chest wall the lungs were inflated 
manually to exclude excess air from the pleural cavity, the ventilator was 
then discontinued to allow spontaneous respiration to re-commence.
Post-operative care consisted of daily intramuscular injections (4 ml) of an 
antibiotic solution (Depomycin, Intervet, Australia) for 5 days following 
surgery. Water and food were offered within 24 h after surgery and ewes 
were carefully monitored until feed intake returned to pre-operative levels.
Gooden and Giles (1991) demonstrated that it took approximately 3 days 
to allow for tissue build up around the probe and then this allows for the
64
acoustic coupling between the pulmonary artery and the probe. For this 
experiment the blood flow probes were assessed 10-12 days after surgery 
thus ensuring adequate time for the acoustic coupling between the probe 
and the pulmonary artery. Direct measurement of cardiac output was 
achieved by connecting the blood flow probe to a bench top blood flow 
meter (Transonics T201, Two-channel ultrasonic blood flow meter, 
Transonics Systems Inc., Ithaca, New York, USA). Data were recorded 
either manually or automatically on a data logger (Tain Electronics, 
Melbourne, Australia).
Fibre-Optic Catheter Placement in the Pulmonary Artery for Oxygen 
Saturation Determination
Three days prior to the commencement of the experiment, the ewes were 
prepared for surgery as described previously. A pre-calibrated Oximetrix 
catheter (Oximetrix: Abbott Laboratories, North Chicago, USA, 2.5 mm 
O.D.) was inserted into the pulmonary artery of each sheep via the jugular 
vein, using a catheter inducer (8.5F with a 13 cm sheath, W.A. Cook, 
Brisbane, Aust). The catheterisation procedure was carried out using the 
Seldinger technique (Seldinger, 1953) which was modified by Giles and co­
workers (1995). A latex balloon at the tip of each catheter was inflated to 
allow easy movement of the catheter through the heart chambers. The 
placement of the Oximetrix catheter within the pulmonary artery was 
proximal to the blood flow probe and its correct position was determined by 
the interference generated by the air filled balloon tip as it passed through 
the acoustic window of the blood flow probe.
Carotid Artery Catheterisation for Arterial Oxygen Saturation and 
Haemoglobin Determinations
Catheterisation of the carotid artery using clear vinyl tubing (I.D. 1.0 mm, 
O.D. 1.5 mm, Dural Plastics Ltd, Dural, NSW) was performed at the same 
time as the catheterisation of the pulmonary artery. To expose the artery, 




The jugular vein catheter (medical grade polythene tubing I.D. 1.0 mm, 
O.D. 1.5 mm, Dural Plastics Ltd, Dural, NSW) was inserted into all animals 
24 h prior to the commencement of the experiment. This was done using a 
topical anaesthetic agent, Xylocaine 10% spray, (Astra Pharmaceuticals Pty 
Ltd., Melbourne) and a sterile 14G catheter placement unit, (Jelco, Johnson 
and Johnson Medical, Japan). Patency of the catheters were maintained by 
flushing the catheters with heparinised saline (500 lU/ml of heparin).
Experimental Design
The exercise regime for this experiment was designed to subject the 
sheep to low intensity exercise (2.5 km/h), the energy supply for which 
should be met by aerobic metabolism, and to high intensity exercise (5 
km/h), during which animals should be dependent on both aerobic and 
anaerobic mechanisms to generate energy.
The exercise pattern is summarised in table 1. 
Table 1
Rest 2.5 km/h Rest 5 km/h Rest
90 min 30 min 60 min 30 min 90 min
infusions
All infusions given to conscious ewes were administered intravenously via 
the jugular catheter using a variable speed peristaltic pump (Gilson Medical 
Electronics, Villiers le Bel, France) at an infusion rate of 0.5 ml/min. 
Propranolol hydrochloride (Sigma Chemicals), was diluted in sterile saline 
and infused for four hours at a concentration of 0.5 mg/kg/h (Bassett,
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1970). Phentolamine methane-sulfonate (Aldrich Chemical Co.) was diluted 
in sterile saline and infused for four hours at a rate of 1.0 mg/kg/h (Bassett, 
1970). Ewes were infused with saline for the first 30 min during the initial 
rest period before drug treatment and again for 30 min at the end of the 
final rest period. To recover from the exercise periods ewes were rested for 
a period of 24 hours between treatments. One ewe from the non-immune 
group and one from the ACTH-immune group were given the same 
treatment for that day and this procedure was maintained throughout the 
course of the experiment.
The pattern of treatments over the 11 days of the experiment is 
summarised in table 2.
Day of the experiment
ewe 1 2 3 4 5 6 7 8 9 10 11
1 S a p
2 S a p
3 a p S
4 a p S
5 p S a
6 p S a
Table 2.
Legend for the pattern of infusions given over the 11 days of the 
experiment. S = saline, a = phentolamine methane-sulfonate, ft -  
propranolol HCI
Blood Sampling
Venous blood samples (3 ml) were drawn from the jugular catheter using 
a 2.5 ml syringe (Terumo Corporation Japan). After each sample, catheters 
were flushed with heparinised saline (100 International lU/ml). Samples
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were taken at 30 min intervals during each rest period and at 5 min 
intervals during both exercise periods. Blood samples were transferred into 
plastic P4 tubes (John Morris Ltd, Sydney, NSW) containing kwickspin 
separation granules (Kwickspin, Disposable Products Padstow, NSW). All 
samples were kept on ice until centrifuged at 2000g for 15 min at 4°C. 
Plasma samples were stored at -20°C until assayed.
Catecholamine Sample Collection
Venous blood samples for the determination of plasma adrenaline and 
noradrenaline were collected in pre-cooled P4 plastic tubes containing 1 mg 
sodium metabisulphite per 10 ml blood. Samples were taken during each 
rest period and immediately following the completion of each exercise 
period. After collection, samples were immediately centrifuged and plasma 
frozen at -70°C until assayed.
Respiratory and Circulatory Analysis
Measurement of Whole Body Oxygen Consumption
Whole body oxygen consumption was determined by the direct 
measurement of cardiac output (L/min) and the difference in oxygen 
content between arterial and mixed venous blood across the lungs (the Fick 
technique). The Fick equation for the determination of oxygen consumption 
used in this experiment is based on the application of the ultrasonic blood 
flow and Oximetrix measurement techniques developed by Gooden and 
Giles (1991).
The Fick equation is as follows:
Q02 = CO x (Sa02-Sv02) x Hb x 1.34 / 10
where Q02 = oxygen consumption (ml/min)
CO = cardiac output (l/min)
Sa02= arterial oxygen saturation (%)
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Sv02 = mixed venous oxygen saturation (%)
Hb = blood haemoglobin content (g%)
Arterial Oxygen Saturation and Blood Haemoglobin Content
Both oxygen saturation and haemoglobin content was determined in blood 
taken from the carotid artery. In the studies of Gooden and Giles (1991), 
the saphenous artery was used. The carotid artery was selected for these 
studies as the catheterisation and subsequent blood sampling would not 
impede the ewe while exercising on the treadmill. Blood samples (1ml) were 
withdrawn from the catheter using a 2.5ml syringe (Terumo Corporation, 
Japan). Syringes were previously filled with heparinised saline (Fissons 
Pharmaceuticals Vic; 100 lU/ml) and then evaporated to dryness prior to 
sampling. Arterial blood samples were taken at the same time intervals as 
for the other plasma samples for the determination of carotid oxygen 
saturation and haemoglobin content and were placed manually in a 
haemoximeter (Radiometer, Copenhagen, Denmark). The patency of the 
catheters was maintained during the experiment by flushing catheters after 
each sampling period with heparinised saline (100 lU/ml) and between 
experiments, by filling the catheters with heparinised saline (1000 lU/ml).
Cardiac Output
Cardiac output in the sheep is measured as the volume of blood passing 
through the pulmonary artery per unit of time (Gooden and Giles, 1991). 
The measurement of blood flow by ultrasound is based on the time taken 
for sound waves to pass through the pulmonary artery, by utilising the 
ultrasonic, transit-time principle, whereby volume flow is sensed 
independently of vessel size (Gooden and Giles, 1991). Thus, the 
determination of cardiac output in this experiment was measured by the 
placement of a transit-time ultrasonic flow meter (Transonic System Inc., 
Ithaca, USA) around the pulmonary artery of each sheep. This transit time 
ultrasonic blood flow method has been validated by Gooden and Giles 
(1991) by comparing it to the dye-dilution technique using the jugular vein
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(Lush et ai., 1989) and to the stop watch/measuring cylinder technique 
using the portal vein (Neutze et a!., 1989). In both comparisons, there was 
no significant difference in blood flow between the techniques.
Mixed Venous Oxygen Saturation
Mixed venous blood oxygen content was determined using the Oximetrix 
catheter containing a fibre optic bundle. This fibre optic bundle transmits a 
light beam of three specific wave lengths to the tip of the catheter. The 
level of the blood oxygen is determined by the amount of reflected light 
transmitted back to a monitor (Oximetrix, Abbott Laboratories, North 
Chicago, USA) from the red blood cells. The difference in light intensity 
between the afferent and efferent fibre optic bundles is related to blood 
colour and therefore to oxygen saturation. Before each experiment the 
Oximetrix monitor was calibrated against a blood sample taken from the 
pulmonary artery and measured manually on a haemoximeter (Radiometer, 
Copenhagen).
Body Temperature
A thermocouple incorporated in the tip of the oximetrix catheter, situated 
in the pulmonary artery, enabled the continuous measurement of deep body 
temperature during the experimental procedure.
4.4. Statistical Analysis
All data are presented as the mean ± the standard error of the mean 
(S.E.M.). The effects of exercise and infusion treatment and their 
interaction were measured by repeated measures ANOVA test (CLR 
ANOVA program; Clear Lake Research Inc., Houston TX, USA).
The differences in the mean catecholamine levels during exercise and 




The plasma cortisol levels are shown in figure 4.1. During the saline 
infusion circulating cortisol levels in the non-immune group increased during 
both exercise periods compared to the rest periods with a significant 
increase (P< 0.05) in plasma cortisol occurring during the 5 km/h exercise 
period {Fig 4.1a). There was no significant treatment effect with either of 
the adrenergic antagonists. However, during the infusion with phentolamine 
methane-sulfonate (Fig 1c) circulating cortisol levels in the non-immune 
sheep were markedly higher during the 2.5 km/h exercise period and the 
rest periods compared to either the saline or the propranolol HCI infusion.
There was no significant effect of exercise or infusion treatment on 
plasma cortisol levels in the ACTH-immune group. Circulating plasma 
cortisol levels in this group remained at or near basal levels for the duration 
of the experiment regardless of treatment (Figs 4.1af 4.1b, 4.1c).
Plasma Noradrenaline Levels
The plasma noradrenaline levels are given in figure 4.2. During the saline 
infusion there was a significant increase (P<0.03) in circulating 
noradrenaline levels in the non-immune group at the end of the first 
exercise period (2.5 km/h) when compared to the initial rest period 
(1.63±0.28 and 0.95±0.15 mmol/L respectively). These levels remained 
elevated into the following rest period and then increased during the second 
exercise period (5km/h) 1.67 ±0.59 mmol/L to 4.46 ±0.07 mmol/L
(P<0.02). Noradrenaline levels remained elevated during the following rest 
period with the mean concentration being 5.83 ±2.67 mmol/L. A similar 
plasma noradrenaline profile was observed in the ACTH-immune group 
during saline infusion with increased circulating noradrenaline levels 
occurring at both exercise periods, (2.5 km/h 2.26 ±0.66 mmol/L, 5 km/h 
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Figure 4.1. Changes in circulating cortisol levels in response to exercise at 2.5 kmh and 5.0 kmh 
■  ACTH-immune □  Non-immune
preceding rest periods (1.72±0.49 mmol/L and 1.73±0.3 mmol/L 
respectively; Fig 4.2a). However, unlike in the non-immune group, 
circulating noradrenaline levels returned to near basal levels during each of 
the rest periods.
Pre-infusion of phentolamine methane-sulfonate before exercise to the 
non-immune and the ACTH-immune groups resulted in a similar plasma 
noradrenaline profile as with saline infusion (Fig 4.2b). The increase in 
plasma noradrenaline concentrations for both groups during the 5 km/h 
exercise period was greater than that seen during the saline infusion (Fig 
4.2b). There was no significant difference of immunisation on the plasma 
noradrenaline levels after phentolamine methane-sulfonate treatment.
The pre-infusion of propranolol HCI to both the ACTH-immune and the 
non-immune groups resulted in an increase in plasma noradrenaline levels 
during the exercise periods. The increase during the 5 km/h exercise regime 
was greater than during the saline infusion but was not significant (Fig 
4.2c). There was no significant difference due to immunisation treatment. 
However, the plasma noradrenaline levels during all the sampling periods 
were elevated when compared to either the saline or the propranolol 
treatment.
Plasma Adrenaline Levels
Plasma adrenaline levels are shown in figure 4.3. There was no significant 
difference during the saline infusion in plasma adrenaline levels. For both 
groups, the levels remained at or near basal levels until the 5km/h exercise 
period when there was an increase, although this was not significant (Fig 
4.3a). These increased levels remained into the following rest period.
The pre-treatment with either propranolol HCL (Fig 4.3b) or phentolamine 
methane-sulfonate (Fig 4.3c) before exercise period gave a similar plasma 
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Figure 4.3 Changes in circulating adrenaline levels in response to exercise at 2.5 km/h and 5.0 km/h 
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adrenaline levels during the 5 km/h exercise period for both treatment 
groups given either pharmacological treatment when compared to the saline 
treatment alone. There was no difference in plasma adrenaline levels 
between the ACTH-immune and the non-immune groups with either of the 
two antagonists during the study period.
Plasma Free Fatty Acid Levels
The plasma free fatty acid levels are given in figure 4.4. An immediate 
increase in plasma FFA levels were observed in the non-immune group 
during both exercise regimes (Fig 4.4a), although, this increase was not 
significant until the ewes were exercised at the 5 km/h exercise (P< 0.01). 
For the ACTH-immune group no increase in FFA levels occurred in response 
to either of the exercise regimes. For these ewes the FFA levels remained 
at or near basal levels for the duration of the experiment (Fig 4.4a).
Pre-treatment with phentolamine methane-sulfonate before exercise gave 
rise to a gradual increase in the basal plasma FFA's levels in both groups 
(Fig 4.4b). Exercise at 2.5 km/h resulted in a small but not significant 
increase in circulating FFA's in both groups. When the intensity of the 
exercise was increased to 5 km/h there was an immediate and significant 
(P< 0.01) increase in FFA's in the non-immune group. Plasma FFA levels in 
this group continued to increase throughout the exercise period and 
declined after its cessation. In contrast, there was no increase in the 
plasma FFA levels in the ACTH-immune group in response to the 5 km/h 
exercise regime (Fig 4.4b) with levels remaining at the level seen during the
2.5 km/h exercise period.
The pre-treatment with propranolol HCI prevented the exercise induced 
increase in plasma FFA levels in the non-immune group with FFA 
concentrations remaining at or near basal values for the duration of the 
experiment (Fig 4.4c). There was no significant difference between the 
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Figure 4.4 Changes in circulating free fatty acid levels in response to exercise at 2.5 km/h and 5.0 km/h
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irrespective of the level of exercise (Fig 4.4c).
Plasma Lactate Levels
Plasma lactate levels (Fig 4.5) increased significantly (P<0.05 non­
immune, P<0.01 ACTH-immune) in both groups during the 5 km/h exercise 
period (Fig 4.5a). During this period circulating lactate levels increased in 
both groups at the onset of the exercise and then continued to increase 
throughout the exercise period. While there was no significant difference in 
the lactate profile between the non-immune or the ACTH-immune groups 
the concentrations in the ACTH-immune group tended to be higher (Fig 
4.5a).
In contrast the pre-treatment with phentolamine methane-sulfonate before 
the 2.5 km/h exercise period resulted in a small but insignificant increase in 
plasma lactate levels in the non-immune ewes. No change in circulating 
lactate levels for the ACTH-immune ewes in response to the 2.5 km/h 
exercise (Fig 4.5b) was recorded. There were significant increases (P< 
0.05 non-immune, P< 0.01 ACTH-immune) in plasma lactate levels in both 
groups from the start of exercise at 5 km/h. The duration of this increase in 
lactate levels tended to be longer in both groups when compared to 
treatment with either saline or propranolol HCL. Plasma lactate was still 
significantly elevated (P< 0.05) for at least 30 minutes after the exercise 
ceased (Fig 4.5b), whereas during the propranolol and saline treatment 
periods, the plasma levels tended to decrease more quickly.
The pre-treatment with propranolol HCI before and during the exercise 
periods resulted in a similar plasma lactate profile to that following saline 
infusion. Plasma levels in both the ACTH-immune and the non-immune 
groups increased in response to the 5 km/h exercise period (Fig 4.5c), but 
there was no significant difference between groups, although again the 
response in the ACTH-immune group to 5 km/h exercise tended to be 
lower.
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Plasma Glucose Levels
Plasma glucose levels are given in figure 4.6. During the saline infusion 
glucose levels in both groups did not increase until the 5 km/h exercise 
period (Fig 4.6a). Plasma glucose levels for the ACTH-immune group were 
significantly higher (P<0.05) during the 5 km/h exercise period when 
compared to the levels in the non-immune group.
In the non-immune ewes the pre-treatment with phentolamine methane- 
sulfonate before exercise resulted in a similar glucose profile to that seen 
during saline infusion, there being no increase in plasma glucose levels until 
the 5 km/h exercise period (Fig 4.6b). However, in the ACTH-immune group 
plasma glucose levels tended to decline from the start of the phentolamine 
infusion, resulting in a significant decrease in glucose levels (P<0.01) 
during the 2.5 km/h exercise period. During the 5 km/h exercise period 
there was a significant (P<0.05) increase in plasma glucose levels in the 
ACTH-immune group. Although glucose levels increased in the non-immune 
group in response to the exercise the increase was not significant.
For both groups, plasma glucose levels increased during the 2.5 km/h and 
then significantly increased (P<0.05) during the 5 km/h exercise regime 
when pre-treated with propranolol HCI (Fig 4.6c), however, there was no 
significant difference between the groups.
Plasma Insulin Levels
The plasma insulin levels are shown in figure 4.6. No significant changes 
in circulating insulin levels were observed in either the non-immune or the 
ACTH-immune groups, although insulin levels tended to increase in 
response to the intensity of exercise during the study (Fig 4.6a) in both the 
ACTH-immune and the non-immune groups.
Phentolamine methane-sulfonate treatment caused an increase in plasma 
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for both groups increased further in response to exercise with the largest 
increase occurring during the 5 km/h. However, the increase in insulin 
levels for both groups at both exercise regimes was not significant. No 
significant differences between either group were observed.
Propranolol HCI treatment prior to exercise decreased plasma insulin levels 
in both the ACTH-immune and the non-immune groups (Fig 4.6c). For both 
groups insulin levels decreased from the start of the infusion with a 
significant decrease (P<0.05) occurring in the non-immune group during 
the 5 km/h exercise period. Although the insulin levels declined in the 
ACTH-immune group during the 5 km/h exercise, the decrease was found 
to be insignificant.
Arterial Haemoglobin (Hb) Concentrations
Arterial Hb concentrations are shown in figure 4.7. Exercise at 2.5 km/h 
and at 5 km/h induced an increase in arterial Hb concentrations in both 
groups (Fig 4.7a) with no significant difference between groups, although 
there was a tendency for ACTH-immune ewes to have lower Hb 
concentrations.
Neither antagonist had any significant effect on arterial Hb concentrations 
(Fig 4.7b, Fig 4.7c). During both the propranolol and phentolamine 
treatments the Hb concentrations in the ACTH-immune ewes were 
consistently lower than the non-immune ewes. Treatment with 
phentolamine tended to suppress these levels in both groups over the entire 
study, although a similar effect was not apparent in response to the saline 
and propranolol infusion.
Body Temperature
Body temperature in both groups tended to rise from the onset of the 
saline infusion and then increase during both exercise regimes (Fig 4.8a). 
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during the 5 km/h exercise. However, even though body temperature 
increased in the ACTH-immune ewes in response to the exercise the 
increase was not significantly different when compared to the rest periods.
A similar pattern of body temperature to that seen during the saline infusion 
was observed after treatment with both antagonists. The ACTH-immune 
group had a consistently lower body temperature when compared to the 
non-immune group throughout the study.
Blood Flow Levels (Cardiac Output)
Blood flow levels are given in figure 4.9. Blood flow increased significantly 
(P<0.05) in both groups during the 2.5 km/h and 5 km/h exercise periods 
(Fig 4.9a) but no significant difference between the treatments was 
observed.
Cardiac output in both groups tended to increase from the onset of the 
phentolamine infusion. There was a further increase during the 2.5 km/h 
exercise period and then significantly increased (P<0.05) during the 5 km/h 
exercise period (Fig 4.9b). Phentolamine treatment tended to increase 
cardiac output when compared to the saline and the propranolol treatments, 
but again there was no significant difference between the ACTH-immune 
and the non-immune groups throughout the experimental period.
The infusion of propranolol HCI tended to decrease cardiac output over 
the experimental period when compared to both the saline and 
phentolamine treatments. There was no significant difference between 
either the ACTH-immune and the non-immune groups. During the 2.5 km/h 
exercise period cardiac output increased and significantly increased 
(P<0.05) during the 5 km/h exercise period (Fig 4.9c).
Oxygen Consumption
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Figure 4.10 Changes in oxygen consumption levels in response to exercise at 2.5 km/h and 5.0 km/h
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significant increase (P<0.01) in 0 2 consumption in both the ACTH-immune 
and the non-immune ewes (Fig 4.10a). The 0 2 consumption profile over the 
experimental period was similar for both groups, however, the ACTH- 
immune group tended to consume less oxygen at both exercise periods.
Phentolamine or propranolol treatments resulted in a similar 0 2 
consumption in both groups as seen during the saline treatment with 
significant (P<0.01) increases in 0 2 consumption during both exercise 
periods. Oxygen consumption in the ACTH-immune group was reduced 
when compared to the non-immune group during the 2.5 km/h and the 5 
km/h exercise period (Fig 4.10b). On the other hand treatment with 
propranolol resulted in a significant (P<0.05) reduction in 0 2 consumption 
at both exercise periods in the ACTH-immune group compared to the non­
immune group (Fig 4.10c).
Sa02 and Sv02 Saturation Difference
The difference between arterial 0 2saturation and the venous 0 2 saturation 
are shown in figure 4.11. Oxygen saturation in the arterial blood of all 
animals remained at or near 100% throughout the experimental period 
regardless of treatment. Therefore the difference in oxygen saturation was 
principally derived from the 0 2 saturation of the venous return.
The A-V 0 2 saturation difference increased in the ACTH-immune ewes and 
significantly increased (P<0.05) in the non-immune during both exercise 
periods (Fig 4.11a). There was no significant difference in this parameter 
between the two exercise periods; however, the oxygen saturation for the 
ACTH-immune group tended to be lower for both exercise periods when 
compared to the non-immune group.
The A-V 0 2 saturation difference profile during both of the antagonist 
treatments were similar to that seen during the saline treatment with an 
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4.11c). Treatment with phentolamine resulted in an insignificant increase 
for both groups at both exercise periods, whereas treatment with 
propranolol tended to increase the difference in the A-V 0 2 saturation 
profile during exercise resulting in a significant increase (P<0.05) in the 
non-immune ewes when compared to either the saline and phentolamine 
treatments (Fig 4.11c). The A-V 0 2 saturation difference in the ACTH- 
immune group tended to be lower compared to the non-immune group 
throughout the experimental period.
5.6. Discussion
Adrenaline and Noradrenaline
In man, the plasma concentrations of both adrenaline and noradrenaline 
have been shown to increase in response to exercise and the amount of 
catecholamines released are a function of both the intensity and the 
duration of the exercise (Christensen and Galbo, 1983). Chin and Evonuk
(1971) reported a significant increase in noradrenaline concentrations in 
exhaustively exercised rats compared to those which were moderately 
exercised. A similar observation was reported for calves by Blum and 
Eichinger (1988): in this study of ewes, catecholamine levels increased in 
proportion to the intensity of exercise, with no increase in either 
adrenaline and noradrenaline in ewes exercised on a treadmill at 2.5 km/h 
but a significant increase in both when they were exercised at 5 km/h.
Interestingly, the increases in adrenaline and noradrenaline levels during 
exercise were enhanced during the infusion of the adrenergic antagonist 
phentolamine methane-sulfonate. In a recent experiment of Benthem et al. 
(1995), the pre-treatment of rats with phentolamine before exercise 
induced both adrenaline and noradrenaline release. The increase in 
catecholamine levels in response to the infusion of phentolamine may be 
due to a lower level of feedback to the central nervous system, with the 
result of an enhancement of neural excitation in the absence of negative 
feedback. This teleological hypothesis is in agreement with the arguments
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put forward by Benthem et a/. (1995) when explaining their results on the 
sympathetic response in rats following treatment with adrenergic 
antagonists. They suggested that such a response was due to an alteration 
in the negative feedback control mechanism following the antagonism of 
adrenergic receptors within the sympathetic nerve endings. In the rat there 
are both a2- and /?2-adrenergic receptors in the pre-synaptic membranes of 
the sympathetic nerve endings (Scheurink et aL, 1989a). Benthem et al. 
(1995) suggested that a masking of the or2-adrenergic receptors within the 
synaptic membranes would lead to an elimination of the inhibitory role of 
this receptor type on catecholamine secretion thus leading to the 
exaggerated catecholamine release. A similar mechanism may be operating 
in ewes following administration of phentolamine.
Cortisol
Circulating cortisol levels increased during exercise with the greatest 
increase occurring during the 5 km/h exercise period. As with 
catecholamines, this rise in cortisol secretion during exercise has been 
shown to be proportional to the intensity of the exercise, a response similar 
to that reported in sheep by Apple et al. (1994). These workers determined 
that in sheep, activation of the hypothalamic-pituitary-adrenal axis occurs 
when the exercise intensity provokes a greater than 70% V02 max. 
Treatment with either a- or ^-adrenergic antagonists did not significantly 
alter the cortisol profile or the circulating levels of cortisol in the non­
immune group during the present study.
In the ACTH-immune group, circulating cortisol levels were unaffected by 
exercise or by treatment with the adrenergic antagonists. Cortisol 
concentrations remained at or near basal levels for the duration of the study 
period. This lack of adrenal responsiveness to exercise clearly demonstrates 
the efficacy of ACTH 1-24 immunisation in suppressing stress-induced 
cortisol secretion.
80
The physiological significance of the rise in cortisol secretion during 
exercise is still to be determined. Glucocorticoids are thought to play a 
minor role during exercise with the effects of these hormones generally 
taking hours to be manifested. There is some evidence to show that the 
glucocorticoids may increase intrahepatic gluconeogenesis, although this is 
only seen during prolonged exercise periods rather than in response to brief 
periods of intensive exercise (Wasserman, 1995). It is known that the 
glucocorticoids act permissively to mediate the actions of glucagon and 
adrenaline and this is done by influencing gluconeogenic enzymes in the 
liver. There is recent evidence to suggest that the glucocorticoids may be 
acting directly to influence adrenergic sensitivity at the level of the 
adrenergic receptor. A recent study using human lymphocytes (Allolio et 
a!., 1994) demonstrated a direct influence of the glucocorticoids on the 
regulation of the /?2-adrenergic receptor status. This group reported a 
correlation between glucocorticoid concentration, the density of the binding 
sites and altered c-AMP levels. A reduced glucocorticoid concentration 
decreases the binding site density of the /?2-adrenergic receptor and 
reduces intra-cellular c-AMP levels in response to agonist activation. Thus, 
it appears that glucocorticoids may influence energy substrate metabolism 
during intense exercise indirectly by modulation of the /?-adrenergic 
receptor. This may be especially pertinent to FFA metabolism, quantitatively 
the most important fuel used for energy generation during exercise (Harman 
1991).
Free Fatty Acids
In the present study, FFA levels in the non-immune ewes increased during 
exercise, presumably in response to the elevated catecholamine levels. The 
exercise-induced release of adrenaline and noradrenaline has a direct 
influence on lipid metabolism and results in increased peripheral glycerol 
and FFA levels, (man Christensen and Galbo, 1983; sheep Bird et a!., 
1981). Interestingly, there was no increase in FFA levels in the ACTH- 
immune ewes during either of the exercise regimes. A similar result was
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obtained during a-adrenergic blockade.
The failure of FFA levels to increase during exercise in the ACTH-immune 
ewes may reflect an association between glucocorticoid concentration and 
the ^-adrenergic receptor status. The low levels of FFA's seen during 
exercise in the ACTH-immune ewes may be a result of a decrease in /?- 
adrenergic receptor concentration, resulting from the suppression of 
glucocorticoids by the immunisation regime. The requirement for 
glucocorticoid interaction in the regulation of lipid metabolism during 
exercise is made even more prominent when the catecholamine levels are 
considered. There was no significant difference in the catecholamine levels 
between the ACTH-immune and the non-immune groups during the study 
period regardless of treatment. This result indicates that the catecholamines 
per se are unable to initiate FFA release during exercise without the 
secretion of the glucocorticoids.
The a-adrenergic antagonist, phentolamine, induced an abnormal elevation 
in insulin secretion, especially during the 5km/h exercise period; however, 
this treatment did not appear to affect lipolytic activity. This is of interest 
because insulin is highly antilipolytic, especially in the ruminant (Vernon, 
1980; West and Passey, 1967). A similar result to the current study was 
reported by Benthem et al. (1995) in exercising rats during a-adrenergic 
blockade with phentolamine. These workers suggested that the effects of 
elevated insulin levels may have been negated by the increase in plasma 
noradrenaline and adrenaline levels which occurred during exercise and 
following a-adrenergic blockade. This hypothesis could explain the results 
from the present study in which there was a 7-fold increase in 
noradrenaline levels and a 6-fold increase in adrenaline levels which was 
measured in response to the 5 km/h exercise period.
Insulin
Insulin levels for both the ACTH-immune and the non-immune ewes
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treated with saline were mostly unaffected during the study up until the 
end of the 5 km/h exercise period, when levels increased sharply, 
particularly in the ACTH-immune group. Presumably the insulin levels 
increased at this time in response to the elevation in glucose levels which 
rose at the onset of the exercise. Insulin levels remained unchanged during 
the 5 km/h exercise period even though plasma glucose levels had 
increased. This finding is in agreement with other studies for the sheep 
(Brockman, 1979) and for studies done in other species including man 
(Galbo, 1981) cattle (Blum and Eichinger, 1988) and rats (Benthem et a!.,
1995). These authors reported that plasma insulin concentrations declined 
during exercise. The apparent disassociation between circulating insulin and 
glucose levels may be a consequence of the elevated catecholamine levels 
observed during the more intensive exercise period.
Both adrenaline and noradrenaline inhibit insulin secretion in humans and 
in cattle through their interaction with the a-adrenergic receptor sites on the 
pancreatic fi-ce\\s (Smith and Porte, 1976; Blum and Eichinger, 1988). The 
present experiment indicates clearly that for the sheep, inhibition of insulin 
release is mediated via the a-adrenergic receptors on the pancreatic islet 
cells. Insulin release is enhanced when the a-adrenergic receptors are 
blocked and conversely is suppressed when the /^-adrenergic receptors are 
blocked. These effects were only apparent when animals were exercised 
intensively, which also corresponded to the higher circulating levels of the 
catecholamines. The possible involvement of the /^-adrenergic receptor in 
the regulation of insulin secretion during exercise is also highlighted by this 
study in that both stimulatory (/?-adrenergic) and inhibitory (a-adrenergic) 
receptors are activated on the pancreatic /?-cells during intensive exercise. It 
is likely therefore, that the ratio of stimulatory to inhibitory adrenergic input 
which is altered by the intensity of the exercise, presumably via the 
circulating catecholamine concentrations, is the ultimate determinant of the 
nature of the catecholaminergic response in the pancreas.
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Glucose
Plasma glucose levels increased in both the ACTH-immune and the non­
immune ewes only during the more intense exercise (5 km/h) period. This 
result is in keeping with other studies for the sheep (Brockman 1979, 
Pethick et aL, 1991, Apple et al., 1994) and similar results have also been 
reported in man (Wasserman, 1995). Wasserman (1995) suggested that 
during moderate exercise an increase in glucose production matches the 
rate of glucose utilisation in muscle and as a result only small deviations in 
blood glucose levels are detected. In contrast, during the high intensity 
exercise, the glucoregulatory response resembles a stress condition 
resulting in overt glucose production which exceeds the increase in glucose 
utilisation as the glucoregulatory system strives to maintain the supply of 
energy substrate for the CNS. Therefore, during high intensity exercise 
blood glucose levels rise. These considerations may account for the 
observations seen in the current experiment where both adrenaline and 
noradrenaline levels, known for their primary role as stimulators of 
glycogenolysis (Christensen and Galbo, 1983) increased only in response to 
the intense exercise. Similar reports for rats (Scheurink et al., 1989a) and 
calves (Blum and Eichinger, 1988) showed that a rise in blood glucose was 
matched by increases in catecholamine concentrations. A similar close 
relationship between glucose mobilisation and catecholamine status has 
been found in man subjected to intensive exercise (Marliss et a!., 1992).
In the current study, ^-blockade with propranolol enhanced the plasma 
glucose response during both exercise periods in both the ACTH-immune 
and the non-immune ewes. This increase in plasma glucose may be the 
result of an altered hepatic or-adrenergic receptor activity which may have 
been sensitised in response to the /?-blockade. Consistent with the present 
finding is that glucose production, when measured as the glucose 
appearance rate, is also mediated by the hepatic a-adrenergic receptors, in 
man (Sigal et al., 1994) and rat (Morgan et a!., 1984). In addition to the 
proposed glucoregulatory effects of the catecholamines, propranolol
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induced up-regulation of the a-receptor which resulted in an inhibition in 
insulin secretion may also have contributed to the increase in plasma 
glucose levels.
The o-adrenergic antagonist phentolamine, failed to prevent the rise in 
plasma glucose observed during the 5 km/h exercise period, although 
glucose levels did decline during the 2.5 km/h exercise regime. This decline 
may have been the result of a number of altered physiological mechanisms 
which are mediated via the cr-adrenergic receptor. Most important among 
these is the inhibition of liver glycogenolysis and enhanced plasma insulin 
levels. The increase in plasma glucose levels during the 5 km/h exercise 
period is of interest as it demonstrates either ineffective adrenergic 
blockade with phentolamine or an increase in the efficacy of some 
hormones involved in glucose mobilisation especially the catecholamines. 
This is an important consideration as both responses to adrenaline and 
noradrenaline increased dramatically during the a-adrenergic blockade. The 
largest increase was in plasma noradrenaline levels, suggesting that the 
increase in plasma glucose may be a consequence of an elevation in 
noradrenaline levels.
Lactate
Circulating lactate levels in both the ACTH-immune and the non-immune 
ewes increased only during the 5 km/h exercise period, indicating that both 
groups had surpassed the anaerobic threshold (Pethick et a!., 1991) during 
this time. The fact that lactate levels did not increase during the 2.5 km/h 
exercise is in agreement with other studies for the sheep (Pethick et af., 
1991; Harman, 1991). Pethick and co-workers (1991) suggested that the 
circulating lactate levels are dependent on the intensity of the exercise and 
they reported that lactate levels increase dramatically at exercise intensities 
which require anaerobic metabolism. Although there was no observed 
increase in peripheral lactate levels during exercise at 2.5 km/h, this does 
not exclude the possibility of increased lactate turnover during this exercise
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period. Studies in man (Stanley et a!., 1988) and in the dog (Issekutz, 
1984) have shown increased lactate turnover during submaximal exercise 
without a concomitant increase in plasma lactate levels.
The increased circulating lactate levels observed during the 5 km/h 
exercise period may be a consequence of the increased adrenaline and 
noradrenaline levels. The association between exercise intensity, lactate 
production and catecholamine levels in the sheep has been suggested by 
Apple et at. (1994). Support for this hypothesis come from studies 
conducted in man, where there is a direct linear relationship between the 
catecholamine concentration and lactate production during exercise of 
increasing intensity (Mazzeo and Marshall, 1989). It would appear that the 
catecholamine effects are not the only means by which muscle 
glycogenolysis and the associated increase in circulating lactate levels are 
affected. Studies in the rat, (Richter et al., 1982) and the dog (Issekutz, 
1984) have shown that muscle glycogenolysis is under the dual control of 
both adrenaline and intracellular Ca2+ levels acting on the /?2-adrenergic 
receptor to stimulate the generation of cAMP. Muscle contractions elevate 
intracellular Ca2+ levels and this in turn stimulates muscle glycogenolysis 
early in exercise, whereas adrenaline causes a sustained increase in muscle 
glycogenolysis (Richter et a!.f 1982, Issekutz, 1984).
In the current experiment, ^-adrenergic blockade with propranolol failed to 
inhibit the rise in circulating lactate levels during the 5 km/h exercise 
period. This failure was unexpected as ^-adrenergic blockade has previously 
been shown to inhibit the exercise induced increase in muscle 
glycogenolysis in dogs (Issekutz, 1984) and cattle (Blum and Fluckinger, 
1988). In addition, Bassett (1970) demonstrated, using propranolol HCI in 
the sheep an effective ^-adrenergic receptor blockade of muscle 
glycogenolysis by preventing the adrenaline-induced increase in lactic acid. 
It is difficult to give a reason for this failure of plasma lactate to rise in the 
sheep. However, it may be associated with the increased muscle
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contractions induced during the 5 km/h exercise period. A recent study 
using human lymphocytes has shown that dynamic exercise induces the 
translocation of ^-adrenergic receptors from intracellular sites to the cell 
surface (Fujii et a!., 1993). These workers also demonstrated that the 
increase in the rate of translocational activity of the ^-adrenergic receptor 
was proportional to the exercise intensity. The concentration of propranolol 
HCI level used may not have been sufficient to have blocked all the 
receptors during the intense exercise period. The possible failure on the 
antagonist to completely block /^-adrenergic receptor activity may be related 
to an increase in cell surface /^-adrenergic receptor status similar to that 
reported by Fujii et a/. (1993). The exercise induced increase in /?-adrenergic 
receptor status may also account for the graded physiological response 
observed during the two exercise regimes.
The concentration of propranolol used in the current study was effective 
in preventing the rise in FFA's at both exercise regimes. This may reflect 
the specificity for the increase in translocational activity of the /^-adrenergic 
receptor in that its regulation may be confined to the working tissue, in this 
case the exercising muscle. This suggestion is supported by Bassett's 
(1970) study in which he demonstrated effective blockade of /?-adrenergic 
induced muscle glycogenolysis using propranolol HCI in the resting sheep.
The elevated lactate levels observed during blockade of the ^-adrenergic 
receptors seen in the present study may be a direct consequence of an 
increase in muscle contractions. This may be an explanation for the 
difference observed in Bassett's study where sheep were infused with 
exogenous catecholamines but not subjected to exercise. As a result 
neither the activation in intracellular muscle Ca2+ levels nor an activation of 
the increased number of ^-adrenergic receptors would have occurred.
The increased lactate levels at these two exercise regimes demonstrates 
the efficacy of the ^-adrenergic receptor in mediating adrenergic activation
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of muscle glycogenolysis. It would appear that the phentolamine enhanced 
catecholamine levels may have contributed to the increased plasma lactate 
levels. The plasma lactate levels were still significantly elevated by the end 
of the experiment, 90 minutes after the completion of the exercise. This 
may simply reflect a slower return to basal levels owing to the higher 
lactate concentration attained during the 5 km/h exercise period (a 30% 
increase in concentration compared to the saline treatment). However, the 
dramatically increased insulin levels, resulting from the a-adrenergic 
blockade, may have also contributed to this high lactate level post exercise. 
In man, insulin has been shown to have a direct inhibitory effect on 
gluconeogenesis firstly by decreasing the flow of gluconeogenic substrates 
from the peripheral tissues and secondly by directly inhibiting their 
conversion into glucose within the liver (Liljenquist et a/., 1979). For the 
sheep, insulin has also been shown to inhibit gluconeogenesis by reducing 
the net hepatic uptake of gluconeogenic substrates (Brockman and 
Laarveld, 1986). Interestingly, the uptake of lactate has been shown to be 
more sensitive to insulin effects than the other gluconeogenic substrates 
(Brockman and Laarveld, 1986) and so a reduction in hepatic uptake of 
lactate in response to insulin may occur before reduced uptake of the other 
gluconeogenic substrates.
Haemoglobin
Arterial haemoglobin (Hb) levels increased in response to both exercise 
regimes. This increase is most likely due to the release of blood from the 
splanchnic bed and in particular from the spleen. The elevated Hb levels 
observed in this study may be related to the exercise induced increase in 
catecholamine levels. Studies in man have shown the spleen is innervated 
by a dense sympathetic adrenergic network which, when activated, results 
in the expulsion of blood (Donald, 1983). In addition, neural activation of 
the spleen during exercise results in an increased discharge of erythrocytes 
into the circulation with an accompanying increase in haematocrit 
(Detweiler, 1984). The increased release of erythrocytes, especially during
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exercise increases the supply of oxygen to the tissues. The ability to 
increase Hb levels and therefore oxygen carrying capacity is an important 
mechanism which enables ruminants to increase oxygen transport to the 
exercising muscle (Kuhlmann et a/., 1985).
During the 2.5 km/h exercise, Hb levels initially increased and then 
declined throughout the remainder of the exercise period. When the 
intensity of the exercise was increased to 5 km/h, Hb levels were 
maintained at an elevated level for the duration of the exercise. The 
maintenance of elevated Hb levels throughout the 5 km/h exercise period 
probably reflects an oxygen debt that the animal develops during this more 
intensive exercise and which the animal attempts to overcome by 
maximising blood haemoglobin levels. These elevated Hb levels during 
anaerobic exercise have also been reported in other studies for sheep 
(Apple et a!., 1994) and calves (Kuhlmann et a!., 1985).
One of the most interesting results which arose from this study was the 
observed difference in Hb levels between the ACTH-immune and the non­
immune ewes. Haemoglobin levels for the ACTH-immune group tended to 
be lower throughout the experimental period regardless of the treatment. It 
appears from the results of this study that manipulation of the HPA axis by 
the immunisation of ACTH 1-24 may result in an alteration of the Hb 
content and possibly the oxygen carrying capacity within sheep 
erythrocytes The reason for this reduction in Hb levels in the ACTH-immune 
group remains to be elucidated.
Oxygen Consumption
In the current experiment, oxygen consumption (V02 ) increased in 
response to both exercise regimes, the greater increase being observed 
during the 5 km/h exercise period. This finding is in accordance with other 
studies which have shown a similar relationship between exercise intensity 
and V 02 for the sheep, (Mundie et a/., 1991; Apple et a 1994) calves
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(Kuhlmann et al., 1985) and in man (Epstein etaL,  1965). This relationship 
was further expanded by Pollock (1973), who showed that V02 
represented the total muscular effort expended and that it was influenced 
by both the intensity and the duration of the exercise. A number of 
physiological factors are involved in the alteration of V02 in response to 
exercise, with changes in cardiovascular control, including cardiac output 
and differences in arterial and venous 0 2 saturation being the most 
prominent. In addition, the availability and type of energy substrate oxidised 
(glucose, FFA's) is also important to V02 during exercise (Benthem et at., 
1995).
An intriguing result from the present study was the observation from the 
ACTH-immune ewes consumed less oxygen during both exercise regimes 
compared to the non-immune ewes. This reduced V02 in the ACTH-immune 
group was consistent throughout the exercise periods regardless of the pre­
treatment. The finding that ACTH immunisation reduced the 0 2 
consumption in exercising ewes was first reported by Shahneh et al., 
(1994). Shahneh and co-workers (1994) also found that cortisol 
replacement of ACTH-immune ewes did not alter the reduced V02 in 
response to aerobic and anaerobic exercise. It thus appears that factors 
other than reduced cortisol levels may be responsible for the reduction in 0 2 
consumption observed in the ACTH-immune ewes.
Cardiac Output
Cardiac output increased in response to both exercise regimes with the 
greater response occurring during the more intense exercise period. Skinner 
and McLellan (1980) have reported that in man there is a linear relationship 
between heart rate and exercise intensity. A similar relationship has been 
reported for sheep when exercised on a treadmill (Apple et a!., 1994; 
Newman et a!., 1986).
The increase in cardiac output during exercise, especially during the more
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intense exercise, is the result of the requirement for the increased oxygen 
demand imposed by the working muscles of the sheep. In man, the normal 
pacemaker of the heart is under the opposing influences of the sympathetic 
and parasympathetic nervous systems. The effects of ^-adrenergic receptor 
blockade decreased cardiac output both during exercise and during the rest 
periods. This finding was also observed in man by Epstein and co-workers 
(1965) who demonstrated that treatment with propranolol reduced cardiac 
output at rest. In contrast, a-adrenergic receptor blockade tended to 
increase cardiac output during exercise and the rest periods. The fact that 
both propranolol and phentolamine influenced cardiac output during the rest 
periods indicates that sympathetic regulation of the heart is also important 
in maintaining cardiac output during the resting state.
During exercise it seems that sympathetic stimulation does not appear to 
be the only regulatory mechanism by which cardiac output is modulated. 
Although /^-adrenergic blockade with propranolol reduced cardiac output 
during rest periods, the same antagonist was unable to prevent the 
substantial increase in cardiac output observed during exercise. This finding 
is in agreement with studies conducted in man that show an increased 
cardiac output in response to exercise in the presence of /?- receptor 
blockade with propranolol (Epstein et a/., 1965). Therefore, in sheep as in 
man, the contribution of the sympathetic nervous system to the stimulation 
of cardiac output during exercise appears to be relatively small and so 
control may be modulated by other mechanisms.
Arteriovenous Oxygen Difference
During exercise, the arteriovenous oxygen difference of the mixed venous 
blood (AVD) increased during the two exercise periods. In man, this 
difference is mainly due to the escalation in the oxygen extraction ratio 
from the blood (Brundin, 1978). The increase in the AVD in the present 
study appears to be associated with the level of cardiac output. During /?- 
receptor blockade, the decline in cardiac output was compensated for by
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the increase in the AVD, indicating that there was an increase in the 
oxygen extraction. Conversely, when cardiac output increased during a- 
receptor blockade the decrease in the AVD was not as great, indicating a 
reduced requirement for oxygen uptake from the blood. Thus, the animal is 
highly sensitive to its oxygen requirements and is able to acutely regulate 
oxygen extraction to meet this need.
Interestingly, the AVD in the ACTH-immune ewes was not as great as in 
the non-immune ewes, indicating a reduced 0 2 extraction from the mixed 
venous blood. This finding also reflects and confirms that the ACTH- 
immune ewes' have a reduced 0 2 requirement for the same work load. As 
yet, it is difficult to determine why active immunisation against ACTH 1-24 
should have such a marked effect on oxygen consumption during exercise. 
Thus, the need for further investigation into this area is evident.
Body Temperature
Body temperature, as measured in the pulmonary artery increased in 
response to both exercise regimes; the more intense exercise give rise to 
the greater increase in this parameter. The measurement of body 
temperature using the mixed venous blood has been shown to represent 
the true body temperature as it more accurately reflects the balance 
between the production and the elimination of heat (Brundin, 1975). Nelson 
(1969) demonstrated in man that the increase in body temperature during 
dynamic exercise was the result of increased muscular activity. In addition, 
the rise in temperature during exercise has been shown to be directly 
related to the amount of energy released and is inversely related to the 
magnitude of the perfusion of blood to the skin as increased skin blood 
perfusion can increase the heat loss (Johnson et at., 1974). This finding 
appears to be analogous to the current experiment, as the increase in body 
temperature mirrored the V02, and therefore energy expenditure.
Adrenergic receptor blockade with either propranolol or phentolamine
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increased the arterial body temperature during both exercise regimes. This 
was expected as adrenergic blockade has previously been shown to 
interfere with the thermoregulatory response to short term exercise in man 
(Brundin, 1978). This interference by the adrenergic blockade may be due 
to the suppression of skin blood perfusion by 0- blockade (Johnsonef a/., 
1974) and the known effects of a- blockade on the dilation of the blood 
vessels (Van Zwieten, 1988).
4.7 . Conclusions.
This experiment clearly demonstrates that dynamic exercise in the ewe is 
an effective means of activating the two "stress axes", the 
sympathomedullary axis and the hypothalamic pituitary adrenal axis. As 
with humans, the degree to which these axes are stimulated is proportional 
to the intensity of the exercise, and as such, influences the degree of the 
physiological response. Exercise induced an increase in plasma FFA's, 
plasma glucose and plasma lactate, while insulin secretion remained at or 
near basal levels. The increase in plasma FFA's during surgery is mediated 
by the ^-adrenergic receptor, and plasma glucose levels by the a-adrenergic 
receptor. The inhibition of insulin secretion from the pancreatic /?-cells is 
mediated by both a- and /?-adrenergic receptors. The a- receptor inhibits 
insulin secretion and the 0- receptor stimulates insulin secretion.
The cardiovascular response was also altered in response to exercise; 
increased cardiac output, and oxygen extraction from the blood, increased 
oxygen consumption and an increase in the haemoglobin levels were all 
demonstrated. The adrenergic involvement of the above responses was not 
conclusive with little or no change during receptor blockade. Although, as 
expected cardiac output declined during treatment with the 0- blocker 
propranolol and increased when treated with the a- blocker phentolamine. 
The ACTH-immune ewes consumed less 0 2 than the non-immune ewes 
during exercise. The greatest demand for 0 2 was during the more intensive
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exercise, at 5 km/h. The ACTH-immune ewes requirement for less 0 2 was 
also reflected in this groups reduced 0 2 extraction from the venous return 
during exercise when compared to the non-immune ewes.
The stimulation of the sympathomedullary stress axis and the subsequent 
release of the catecholamines was found to be the most important of the 
two stress axes in mediating the physiological responses seen during 
dynamic exercise. However, the HPA axis also plays a significant role 
during dynamic exercise, especially in its ability to influence energy 




Metabolic and Blood Pressure Changes Associated with the 
Endogenous Release of Noradrenaline Induced by Tyramine Hydrochloride 
Infusion
5.1. Introduction
Stimulation of the sympathetic nervous system results in the rapid release 
of the catecholamines, (dopamine, adrenaline and noradrenaline) from the 
adrenal chromaffin cells and sympathetic nerve terminals into the peripheral 
circulation (Harvey et a!., 1984). This increase in circulating
catecholamines, principally adrenaline and noradrenaline has been shown to 
have wide ranging effects on intermediary metabolism and results in the 
rapid mobilisation of energy substrates from the storage tissues of the body 
(Webber and Macdonald, 1993). Catecholaminergic effects on metabolism 
can be by direct stimulation of the adrenergic receptors in metabolically 
active tissues, and by indirect interactions with other endocrine regulators 
(Webber and Macdonald, 1993).
Previous studies in many species have demonstrated both metabolic and 
haemodynamic changes following the infusion or injection of 
catecholamines (for review see Himms-Hagen, 1967). These changes are 
mediated by stimulation of specific adrenergic receptors that influence 
blood pressure and metabolic processes which include lipid and 
carbohydrate metabolism (Himms-Hagen, 1967). Increases in plasma 
glucose, lactic acid and free fatty acids have been reported after infusions 
of adrenaline and noradrenaline into sheep (Bassett, 1970; Halmagyi et al.f 
1967). Increases in systemic arterial pressure and cardiac output following 
adrenaline infusion have also been reported for the sheep (Halmagyi et a!., 
1967).
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The investigation of the physiological effects of any hormone when 
administered exogenously to animals is inevitably compromised by the 
failure of the mode of administration to mimic endogenous secretory 
pattern of the hormone. Thus it is not surprising that studies involving 
catecholamine infusions suffer from the same compromise (Webber and 
Macdonald, 1993). This problem of exogenous catecholamine 
administration is especially apparent when defining the metabolic 
consequences of noradrenaline release. Noradrenaline primarily functions as 
the major neurotransmitter within the sympathetic nervous system and thus 
it's physiological effects are directed at a local tissue level. Therefore, the 
administration of exogenous noradrenaline does not reflect the typical 
endogenous sympathetic response (Himms-Hagen, 1967).
The administration of tyramine HCI results in the displacement of 
noradrenaline from it's storage vesicles and displaces noradrenaline into the 
cytosol (Poch and Kopin, 1966) and in turn, can stimulate the noradrenergic 
receptors (Usdin and Snyder, 1973). Haemodynamic changes in the sheep 
have been demonstrated after the infusion or injection of tyramine HCI 
resulting in increased blood pressure (Lumbers et a/., 1980; Walker and 
Schuijers, 1989). As well, alteration of the secretion rates of both insulin 
and glucagon from the rat pancreas have been demonstrated after the 
administration of tyramine HCI (Hirose et aL, 1994).
The use of a- and /?- adrenergic antagonists has been shown to facilitate 
the understanding of the metabolic responses mediated by the activation of 
the sympathetic nervous system. In the sheep, the a-adrenergic antagonist 
propranolol HCI and the ^-adrenergic antagonist phentolamine methane- 
sulfonate have been used in to determine the metabolic responses after 
infusion with catecholamines (Bassett, 1970).
In the present study, we have investigated the physiological effects of 
catecholamines by altering the pattern of endogenous secretion using the
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sympathomimetic amine tyramine hydrochloride. This method of initiating 
catecholamine release more closely mimics the stress induced cascade of 
events that result in catecholamine secretion.
5.2. Aims
1: To determine the blood pressure, metabolic and endocrine changes in the 
sheep during infusion with tyramine HCI.
2: To determine the blood pressure, metabolic and endocrine status when 
sheep are pre-treated alone or in combination with the adrenergic 
antagonists, propranolol HCI and phentolamine methane-sulfonate prior to 
tyramine HCI infusion.
5.3. Materials and Methods 
Animals
Eight mature Border Leister x Merino ewes with a mean body weight of 
67.9 ± 1.2 kg were housed at the CSIRO Division of Animal Production 
Prospect N.S.W. (latitude 34°S). Ewes were acclimated to single pens and 
handled frequently for a period of three months to accustom them to the 
experimental procedure. Subsequently, the ewes were transferred to 
individual metabolic cages (Till and Downes, 1963) and housed in a 
thermoneutral environment under continuous light. Ewes had access to 
water at all times and were fed a pelleted ration (800 gms) consisting of 
60% hammermilled lucerne and 40% crushed oats. It was estimated that 
the metabolisable energy the ewes were receiving was 10.4 MJ/Kg. All 
ewes were fed 2 hours after the final infusion.
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Surgical Procedures
Saphenous /Femoral Artery Cannulation for Blood Pressure Determination
Ewes were fasted for 24 hours and denied water for 12 hours prior to the 
surgical procedure. To allow insertion of the endotracheal tube, the short 
acting anaesthetic agent Thiopentone sodium (Boehringer) was 
administered intravenously at a rate of 15-20 mg/kg body weight. Ewes 
were then induced with 2-4% Fluothane (ICI) in oxygen to maintain general 
anaesthesia.
Sterile catheters, medical grade single lumen polyethylene tubing (1.0mm 
i.d., 1.5mm o.d, Dural Plastics, N.S.W.) were introduced approximately 
100mm into the femoral artery via the saphenous artery. Catheters were 
filled with heparinised saline (Fissons Pharmaceuticals Vic; 250 lU/ml.) 
containing Terramycin (Pfizer N.S.W.) at 200 mgs / ml. saline (Baxter 
Healthcare N.S.W.).
All ewes were given an intramuscular injection (4ml) of an antibiotic 
solution (Depomycin, Intervet, Australia) for 5 days following surgery.
Jugular Vein Catheterisation
A cannulae (medical grade polyethylene tubing i.d. 1.0 mm o.d. 1.5mm) 
was inserted into both jugular veins using a local topical anaesthetic 
(Xylocaine 10% spray, Astra Pharmaceuticals Pty Ltd., Melbourne). The 
cannulae were inserted through a sterile 14G catheter placement unit, 
(Jelco, Johnson and Johnson Medical, Japan) 100mm into each vein. Daily 
the contents of the cannulae were withdrawn and then flushed with sterile 
saline to maintain patency, and then refilled with fresh heparinised saline 
(500 lU/ml of heparin).
Measurement o f Arterial Blood Pressure
To measure arterial blood pressure the established femoral artery cannulae 
was connected to a disposable strain gauge pressure transducer (Viggo-
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Spectramed Aust.). The blood pressure transducer was placed at the level 
of the sheep's heart and connected to a recorder (Neo Trace). Calibration of 
the physiological recorder and transducer was carried out using a mercury 
manometer. The graded changes in Hg pressure were transposed onto 
thermal chart paper (Graphtec Corp. Japan Chart No PZ468-2B).
5.3.1. Experiment 1
All experimental procedures were carried out in accordance with the 
requirements of the Ethics Committee, CSIRO Prospect.
Determination o f the Arterial Blood Pressure Response to Tyramine Doses
The first need was to determine what tyramine dose would be effective in 
raising the arterial blood pressure by not more than 50% above resting 
levels.
Concentrations of 0.1, 0.5, and 1.0 mg Tyramine HCI (Sigma Chemicals) 
Kg body weight were diluted in 10 mis sterile saline (Baxter Healthcare 
N.S.W.) and infused into 2 ewes via a jugular cannulae using a peristaltic 
pump at a rate of 0.22 mis / min.
5.3.2. Experiment 2
Noradrenergic Regulation o f Metabolism and Blood Pressure Procedure
Six ewes were divided randomly into two groups of 3. Identical 
procedures were carried out on both groups with a time interval of 2 weeks 
between each group. The saphenous artery was catheterised 7 days prior 
and jugular catheters were inserted 2 days prior to the commencement of 
the treatments. Two ewes from the first treatment group were selected for 
the experiment based on the patency of the saphenous arterial catheter. 
The remaining ewe was used as
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a reserve and was not used for the experiment.
Infusions
All infusions into conscious ewes were given intravenously via one of the 
jugular cannulae. Tyramine hydrochloride (Sigma Chemicals) was diluted in 
10 mis of sterile saline and infused for 45 min at a concentration of 0.5 
mg/kg/45 min. Propranolol HCI (sigma Chemicals) a non selective /?- 
adrenergic receptor antagonist was diluted in 20 mis sterile saline and 
infused for 60 min. at a dose rate of 0.5 mg/kg/60 min (Bassett 1970). 
Phentolamine methane-sulfonate, (Aldrich Chemical Co.) a non selective a- 
adrenergic receptor antagonist was diluted in 20 mis sterile saline and 
infused for 60 min. at a dose rate of 1.0 mg/kg/60 min (Bassett 1970). 
During and after treatment periods ewes were infused with sterile saline.
The treatments were administered in the following order:
Day 1: Tyramine HCI.
Day 3: Propranolol HCI followed by Tyramine HCI.
Day 5: Phentolamine methane-sulfonate followed by Tyramine HCI.
Day 7: A combination of Propranolol HCI + Phentolamine methane- 
sulfonate followed by Tyramine HCI.
The above experimental procedure was repeated on the second group of 
ewes 14 days later.
Blood Sampling
Venous blood samples were withdrawn from the second jugular cannulae 
using a 5ml syringe (Terumo Corporation Japan) after each sample 
catheters were flushed with heparinised saline (100 International lU/ml). 
Samples were taken at 15 min intervals for 30 min prior to the 
commencement of all infusions and again at 20 min intervals for 12 hours
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post infusion treatment. During infusion of the tyramine HCI, blood samples 
were taken at 5 min intervals for 60 min. During infusion of the antagonists 
blood samples were taken at 10 min. intervals for 60 min.
Blood samples were transferred into plastic P4 tubes (John Morris Ltd, 
Sydney, NSW), containing glass separation granules (Kwickspin Disposable 
Products Padstow) to facilitate plasma separation after centrifugation. All 
samples were kept on ice prior to centrifugation at 2000g for 15 min at 
4°C (Beckman GPR, USA). Plasma samples were stored at -20°C. until 
assayed.
Catecholamine Sample Collection
Blood samples for adrenaline and noradrenaline analysis were collected 
into sterile 5ml blood collection tubes containing EGTA and reduced 
glutathione (Amersham U.K.). A sample was taken 25 min before 
commencement of all infusions, and again at 15 min and 6 hours after the 
end of the tyramine infusion. During the tyramine infusion samples were 
taken at 20 and 40 min after the infusion began. During the infusion of the 
antagonists a sample was taken at 30 min after the start of the infusion. 
After collection, the samples were immediately centrifuged and the plasma 
collected and stored at -70°C.
5.4. Statistical Analysis
All data are presented as the mean ± S.E. of the mean. Baselines and 
post treatment measurements were analysed via ANOVA. For all data 
except noradrenaline repeated measures ANOVAs with Greenhouse and 
Geisser (1959) adjustment were carried out on pre-tyramine infusion data 
or during and/or post tyramine infusion. In addition, numbers of cortisol 
peaks and related statistics were estimated by Littlejohn's (1989) 





The pre infusion (resting level), blood pressure was 79.3 ± 2.3 mm Hg.
Changes in Arterial Blood Pressure to 3 concentrations of tyramine HCI
tyramine HCI 0.1 mg/Kg 0.5 mg/Kg 1.0 mg/Kg
B.P. x 79 mm Hg x 145 mm Hg >150 mm Hg
From the above table a dose rate of 0.5 mg / kg was chosen for the 
tyramine HCI infusions in experiment 2.
5.5.1. Experiment 2
Plasma Noradrenaline Levels
By 20 min after the start of the tyramine HCI infusion there was a small 
but insignificant increase in peripheral noradrenaline levels in 3 of the 4 
ewes (fig 5.1a) 2.59 ± 0.36 nmol/L compared to the pre-infusion level of 
1.48 ± 0.67 nmol/L. Circulating noradrenaline levels in all 4 ewes were 
elevated although not significantly 40 min after the commencement of the 
infusion ( 2.23 ± 0.91 nmol/L) and noradrenaline levels remained unaltered 
6 hours post infusion (2.13 + 0.88 nmol/L).
There was no change in plasma noradrenaline concentrations during the 
infusion of propranolol HCI in any of the 4 ewes (1.84 ± 1.43 nmol/L) 
compared to the pre-infusion concentration of 1.71 ± 1.33 nmol/L (Fig 
5.1b). However, circulating noradrenaline levels increased to 3.20 ± 1.53 
nmol/L after 20 min infusion with tyramine HCI. Noradrenaline levels then 



































Figure 5.1 changes in circulating noradrenaline levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion
Legend
phent=phentolamine methane-sulfonate, prop=propranolol HCI, T20 & 
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Figure 5.2 changes in circulating adrenaline levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion
Legend
phent=phentolamine methane-sulfonate, prop=propranolol HCI, T20 & 
T40=tyramine HCL 20 min. & tyramine HCI 40 min.
There was no significant change in plasma noradrenaline levels during the 
infusion of phentolamine (Fig 5.1c) (2.83 ± 1.37 nmol/L) when compared 
to the pre-infusion concentration (1.96 ± 1.11 nmol/L). Noradrenaline 
levels increased significantly by 20 min after the start of the tyramine HCI 
infusion (6.73 ± 1.53 nmol/L, P<.05). Levels fell to 3.76 ± nmol/L by 6 
hours post tyramine infusion, although, this concentration was still elevated 
compared to the pre- infusion sample.
There was a significant rise (Pc.05) in plasma noradrenaline levels during 
the infusion of both antagonists when compared to the pre-infusion (3.79 
± 1.45 nmol/L and 1.34 ± 0.81 nmol/L respectively) (Fig 5.1 d). Plasma 
noradrenaline levels remained elevated during the subsequent tyramine HCI 
infusion and then declined to basal levels (1.42 ± 0.60 nmol/L) by 6 hours 
post-tyramine HCI infusion.
Plasma Adrenaline Levels
The plasma adrenaline levels are shown in figure 5.2. There was no 
observed change in circulating adrenaline levels for any of the treatments. 
Concentrations were either low (tyramine HCI infusion alone Fig 5.2a and 
propranolol HCI infusion Fig 5.2b). or undetectable (phentolamine infusion 
fig 5.2c and the combined antagonist infusion Fig 5.2d).
Plasma Free Fatty Acid Levels
The plasma free fatty acid levels are given in figure 5.3. Free fatty acids 
rose following the tyramine HCI infusion when compared to the pre-infusion 
level (Fig 5.3a). This increase in plasma FFA's occurred 35 min after the 
start of the infusion. The mean FFA concentrations decreased 20 min after 
the cessation of the infusion to 0.36 ± .06 /ymol/L, which was similar to 
the pre-treatment level.
Infusion of propranolol HCI before tyramine HCI prevented the rise in FFA 
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Figure 5.3 changes in plasma free fatty acid levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion
animal had significantly higher basal FFA levels and this higher level 
persisted throughout the experimental period, but the maximum levels 
occurred during the tyramine infusion. Levels of FFA's began to increase in 
the ewes at the end of the tyramine infusion (0.92 ± 0.30 //mol/L) when 
compared to a pre infusion levels (0.57 ± .09 //mol/L).
Infusion with phentolamine before tyramine failed to prevent the rise in 
FFA levels following tyramine infusion alone (Fig 5.3c). Phentolamine 
infusion alone had no effect on FFA concentrations. Plasma FFA levels 
increased from the onset of the tyramine infusion reaching a maximum 
concentration of 1.54 ± 0.41 //mol/L after 40 min. Levels then declined to 
a mean level of 0.57 ± 0 .1 4  //mol/L 80 min post tyramine infusion.
There was no increase in circulating FFA concentrations during tyramine 
infusion in ewes previously infused with both propranolol and 
phentolamine. The combined infusion of the antagonists resulted in FFA 
levels which were higher than for the infusion of tyramine HCI (0.82 ±0.24 
//mol/L and 0.58 ± 0 .1 6  //mol/L respectively) but this was not significant.
Plasma Glucose and Plasma Insulin Levels
Circulating glucose and insulin levels for the treatments are shown in 
figure 5.4.
Both circulating glucose and insulin levels increased in response to the 
tyramine infusion (Fig 5.4a). Whereas the glucose levels increased gradually 
by 60 min at the end of the infusion, insulin levels showed a bi-phasic 
response, with an initial peak 20 min after the commencement of infusion 
followed by a higher peak 5 min after the cessation of the infusion. Both 
parameters decreased near to basal levels by 100 min after the cessation of 
the infusion.
Infusion of propranolol HCI before tyramine failed to prevent the increase 
in plasma glucose seen with the tyramine infusion alone (Fig 5.4b).
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Figure 5.4 changes in plasma glucose and circulating insulin levels in 
response to:
(a) : tyramine HOL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion
However, the pre-treatment with this antagonist resulted in lower insulin 
levels for the first 35 min of the tyramine infusion. Propranolol infusion 
alone had no effect on plasma glucose concentrations. The maximum 
glucose concentration of 85.2 ± 7.0 mg% occurred 40 min after the start 
of tyramine infusion while insulin levels began to increase 35 min after, 
increasing by 2 fold during the last 10 min of the infusion. Insulin levels 
continued to be high for the remainder of the study.
Infusion of phentolamine before tyramine prevented the rise in plasma 
glucose seen following tyramine infusion alone (Fig 5.4c). There was a 
small decrease in glucose levels during the infusion of tyramine HCI alone. 
In contrast, phentolamine infusion alone induced a significant increase 
(P<0.05) in plasma insulin levels which persisted for the first 15 min of the 
infusion and thereafter fell to basal levels by the end of the study. Glucose 
levels rose significantly (P<0.05) following the end of tyramine HCI 
infusion (49.23±1.82 mg% compared to the pre infusion concentration of 
46.13±0.99 mg%). Phentolamine infusion alone had no effect on glucose 
levels.
The combined infusion of propranolol + phentolamine before tyramine HCI 
prevented the rise in glucose concentrations seen following tyramine alone 
(Fig 5.4d). Similarly the combined antagonist infusion prevented any 
increase in insulin levels with the insulin concentrations remaining at pre­
infusion levels throughout the study.
Plasma Cortisol Levels
Plasma cortisol levels are shown in figure 5.5. Plasma cortisol levels were 
not affected during the tyramine infusion (Fig 5.5a). However, 15 min after 
the cessation of the infusion levels increased to reach a peak of 32.4± 10.9 








Figure 5.5changes in circulating cortisol levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
The pattern of plasma cortisol during the propranolol and the tyramine 
infusion was similar to that for the infusion of tyramine alone (Fig 5.5b). 
The mean levels in the propranolol treated group were higher than the 
tyramine treated group. These higher cortisol levels were attributed to ewe 
1309 which had higher cortisol levels for the duration of the study period. 
Propranolol per se had little effect on cortisol levels although the 
subsequent infusion of tyramine resulted in a 2 fold increase within 40 min 
of the commencement of the infusion.
Blood Pressure Levels
The blood pressure levels are shown in figure 5.6. Blood pressure (Fig 
5.6a) was elevated during the tyramine HCL infusion when compared to the 
pre-infusion level (157.9±7.8 mmHg, 94.7±3.3 mmHg respectively). 
Blood pressure levels fell immediately following the end of the tyramine 
infusion.
Infusion of propranolol HCI before tyramine prevented the tyramine 
induced increase in blood pressure (Fig 6b). There was no response in 
blood pressure to the propranolol infusion and blood pressure levels 
remained constant throughout the experimental period.
Infusion of phentolamine before tyramine prevented the tyramine induced 
increase in blood pressure (Fig 6c). Blood pressure levels remained 
constant throughout the experimental period.
Infusion of propranolol + phentolamine before tyramine prevented the 
tyramine induced rise in blood pressure (Fig 6d). Blood pressure levels 
remained constant throughout the experimental period.
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Figure 5.6 changes in arterial blood pressure levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion
5.6. Discussion
Plasma Noradrenaline
Intravenous infusions of tyramine HCL resulted in an increase in 
circulating noradrenaline levels regardless of prior treatment with either an 
a- or /?-adrenergic antagonist. The finding that tyramine HCL infusion 
increases circulating noradrenaline levels is consistent with previous 
infusion studies in foetal sheep (Walker and Schuijers, 1989), and man 
(Scriven et aL, 1983), however, adrenergic antagonists were not used in 
either of these studies.
The increase in peripheral noradrenaline levels following tyramine infusions 
were variable with the greatest increase in concentration after pre­
treatment with phentolamine methane-sulfonate before tyramine HCL The 
two adrenergic antagonists, propranolol HCI and phentolamine methane- 
sulfonate when infused alone had no effect on the release of plasma 
noradrenaline. When both antagonists were infused together plasma 
noradrenaline levels increased. This increase in noradrenaline levels could 
be as a result of noradrenaline released during synaptic transmission which 
is unable to bind to either the a-adrenergic or ^-adrenergic receptors 
because of the action of the antagonists. A result of this could be an 
increase in plasma noradrenaline levels due to a "spill over" into the 
peripheral circulation from the sympathetic nerve endings. This response 
may be magnified by the loss of negative feedback to the central nervous 
system, resulting in further neural excitation. This may be the case 
following the adrenergic blockade by the combined antagonists.
Plasma Adrenaline Levels
The infusion of tyramine HCL or tyramine infusion following the infusion 
of propranolol or phentolamine alone or in combination had no effect on 
plasma adrenaline levels. This is in agreement with Walker and Schuijers
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(1989) who showed that tyramine HCI failed to significantly change either 
plasma adrenaline or dopamine concentrations when infused into foetal 
sheep. The increase in plasma noradrenaline levels is consistent with 
tyramine HCI being a specific competitive inhibitor for noradrenaline uptake 
(Burgen and Iverson, 1965).
Plasma Free Fatty Acids
Tyramine HCL infusion caused a dramatic increase in plasma FFA levels. 
This increase occurred during the period of the tyramine HCI infusion and 
the levels decreased within 5 min following the end of the infusion. This 
increase in FFA levels was associated with the increase in endogenous 
noradrenaline. The increase in noradrenaline levels may stimulate FFA 
release because exogenous noradrenaline given to sheep (Bassett, 1970) 
and cattle (Blum et al., 1982) stimulate FFA release. The involvement of 
noradrenaline in FFA release is supported by the modulatory influences of 
the application of both a- and /?- adrenergic receptor antagonists.
Pre-treatment with the non selective ^-antagonist propranolol HCI 
prevented the tyramine induced rise in FFA, whereas pre-treatment with the 
non selective or-antagonist, phentolamine had no effect on the FFA release 
induced by tyramine. These results agree with studies in adipocytes which 
possess both stimulatory ^-adrenergic receptors and inhibitory a2- 
adrenergic receptors (Vernon, 1980). The anti-lipolytic effect of propranolol 
HCI in preventing the tyramine induced rise in FFA release is in agreement 
with infusion studies that have used propranolol HCI to prevent the 
adrenaline induced rise in FFA's in the sheep (Bassett, 1970) and in steers 
(Blum et al., 1982). Of interest from Bassett's study was the finding that 
pre-treatment with either phentolamine or phenoxybenzamine (a non 
selective cr-adrenergic antagonist) also prevented the adrenaline induced 
release of FFA. This result is in contrast to our own and is difficult to 
explain as both the concentration of the antagonist and the method of 
infusion were the same for both studies. However, the results reported here
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are in agreement with studies in other species, where treatment with 
phentolamine had no effect on the adrenaline induced release in FFA levels 
in steers (Blum et at., 1982; Frohli and Blum 1988) and in rabbits 
(Knudtzon, 1984).
The influence of the combined antagonists in preventing lipolysis is most 
likely due to the effects of the propranolol HCI with its ability to 
competitively inhibit the noradrenergic inputs via the /^-adrenergic receptors.
Plasma Glucose and Plasma Insulin
Tyramine HCI infusion increased plasma glucose and levels remained 
elevated throughout the infusion period. The increased plasma glucose 
could be as a result of the effect of noradrenaline whose levels increased 
during the tyramine infusion. Noradrenaline is known to stimulate peripheral 
glucose levels by increasing glycogenolysis and gluconeogenesis (Himms- 
Hagen, 1967). Glucose levels are influenced by activation of the /?- 
adrenergic receptors and more specifically, the /?2-receptor in response to 
increased circulating levels of adrenaline and noradrenaline (McDowell and 
Annison, 1991). The idea that the increased noradrenaline levels resulting 
from the tyramine infusion give rise to the increase in plasma glucose is in 
contrast to the study of Bassett (1970), who showed that in sheep, 
infusion of noradrenaline had little effect on circulating glucose levels. This 
difference is in the two studies may be due to the problems associated with 
exogenous infusion of catecholamines, especially with noradrenaline 
infusion. In Bassett's study (1970) the amount of noradrenaline infused 
may not have been sufficient with noradrenaline being broken down before 
it reached the adrenergic receptors but, more likely, the peripheral infusion 
used in his study was not appropriate, as it fails to mimic the normal 
manner of endogenous noradrenaline release.
Tyramine HCI infusion and the associated release of noradrenaline had no 
direct influence on circulating insulin levels. The observed lag between
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changes in glucose status and insulin levels suggest that changes in insulin 
status are due to a response in glucose levels rather than a direct 
catecholaminergic effect on the pancreas. Insulin levels increased during 
the infusion periods and this increase appeared to be correlated with the 
rise in plasma glucose levels and not associated with the increased 
noradrenaline levels because plasma insulin concentrations fell only when 
plasma glucose levels fell. The pattern of insulin secretion was surprising 
as it had been expected that the insulin levels would be suppressed due to 
an increase in noradrenaline levels. This is a result that is contrary to other 
published studies in sheep (Bassett, 1970) and cattle (Frohli and Blum 
1988) where the intravenous infusion of noradrenaline and adrenaline were 
found to attenuate the insulin response to an increase in glucose and 
FFA's. Of relevance to the present study, is the recent observation of 
Hirose et at. (1994) who showed that the rate of insulin secretion from the 
isolated rat pancreas decreases when incubated with tyramine HCI.
The results of the present study are further complicated by the 
observations following treatment with the /^-adrenergic receptor antagonist 
propranolol HCI before the infusion of tyramine HCI. Pre-treatment with 
propranolol inhibited insulin secretion during both the infusion of propranolol 
HCI and tyramine HCI regardless of the increase in glucose levels in 
response to the tyramine HCI infusion. Inhibition of insulin secretion has 
been shown to be mediated by a2-adrenergic receptors of the /?- pancreatic 
cell (Clutter et a!., 1980) and enhanced via the /?2-adrenergic receptors 
(Remie et a!., 1989). Therefore, the specific blockade of the pancreatic /?- 
adrenergic receptors, thus leaving the a-adrenergic receptor population 
intact and available for noradrenergic binding would then result in the 
suppression of insulin release and a concomitant increase in plasma glucose 
levels. The question that this study has not been able to answer entirely is 
whether the decrease in plasma insulin and the simultaneous increase in 
plasma glucose seen during the tyramine infusion the result of a-adrenergic 
receptor stimulation due to the associated noradrenaline release or as a
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result of the propranolol HCI infusion itself? However, it does appear from 
the data that tyramine per se increases insulin release and that propranolol 
HCI per se decreases insulin release.
Pre-treatment with phentolamine stimulated insulin release before the 
tyramine HCI was infused resulting in an uncoupling of the close 
association between insulin and glucose levels seen in previous studies. 
This regime was presumably due to the blockade of the suppressive 
influence of a2 adrenergic mechanisms on insulin release which in turn 
suppressed glucose levels by increasing uptake into peripheral tissues. 
These results are important as they demonstrate that metabolic processes 
can be altered by the use of adrenergic antagonists and that care should be 
taken in determining the metabolic action of catecholamines especially 
when agonists and antagonists are infused simultaneously. It also highlights 
the metabolic role the catecholamines play in the tonic regulation of plasma 
insulin.
When both or-and ^-adrenergic receptors are blocked, there are no 
stimulatory or inhibitory effects on either plasma insulin or plasma glucose 
production. This combined antagonist infusion negates any physiological 
response to tyramine infusion and plasma levels of both insulin and glucose 
remain at basal levels throughout the infusion period. However, should any 
specific demand on glucose supply be imposed such as for example a 
stressor such as exercise it is unlikely that the animal undergoing such 
pharmacological blockade would survive.
Plasma Cortisol
Circulating cortisol levels were measured in this study to determine 
whether tyramine HCI could induce an increase in the secretion of this 
glucocorticoid and if so whether this rise would correlate with the metabolic 
changes observed during the tyramine HCI infusion.
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During the period of tyramine HCI infusion there were no significant 
changes in circulating cortisol levels. Therefore, the metabolic changes 
mediated by the tyramine HCI infusion are not associated with increased 
cortisol levels but are more likely a direct response to the increased 
noradrenaline levels rather than a change in glucocorticoid status.
Following termination of the tyramine HCI infusion, cortisol levels 
increased and reached a peak by 45 min. This peak may coincide with an 
endogenous circadian rhythm because the timing of the peak level for the 
tyramine infused treatment was similar to that of the propranolol HCI 
infused treatment, occurring at 1100 hrs and 1115 hrs respectively. The 
circadian rhythm for cortisol secretion is entrained to the prevailing 
photoperiod (Fischman et aL, 1988), with peak levels corresponding to the 
period of darkness. Photic information received by the eye modulates a 
circadian pattern of release of melatonin, which is translated into a neural 
signal in the hypothalamus. This release pattern of melatonin has been 
demonstrated to mediate the circadian rhythm for other endocrine profiles 
including those of the pituitary-adrenal axis, in sheep (Jones, 1990) and 
deer (Newman et aL, 1991). In the present study, peak cortisol levels from 
both infusion treatments occurred in the mid morning. This finding is in 
agreement with studies in deer (Newman et aL, 1991) and in the sheep 
(Fulkerson and Tang, 1979). These groups showed a bi-phasic cortisol 
rhythm in the fallow buck and in the Merino ewe with peak cortisol 
concentrations occurring during the hours of darkness and mid morning. Of 
interest in the present study was that the increase in cortisol levels 
occurred even though the ewes were subject to a constant light 
photoperiod regime (24L:0D). Therefore, factors other than entrainment to 
the prevailing photoperiod may also modulate these endocrine rhythms.
Blood Pressure
Changes in arterial blood pressure were used as a reference to monitor the 
physiological action of the tyramine HCI infusion and that blocking the
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adrenergic receptors was also effective. This physiological parameter 
proved a very sensitive measure of adrenergic bioactivity, irrespective of 
whether it is a stimulation or a blockade of adrenergic receptors.
Tyramine HCI infusion resulted in an increase in arterial blood pressure 
from the onset of the infusion, a response that persisted for the duration of 
the infusion period. These findings are in agreement with other studies 
using tyramine HCI infusion and injection in foetal sheep, (Walker and 
Schuijers, 1989) and new born lambs, (Lumbers et a/., 1980) in which 
increases in blood pressure were recorded. The Infusion of tyramine HCI 
has also been shown to elevate systolic blood pressure in humans, (Scriven 
et aL, 1983). In the present study the increase in arterial blood pressure 
was associated with the increase in plasma noradrenaline levels induced 
during the tyramine HCI infusion, which most likely caused systemic 
vasoconstriction. In agreement with this finding is the study by Hjemdahl et 
a!., (1983) who showed that the intravenous infusion of noradrenaline also 
elevated both systolic and diastolic blood pressure in man.
Pre-treatment with either propranolol HCI or phentolamine methane- 
sulfonate significantly reduced the tyramine HCI induced response. Again, 
this result is in agreement with those observed in sheep by Wood et aL 
(1979) and Halmagyi et aL (1967) who have shown that the prior infusion 
of either propranolol HCI or the infusion of the non selective a-adrenergic 
antagonist phenoxybenzamine inhibited the catecholamine induced rise in 
blood pressure. This result demonstrates that there are both a- and /?- 
adrenergic receptors within the systemic circulation that are involved 
equally in the modulation of blood pressure responses.
5.7. Conclusions
This experiment has demonstrated that by the intravenous infusion of 
tyramine HCI modulation of both metabolic and haemodynamic parameters
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can be achieved. In view of the known physiological actions of 
noradrenaline, the changes in metabolic and haemodynamic status 
observed in response to the tyramine infusion in the present study are most 
likely the result of the endogenous release of noradrenaline. This finding is 
further substantiated from the results that demonstrated that neither 
adrenaline or cortisol, both potent mobilisers of energy substrates, were 
released during tyramine HCI infusion. In addition, the metabolic and 
haemodynamic changes observed in this study were mediated by the 
adrenergic antagonists, propranolol HCI and phentolamine methane- 
sufonate. These agents bind to the catecholamine receptor thus preventing 
their activation by the catecholamines.
The endogenous noradrenaline released in this experiment stimulated the 
release of free fatty acids, and glucose as well as blood pressure levels. 
The release of FFA's were attenuated after /7-receptor blockade confirming 
that in the ewe the ^-adrenergic receptor function is responsible for the 
liberation of FFA after stimulation by noradrenaline. The haemodynamic 
effects (increased blood pressure) were also substantially blocked by the 
prior infusion of either a- or ^-adrenergic antagonists and completely 
blocked by the combination of both agents.
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Chapter 6
Effects of Anaesthetic Stress and Surgical Stress on Selected Metabolic and 
Hormonal Parameters in ACTH Immune Ewes
6.1. Introduction
Surgery under general anaesthesia elicits an acute stress response which 
activates both the sympathetic nervous system, (SNS), and the 
hypothalamic-pituitary-adrenal axis, (HPA). Cortisol, the major 
glucocorticoid in the sheep, is released from the adrenal cortex in response 
to adrenocorticotropin (ACTH). It has been demonstrated in man (Ichikawa 
et aL, 1971) and more recently in the sheep (Jones, 1990) that both ACTH 
and cortisol levels increase in response to surgical stress. Cortisol is a 
potent mobiliser of energy substrates, chiefly glucose and free fatty acids 
and plasma levels of these substrates rise during surgery. Fraioli et a!. 
(1980) established that acute stressors which stimulate ACTH release also 
elevate plasma concentrations of /?-endorphin. This increase in ^-endorphin 
has been suggested by Grossman (1988) to decrease responsivity of the 
"stress hormone' axes, including the SNS and the HPA axis.
Changes in other circulating hormone levels have also been reported 
during surgical stress. These include increases in prolactin and growth 
hormone (Hagen et aL, 1980), increases in thyroxine and a decrease in 
triiodothyronine (Brandt et aL, 1976). These changes may be mediated 
directly through afferent neurogenic stimuli from the traumatised tissue, via 
the sympathetic nervous system, or indirectly through the influence of 
cortisol.
Little is known of the above endocrine responses to anaesthesia alone or 
with surgery in the ewe, or about the factors which may influence this
115
stress response to these procedures.
6.2. Aim
This experiment seeks to determine firstly what effects anaesthesia alone 
has on the sheep stress response, and secondly what roles the HPA axis 
may play during surgical stress in relation to the regulation of endocrine and 
metabolic status in the ewe.
6.3. Materials and Methods 
Animals
Six Border Leicester-Merino ewes were housed at the University Sydney 
farms Camden (latitude 34°S). Ewes were maintained at pasture before 
being acclimated to metabolic cages in a thermoneutral environment under 
a photoperiod regime of 12 L: 12 D. Ewes had free access to water and 
were fed a pelleted ration of 60% hammermilled lucerne and 40% 
hammermilled oats at 95% ad libitum.
Three ewes were actively immunised against ACTH 1-24-ovalbumin 
conjugate (0.5 mg) in Freunds Complete adjuvant (2ml). A primary injection 
was given in mid December 1993 and subsequently booster immunisations 
made up in incomplete Freunds adjuvant were given at six weeks and ten 
weeks after the primary injection. Another three ewes were injected with 
adjuvant alone at each of these times.
All six ewes underwent major surgery (catheterisation of the carotid 
artery). Eighteen days later the three ewes which were not immunised 





A catheter, made from medical grade polythene tubing i.d. 1.0 mm o.d.
1.5 mm (Dural Plastics Ltd, Dural, NSW) was placed into a jugular vein. 
Catheterisation was performed 24 hr prior to the major surgery using a 
topical anaesthetic agent (Xylocaine; 10% spray; Astra Pharmaceuticals Pty 
Ltd., Melbourne). Catheters were inserted through a sterile 14G catheter 
placement unit, (Jelco, Johnson and Johnson Medical, Japan) and patency 
was maintained by filling the catheters with heparinised saline (500 lU/ml 
of heparin).
Catheterisation o f the Carotid Artery
Ewes were fasted for 24 hr and denied water for 12 hr prior to surgery. 
General anaesthesia was induced with intravenous (iv) thiopentone sodium 
(Boehringer) at a dose rate of 15-20 mg/kg body weight. Following 
orotracheal intubation, anaesthesia was maintained with 2-4% Fluothane 
(halothane BP) in oxygen. The oxygen delivery rate was 6-10 mls/min and 
the fluothane rate was regulated according to the reflex responses of the 
individual sheep. The anaesthetic gases were delivered using a Flurotec 3 
vaporiser, and the ewes were maintained at stage 3 (depression of 
respiratory, circulatory, protective reflexes and muscle tone) and plane 2 
(defined as the point where eyeballs remain eccentrically fixed) of 
anaesthesia (Hall and Clarke, 1983). This level of anaesthesia was 
maintained throughout the surgical period which commenced approximately 
20 min after the induction of anaesthesia. Sheep were held in the dorsal 
position throughout surgery upon completion of the surgery, administration 
of the anaesthetic ceased. Duration of the anaesthesia was between 40 
and 50 min after which the ewes were placed in the ventral recumbency 
position until they regained consciousness. The ewes were then left 
undisturbed in a recovery pen until the completion of the experiment.
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To determine the endocrine response to anaesthesia alone, the above 
protocol was repeated 18 days later on the non-immune sheep without 
invasive surgery.
Blood Sampling
Venous blood samples (3 ml) were taken from the indwelling catheters 
using a 5 ml syringe (Terumo Corporation Japan) and after each sample the 
catheters were flushed with heparinised saline (100 lU/ml). Samples were 
taken at 15-min intervals for one hour prior to surgery then every 5 min 
during the surgery, and then every 15 min for one hour after surgery.
Blood samples were transferred to plastic P4 tubes (John Morris Ltd, 
Sydney, NSW), containing Kwick Spin separation granules (Disposable 
Products Padstow, NSW). All samples were kept on ice prior to 
centrifugation. Plasma was harvested and stored at -2 0 °C  until assayed.
Catecholamine Samples
Venous blood samples were collected for determination of plasma 
adrenaline and noradrenaline and placed in pre-cooled P4 plastic tubes 
containing 1mg sodium metabisulphite per 10mls blood. Samples were 
taken 15 min before the onset of inhalation anaesthesia, just after 
inhalation anaesthesia but before surgical incision, at the completion of the 
surgical procedure and coinciding with the time when the anaesthesia 
mixture was discontinued, and at 60 min after completion of the surgery. 
Samples were immediately centrifuged and frozen at -7 0 °C  until assayed.
6.4. Statistical Analysis
All data are presented as the mean ± S.E. of the mean. The effects of 
time and anaesthesia or anaesthesia plus surgery on all ewes and their
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interaction were measured by a repeated measures ANOVA test (CLR 
ANOVA program; Clear Lake Research Inc., Houston TX, USA).
The differences in the mean catecholamine levels for baseline, anaesthesia 




Plasma noradrenaline levels are shown in figure 6.1. There were large 
differences in plasma noradrenaline levels between each animals within 
treatment groups. There was no significant difference in plasma 
noradrenaline levels in the non-immune groups (anaesthesia only and 
surgery + anaesthesia) in response to either anaesthesia or surgery. 
However, plasma levels of noradrenaline in the non-immune ewes 
(anaesthesia only and surgery + anaesthesia) tended to increase when 
anaesthesia was discontinued. There was little change in plasma 
noradrenaline levels in the ACTH-immune group in response to surgery, 
although noradrenaline concentrations tended to decline when anaesthesia 
was discontinued. Peripheral noradrenaline levels in the samples taken 
before and after surgery from the ACTH-immune group were significantly 
greater (P<0.05 ) than those of the non-immune group.
Plasma Adrenaline Levels
Plasma adrenaline levels are given in figure 6.2. Circulating adrenaline 
levels were also variable between each animal and for each treatment 
group. There was no significant difference in peripheral adrenaline levels in 
the non-immune group during surgery, however, plasma adrenaline levels 
tended to decrease in response to the anaesthetic induction then rise when 
anaesthesia was discontinued. Circulating adrenaline levels in the ACTH- 
immune group were unaffected by either anaesthesia or surgery with levels 
remaining at or near pre-surgery concentrations.
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Plasma Cortisol Levels
Circulating cortisol levels are shown in figure 6.3. Anaesthesia stress 
followed by surgical stress resulted in a highly significant (P<0.01) 
increase in circulating cortisol levels in the non-immune group. Plasma 
cortisol levels increased in response to anaesthetic induction with a mean 
pre-induction concentration of 15.3 ± 3.4 ng/ml rising to 48.8 ± 10.2 
ng/ml at anaesthetic induction. Cortisol levels continued to increase 
throughout the surgical procedure, a maximum plasma cortisol 
concentration of 168.3 ±53.0 ng/ml occurring 15 min after the completion 
of surgery. Plasma cortisol levels continued to remain elevated throughout 
the recovery period.
In the ACTH-immune group, there was no increase in circulating cortisol 
levels in response to either anaesthetic induction or surgery, hormone levels 
remaining at or near basal levels throughout the period of surgery. 
However, at the completion of surgery and anaesthetic withdrawal cortisol 
levels increased to a maximum concentration of 49.0 ± 11.0 ng/ml. This 
result being recorded 45 min after the completion of surgery.
In the non-immune anaesthesia only group, there was a significant 
increase (P<0.01) in circulating cortisol concentrations in response to 
anaesthetic induction. Plasma cortisol levels remained elevated throughout 
the period of anaesthetic treatment with elevated cortisol levels persisting 
into the recovery period. However, the relative increase in circulating 
cortisol levels were not as great as those observed in the non-immune 
surgically treated group.
Plasma Growth Hormone Levels
Plasma growth hormone (GH) levels are shown in figure 6.4. Anaesthetic 
induction resulted in a significant increase (P<0.05) in circulating GH levels 
in both non-immune and ACTH-immune surgical treated groups. This 
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Plasma GH levels in these groups followed an episodic release pattern 
which was maintained throughout the period of surgery. The GH release 
pattern and circulating levels were similar for both groups, peaks in GH 
concentrations occurring at 20 min intervals. Plasma GH levels declined 
when surgery and anaesthesia were discontinued, GH concentrations 
returning to basal levels during the recovery period.
There was a marked difference, although this was not significant, in both 
the release pattern and circulating levels of GH in the non-immune 
anaesthesia only group compared to the non-immune and ACTH-immune 
surgically treated groups. In the non-immune anaesthesia only group there 
was an increase in GH levels after anaesthetic induction. However, unlike 
the two surgical operated groups there was no episodic release pattern in 
plasma GH concentrations with levels gradually increasing over time 
reaching a maximum of 14.9 ± 2.9 ng/ml 25 min after the onset of 
anaesthetic induction.
Plasma Glucose Levels
Plasma glucose levels are given in figure 6.5. For the non-immune 
surgically treated group plasma glucose levels tended to increase from the 
time of the surgical incision with a maximum concentration of 4.3 ± 0 . 6  
mmol/L being recorded 20 min from the start of surgery (Fig 6.5a). This 
contrasts with the mean pre-induction level of 3.4±0.1 mmol/L. Plasma 
glucose concentrations declined in all three ewes after 20 min of surgery 
and continued to decline during the recovery period (Fig 6.5a).
In the ACTH-immune surgically treated ewes there was no increase in 
plasma glucose (Fig 6.5b) following the surgical procedure.
For the non-immune ewes given anaesthesia only the plasma glucose 
concentrations remained at or near basal levels (Fig 6.5c). One ewe showed 
a slight increase during anaesthesia.
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Pasma Insulin Levels
Plasma insulin levels are shown in figure 6.5. All three ewes which were 
non-immune but surgically treated had increased plasma insulin levels in 
response to induction of anaesthesia (Fig 6.5a). During the surgical 
procedure plasma insulin levels varied markedly. This variability continued 
for 20 min post incision after which time insulin concentrations declined 
and then stabilised remaining at or near basal levels for the remainder of the 
study.
In the ACTH-immune surgically treated ewes there was an increase in 
plasma insulin levels (Fig 6.5b) following induction of anaesthesia. Similarly 
to the non-immune surgically treated ewes, insulin levels varied markedly 
during the surgical procedure. However, unlike in the non-immune group 
this variability continued throughout the period of surgery.
When the non-immune ewes were anaesthetised only, a significant 
increase (P<0.01) in plasma insulin levels from the pre-induction levels 
occurred (Fig 6.5c). This increase continued for 20 min after which the 
levels declined and remained at or near basal levels for the remainder of the 
study.
Plasma Free Fatty Acid Levels
Plasma free fatty acid (FFA) levels are displayed in figure 6.6. There was a 
significant decline (P<0.01) in plasma FFA levels in all three treatment 
groups following either surgical incision or induction of anaesthesia alone. 
In the non-immune surgically treated ewes plasma FFA levels tended to 
increase around 25 min after the surgical incision was made. In the ACTH- 
immune and the non-immune anaesthesia only groups FFA levels did not 
increase until the recovery period. The FFA profile for the non-immune 
anaesthesia only group was similar to that of the ACTH-immune surgically 
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The plasma /?-endorphin levels are given in figure 6.7. For the non-immune 
sheep anaesthesia alone and surgery + anaesthesia resulted in a significant 
rise in plasma ^-endorphin levels (Fig 6.7a) (P<0.01) in response to
induction with anaesthesia. Maximum levels occurred either 20 minutes 
(anaesthesia only) or 25 minutes (surgical treated) after the onset of 
anaesthesia and then declined to near pre-anaesthetic induction levels by 
the end of the recovery period. Plasma ^-endorphin levels for the 
experimental period in the non-immune groups were similar with the 
surgical procedure having no significant effect on circulating /7-endorphin 
levels.
For 2 of the 3 ACTH-immune surgically treated ewes, the plasma /7- 
endorphin levels were similar to the non-immune groups, although the rise 
in circulating /7-endorphin levels for these two ewes occurred 5 minutes 
after the surgical incision. The plasma /?-endorphin levels for the remaining 
ewe were significantly elevated (P<0.01) from the onset of the study when 
compared to the two other ACTH-immune ewes and its /?-endorphin levels 
remained elevated throughout the treatment period.
6.6. Discussion
Cortisol
The most striking result from this experiment was the demonstration that 
the circulating cortisol concentrations in the ewes immunised against ACTH 
1-24 remained at or near basal levels during the period of surgery. Of 
interest was the finding that cortisol levels in the ACTH-immune group 
increased significantly during the recovery period. This increase in cortisol 
levels may reflect the decrease in the ratio of circulating ACTH antibodies 
to plasma ACTH concentration following its increased release from the 
pituitary.
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In contrast, cortisol levels in the non-immune group increased in response 
to both anaesthesia and surgery with a greater increase in plasma cortisol 
levels elicited by the surgical procedure. An increase in cortisol levels 
during surgery has been reported by other investigators and has been 
shown to occur in a number of different species, including man (Fellander 
et a!., 1994; Bickel et a\., 1991; Clarke et a!., 1970) the sheep (Jones, 
1990; Shutt et a!., 1987) and the horse (Robertson et al., 1990). The 
magnitude and the duration of the cortisol response in man is correlated 
with the intensity of the surgical procedure. Intra-abdominal surgery gives a 
greater response in cortisol release compared to body surface surgery. Little 
or no effect on cortisol secretion is observed during anaesthesia without 
surgery (Clarke et aL, 1970). A similar effect has been demonstrated in the 
horse. Taylor (1985) reported a 10 fold increase in cortisol concentrations 
in pony mares during abdominal surgery, whereas Robertson and co­
workers (1990) reported a 1.6 fold increase in plasma cortisol levels 
following arthroscopic surgery with no significant changes in cortisol 
concentrations during body surface surgery (Robertson, 1987). In the ewe 
an increase in cortisol secretion was reported by Jones (1990) during and 
following ovarian auto transplant surgery. However, unlike the present 
study or those reported for man, plasma cortisol was released in an 
episodic pattern during surgery and did not increase over time. This 
difference in the release pattern between the present study and that of 
Jones (1990) may reflect the association between cortisol and the degree 
of surgical trauma as ovarian transplant surgery involves simultaneous 
surgical procedures of the abdomen and neck (Goding et a!., 1967).
In the present study, anaesthesia alone induced a rise in plasma cortisol 
levels in the non-immune group. This result is in keeping with that of Taylor 
(1985) who reported an increase in plasma cortisol for Welsh ponies during 
halothane anaesthesia. Contrary to these findings is that of Clarke and co­
workers (1970) who found little to no change in the human following 
induction of anaesthesia. This difference may reflect differences in the
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methods of plasma cortisol analysis. Clarke eta!., (1970) measured plasma 
cortisol fluorimetrically while we measured cortisol using radioimmunoassay 
techniques. These assays differ greatly in their sensitivity to plasma 
cortisol. The values reported by Clarke et al. (1970) appear to exceed the 
sensitivity of the assay. Different anaesthetic agents have been shown to 
alter the rate of cortisol released into the circulation, ether and halothane 
being the most potent (Oyama, 1983). Gaseous anaesthetic agents such as 
halothane when introduced into the upper respiratory tract have to be 
transported to the brain before they produce a loss of consciousness (Hall 
and Clarke, 1984). These anaesthetic agents exert their effects on synaptic 
transmission by selectively targeting synaptic ion channels on receptors 
within the central nervous system (Franks and Lieb, 1994). It was 
postulated by these researchers that some anaesthetic agents may act by 
potentiating inhibitory synaptic receptors while inhibiting excitatory 
receptors (Franks and Lieb, 1994). An anaesthetic induced alteration in 
cortisol secretion may be a result of the stimulation of CRH secretion via 
halothane acting at the level of the hypothalamus.
Noradrenaline and Adrenaline
Plasma noradrenaline levels in the ACTH-immune and both the non­
immune groups change very little in response to either anaesthesia or 
anaesthesia and surgery. Circulating noradrenaline levels in the non-immune 
group appeared to increase when the anaesthesia was discontinued 
although this increase was not significant. This finding was not expected as 
studies in man have shown an increase in plasma noradrenaline levels 
during surgery (Tonnesen et a!., 1984: Halter and Pflug, 1980, Halter et a!., 
1977). It has been demonstrated that anaesthetic agents themselves can 
alter the catecholamine response to surgery (man Bickel et a!., 1991; rat 
Roizen et al., 1974). Bickel and co-workers (1991) reported a significant 
difference between the effects of the inhalation anaesthetic agents 
enflurane and neurolept when administered to patients undergoing 
cholecystectomy. Patients given enflurane had lower catecholamine levels
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during and after the surgical procedure compared to patients maintained 
under neurolept anaesthesia. Also, catecholamine levels remained 
unchanged during surgery and recovery in the patients who were induced 
and maintained with enflurane anaesthesia. Halothane the anaesthetic 
agent used in the present study when administered to rats decreased 
peripheral catecholamine concentrations (Roizen et aL, 1974). Roizen and 
co-workers found a significant decrease in total catecholamine levels when 
halothane was used at 1 % and the levels were depressed further when the 
halothane concentration was increased to 1.5%. In the human halothane 
will not depress catecholamine levels (Tonnesen et a/., 1984: Halter and 
Pflug, 1980, Halter et aL, 1977). All ewes in the present study were 
induced and maintained with halothane within a range of 1%-5% 
(dependent on the anaesthetic state of the ewe). The fact that 
catecholamine levels in the ewe did not increase during surgery could be a 
function of not just the anaesthetic agent but possibly a combination of the 
anaesthetic agent and its physiological influence in this species.
For the ACTH-immune ewes the plasma noradrenaline levels were 
significantly elevated before surgery and during the recovery period when 
compared to the non-immune ewes. This finding was not related to any 
change in metabolic parameters such as free fatty acid levels, which have 
previously been shown to be sensitive to sympathetic nervous activity 
(Newman unpublished observations). Increased activity of the sympathetic 
nervous system in the ACTH-immune group is difficult to explain but may 
be a response to the handling procedures.
The pattern of plasma adrenaline levels for the non-immune ewes during 
anaesthesia alone or anaesthesia and surgery is similar to what has been 
reported for man during both anaesthesia and surgery (Halter and Pflug, 
1980, Halter et a!., 1977 and Bickel et aL, 1991). Interestingly, as in man, 
plasma adrenaline levels declined in response to the anaesthetic induction. 
This decline may not be a result of the halothane itself, but may be an
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attribute intrinsic to all anaesthetic agents, as other agents such as 
enflurane and neurolept also depress plasma adrenaline levels (Bickel et a!., 
1991). The decrease in plasma adrenaline levels during anaesthetic 
induction in man is not associated with a decline in plasma noradrenaline 
levels. Halter and co-workers (1977) have suggested that this specific 
adrenomedullary suppression observed during anaesthesia may be 
representative of distinct sympathetic nervous system pathways to the 
adrenal gland and to the peripheral neurones. This hypothesis may also be 
be true for the sheep. In the present study there was only a small increase 
in peripheral adrenaline levels when anaesthesia was discontinued. This is 
in contrast to studies in man, where Halter and co-workers reported a 4.3 
fold increase in plasma adrenaline levels at the end of surgery.
Glucose
The early study of Clarke (1970) demonstrated an association between 
the rise in blood glucose levels and the trauma of surgery. This rise was 
shown to be proportional to the stress of the surgical procedure and its 
duration. Subsequent studies by Madsen et a!., (1976) confirmed this 
finding in patients undergoing major surgery (hysterectomy) compared to 
minor surgery (tympanoplasty). Madsen et at., (1976) reported parallel rises 
in cAMP, blood glucose and plasma cortisol concentrations. The release of 
these three parameters were all shown to be related to the degree of 
surgical trauma. In the present study, blood glucose levels in the non­
immune group increased during surgery, while there was no significant 
increase in response to anaesthesia without surgery. Anaesthetic agents 
will modulate blood glucose levels (Clarke, 1970). Of relevance to the 
present study is the finding that in man halothane does not give rise to a 
significant increase in blood glucose levels in the absence of surgery 
(Hunter, 1959).
A number of investigators have alluded to the role of increased cortisol 
levels during surgery contributing to an increase in blood glucose levels,
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(Clarke eta!., 1970, Lacoumenta et al., 1987). Lacoumenta and co-workers 
(1987) demonstrated the plausibility of this by infusing hydrocortisone into 
patients upon the completion of their surgery. Hydrocortisone resulted in a 
significant increase in blood glucose levels without altering plasma GH, 
ACTH, or insulin levels. Our finding that blood glucose levels did not 
increase during surgery in the ACTH-immune group in which plasma cortisol 
was ablated implies that the relationship between plasma cortisol and blood 
glucose levels exists in the sheep.
It is of interest to speculate as to how increased cortisol levels during 
surgery affect glucose levels. Ingle (1952) postulated that the 
glucocorticoids play a "permissive' role in the modulation of metabolic 
processes and act to influence the actions of both glucagon and adrenaline. 
These hormones use cAMP as their intracellular second messenger 
(Sutherland et a/., 1968). As mentioned previously Madsen et al. (1976) 
demonstrated in man the elevation of plasma cortisol, blood glucose and 
cAMP levels during surgery . These observations led Madsen et al. (1976) 
to suggest that the catabolic hormones such as glucagon or the 
catecholamines may account for the liberation of glucose into the peripheral 
circulation. Plasma glucagon was not measured in this study, therefore, it's 
role in the mobilisation of energy reserves and increased plasma glucose 
during surgery is unable to be assessed. Studies in man suggest that 
glucagon is not a likely mediator of the immediate hyperglycaemic effect 
seen during surgery (Giddings et a!., 1976). Giddings and co-workers 
(1976) reported increased levels of plasma glucagon, but this increase only 
occurred post-operatively and did not coincide with the rise in plasma 
glucose levels which had occurred during surgery. It is more likely that the 
increased levels of catecholamines and plasma cortisol observed in man 
during surgery are responsible for the associated increase in blood glucose 
levels. This association is unlikely to produce an explanation for the 
increased levels of blood glucose seen in the ewe because catecholamine 
levels were not significantly elevated in the current study. In the ewe, it
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would appear that some other catabolic agent is responsible for the 
hyperglycaemic effect seen during surgery.
Insulin
The finding that peripheral insulin levels increase in response to the 
anaesthetic induction is of interest. Increased circulating insulin levels 
occurred regardless of the treatment with the ACTH-immune group 
responding similarly to the non-immune group. The increase in peripheral 
insulin levels following anaesthetic induction has not previously been 
reported in either man or the sheep. Robertson and co-workers (1990) 
found increased plasma insulin levels in the horse approximately 10 minutes 
after anaesthetic induction with halothane. In their study, the delay in 
insulin response to the anaesthetic induction may be attributed to the 
timing of the blood sampling regime as it was 10 minutes after anaesthetic 
induction that the first blood samples were taken. In contrast to the 
ruminant, studies in man have shown either a decline (Halter and Pflug, 
1980) or no change in plasma insulin levels (Clarke et al., 1970) at the time 
of anaesthetic induction. Therefore, it appears from our study and that of 
Robertson et al. (1990) that anaesthetic induction using the anaesthetic 
agent, halothane, initiates insulin release in the ruminant.
The alteration in synaptic transmission within the central nervous system 
in response to anaesthesia (Franks and Lieb, 1994) may influence insulin 
release from the /?-cells of the islets of Langerhans. Both parasympathetic 
fibres from the vagus nerve and sympathetic fibres from the splanchnic 
nerve innervate the pancreas (Berthoud et aL, 1991) providing central 
neural input for the control of hormonal synthesis (Strubbe and Steffens, 
1993). The release of insulin into the peripheral circulation during the 
induction of anaesthesia could be the result of a central neural input in 
response to a perceived glucose depravation in the central nervous system 
following halothane anaesthesia.
129
In the ewe, insulin secretion during surgery appears to be influenced by 
the surgical procedure itself, as plasma insulin levels in the non-immune 
surgically treated group remained elevated but variable for a further 25 
minutes after anaesthetic induction. Contrasted to this was the sustained 
variability in insulin secretion observed in the ACTH-immune group 
throughout the surgical procedure and the recovery period. Insulin levels in 
man have been reported to either decline or to remain constant during the 
surgical procedure (Traynor and Hall, 1881; Giddings et a!., 1976). Further 
studies also in man have demonstrated lower insulin levels in patients 
during surgery who received the /?-adrenergic antagonist propranolol HCI 
(Cooper et a!., 1980). It would appear then that this decline in insulin 
secretion in man is mediated by altered adrenergic activity and most likely 
via the o-adrenergic receptor (Allison, 1971). Porte and Robertson (1973) 
have shown that activation of the or2-adrenergic receptor inhibits insulin 
secretion independently of blood glucose concentrations and that /?2- 
adrenergic receptor activation stimulates insulin release.
In the current experiment, the decline in plasma insulin observed in the 
non-immune group mid-way through the surgery is difficult to explain, as 
catecholamine levels were not significantly elevated, although this may be 
the result of direct innervation via a2-adrenergic receptors on the pancreatic 
¡3 cells. It does appear, however, that the decline in insulin secretion may be 
associated with the elevation in cortisol levels in response to the surgery as 
plasma insulin levels did not fall in the ACTH-immune group. Although 
glucocorticoids generally induce peripheral tissue insulin resistance, thereby 
stimulating plasma insulin levels it is possible that this role is reversed 
during anaesthesia. Thus glucocorticoids in this condition may be 
suppressing insulin action by regulating circulating levels rather than by 
altering insulin receptor effects on glucose transport mechanisms in target 
tissues. This is consistent with the hypothesis of Munk and co-workers 
(1984) who have suggested that the function of the glucocorticoids is to 
prevent insulin-induced hypoglycaemia. Mediation of insulin action by the
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glucocorticoids has also been demonstrated by studies in the rat 
(Barseghian and Levine, 1980). These workers showed that corticosterone 
given at physiological doses strongly inhibited both glucose and arginine 
induced insulin release and that corticosterone had direct effects on the 
pancreatic islet cells. Further, lymphocyte studies conducted in the mouse 
have demonstrated that adrenaline decreased glucose uptake but only in 
the presence of cortisol (Boyett and Hofert, 1972). Therefore, it would 
appear from the present experiment, the decline in circulating insulin levels 
during surgery in the non-immune group may have been mediated either by 
the increased levels of plasma cortisol acting synergistically with the 
catecholamines (specifically adrenaline) or by the direct action of cortisol 
alone.
Free Fatty Acids
Circulating FFA levels decreased in all three treatment groups after the 
induction of anaesthesia and this decline occurred after the anaesthetic- 
induced increase in peripheral insulin concentrations. The decline in free 
fatty acids could be a consequence of the elevation in insulin levels 
because insulin is the principal antilipolytic hormone in ruminants (Vernon, 
1980). This has been demonstrated graphically by studies in which the 
administration of insulin caused a rapid reduction (within 5 min) of 
circulating FFA's and glycerol concentrations (West and Passey, 1967). 
Similar results have been achieved in the horse by Robertson et al. (1990). 
This group also showed a decrease in plasma free fatty acid levels and a 
corresponding increase in peripheral insulin concentrations in response to 
surgery. In contrast, to the effects in ruminants, studies in man have 
demonstrated that lipolysis occurs during both surgery and the induction of 
anaesthesia (Felländer et al., 1994; Clarke et al., 1970). Interestingly, there 
was no increase in plasma insulin levels during either study.
In the human, insulin and the catecholamines are the dominant hormones 
in the acute regulation of lipid mobilisation (Arner, 1988). Both adrenaline
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and noradrenaline are potent lipolytic agents in the sheep (Bassett, 1970). 
The decrease in plasma free fatty acid levels described in the present study 
may be interpreted in two different ways. Firstly, it is possible that 
anaesthesia and surgery induce a marked and acute increase in FFA uptake 
as a source of energy substrate which cannot be compensated for by 
lipolytic mechanisms. Presumably this is due to the suppression of 
adrenomedullary and sympathetic neural activity by the anaesthesia of 
central mechanisms. Thereafter, glucoregulatory mechanisms are 
responsible for supplying the appropriate energy requirements. This is 
evident from the shift in plasma levels of insulin and cortisol, with cortisol 
being generally recognised as the regulator of longer term energy 
requirements as the animal adapts to the stressor (Munk et al., 1984). 
Alternatively, it is possible that the FFA's are unimportant substrates for 
the acute energy needs of the animal during anaesthesia and surgery. 
Therefore, the depletion of circulating levels is simply the result of normal 
peripheral tissue utilisation in response to the stress, which is not replaced 
by lipolytic mechanisms. Thus in this situation glucose becomes the major 
energy yielding substrate and as such, the associated increase in insulin 
levels suppressed any lipolytic response. Evidence for this is provided by 
the finding that when circulating insulin levels declined in the non-immune 
surgically treated ewes mid way through surgery, there was also a 
corresponding increase in plasma FFA concentrations. The finding that FFA 
levels were not suppressed in the non-immune surgically treated group to 
the same degree as and in the ACTH-immune group again implicates 
cortisol indirectly as a possible lipolytic regulator during surgery in the ewe. 
The increase in plasma FFA concentrations in the non-immune surgically 
treated group appears to be a result of the combination of both lipolysis as 
well as reduced insulin levels. However, insulin is not the sole regulator of 
this response since in the anaesthesia only group insulin levels declined 
without a corresponding increase in plasma FFA levels.
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Growth Hormone
Circulating growth hormone (GH) levels in humans increase in response to 
surgery (Lacoumenta etaL,  1987; Hagen et a!., 1980; Noel et aL, 1972; 
Ichikawa et a/., 1971). Plasma GH levels increase after the surgical incision 
and a peak concentration occurring some 30 to 60 minutes later 
(Lacoumenta et a/., 1987; Hagen et aL, 1980). In contrast, the GH 
response to surgery in the present study was different, not only in the 
timing of both the onset and the peak in maximal concentration but also in 
the pattern of release. In the non-immune surgically treated group GH 
increased after anaesthetic induction but before skin incision and then 
reached a maximum concentration 5 minutes after the incision. This 
difference in the timing of the release in response to surgery to that 
reported in man may simply be a consequence of the experimental design. 
The frequency of blood sample collection during surgery in man, for the 
previously mentioned studies, varied between 15 minutes (Ichikawa et aL, 
1971) to an hour (Lacoumenta et aL, 1987; Hagen et aL, 1980) in 
comparison to the present study where blood samples were taken at 5 
minute intervals. The sampling regime may also have contributed to the 
different release patterns for GH during surgery for those studies reported 
for man and that for the ewe given here. Growth hormone was released in 
a pulsatile fashion during surgery in the current experiment whereas in the 
human studies blood levels were elevated consistently.
There was no difference between the non-immune and the ACTH-immune 
surgically treated groups in either the timing of the GH release in response 
to surgery or the pattern of release. An interesting observation was that 
there was an apparent synchronisation of plasma GH release in relation to 
both groups in response to surgery. This synchronisation is most likely due 
to the surgical trauma evoking a response via the lateral spino thalamic 
tract of the spinal chord, the S1, S2 singulate gyrus areas of the brain 
cortex. Neuroendocrine mechanisms regulating GH release from the 
pituitary are provided from a number of sources in the CNS to the arcuate
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nucleus and the paraventricular nuclei to control the synthesis and release 
of somatostatin and GH releasing hormone respectively. This results in the 
modulation of a synchronous release pattern (Tindal et a!., 1982). The 
failure to demonstrate any difference in the timing of the GH stimulation 
between the non-immune and the ACTH-immune groups demonstrates that 
the stress-induced increase in cortisol levels did not influence GH secretion, 
although basal levels may have facilitated this response. This study also 
shows that induction with halothane induces GH release in the ewe. It also 
demonstrates that anaesthesia alone alters the timing of the peak in 
secretion and the pattern of release.
It is difficult to interpret what physiological role GH may play in response 
to surgical trauma in the ewe. Most studies dealing with GH and it's 
involvement in the regulation of metabolism in ruminants have chiefly been 
of a chronic rather than an acute nature. Growth hormone has been 
demonstrated to induce insulin resistance, however, this requires several 
days of hypersecretion for this to develop (Hart, 1983). Its role in the 
stimulation of lipolysis is also well known but again this lipolytic action 
requires at least 4 hours to become evident in sheep adipose tissue 
(Duquette et a/., 1984). Interestingly, the administration of GH has been 
shown to have acute insulin-like effects by significantly reducing blood 
glucose levels in man (Frohman et at., 1967). Goodman (1968) has also 
demonstrated increased glucose uptake and glucose oxidation in excised 
adipose tissue after treatment with bovine GH. It has been suggested that 
the acute effect of GH are to increase tissue permeability, thereby 
increasing the rate of entry of glucose into the tissue (Merimee, 1979). 
Recently, it was shown in the rat adipocyte that this insulin-like effect of 
GH involves the stimulation of the Glutl and Glut4 glucose transporters by 
their translocation to the plasma membrane (Tanner et a!., 1992). This 
ability of GH to stimulate glucose uptake in cells may fulfil the unknown 
acute role of GH in response to surgical trauma in the ewe. Further, Aoki 
and co-workers (1974) have suggested that reparative tissue uses only
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glucose as a substrate. Therefore, during surgery, as tissue is traumatised, 
the requirement for glucose by the cells may be enhanced, thus requiring 
this insulin-like effect of GH to meet the increased glucose demand of the 
traumatised cells.
Growth hormone may also be acting to stimulate local IGF-1 production to 
increase glucose uptake into the traumatised cells (Jones and Clemmons, 
1995). It has been shown that IGF-1 can also stimulate peripheral glucose 
uptake without suppressing hepatic glucose production, in addition, IGF-1 
has been demonstrated to have a positive effect on wound healing (Jones 
and Clemmons, 1995).
/?-endorphin
Plasma /?-endorphin levels increased in both non-immune anaesthesia only 
and surgically treated groups in response to anaesthetic induction (Fig 
6.7a). It appears from this study that this rise in circulating /7-endorphin 
levels in the non-immune groups can be attributed to anaesthetic induction 
and not to the surgical procedure, as there was no difference in either the 
profile or the circulating levels of /7-endorphin between these two 
treatments. Robertson and co-workers (1990) have reported elevated 
plasma /?-endorphin levels during arthroscopic surgery in the horse with 
maximum levels occurring 40 minutes after the onset of surgery. However, 
of more interest to the present study was their observation that the rise in 
plasma /7-endorphin levels began after the horses were sedated. An 
increase in plasma /7-endorphin levels has been reported for sheep by Jones 
(1990), however, unlike the present study and that of Robertson et a/. 
(1990) there was no sequential rise in plasma /?-endorphin levels but an 
immediate increase to maximum concentrations following the surgical 
incision. This difference between the two studies is difficult to explain as 
both the anaesthetic agent and the induction procedure were similar for the 
two experiments.
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A similar pattern in plasma ^-endorphin levels was observed in two of the 
three ACTH-immune ewes undergoing surgery, (ewes S12 and S15). The 
third ewe (S14) had significantly elevated levels of /?-endorphins compared 
to all other ewes regardless of treatment. This high level occurred from the 
onset of the study. Neither anaesthesia or surgery had any effect on the 
concentration of circulating ^-endorphins in this ewe with levels remaining 
at or near the pre-anaesthetic induction level for the duration of the 
experiment. This significantly higher level of plasma /?-endorphins for ewe 
S14 was also associated with significantly lower cortisol levels compared 
to the other ACTH-immune ewes. This higher level of ^-endorphin is 
possibly caused by the immunological neutralisation of ACTH being more 
effective in this animal. Therefore, little negative feedback of the 
glucocorticoids and ACTH on the expression of the precursor molecule, pro­
opiomelanocortin was present resulting in hypersecretion of all the POMC- 
derived peptides, including /7-endorphin.
The physiological role for the increased levels of plasma ^-endorphins 
during anaesthesia and surgery is unclear, although its involvement in the 
mediation of pain responses is worthy of consideration. In human patients 
with intractable pain, endorphins acting via the opiate receptor act to 
modulate this affliction Hosobuchi et at. (1977). However, we were not 
able to determine the effect of pain on /7-endorphin release in the present 
experiment, since the anaesthesia alone had a marked stimulatory effect on 
circulating /?-endorphin levels. Certainly the surgery did not induce a further 
incremental rise in circulating levels. Grossman (1988) has suggested that 
the opioids may act to antagonise the stimulation of the HPA-axis by 
counter-regulating excessive activity and the peripheral effects of CRH. This 
suggestion, however, does not appear to be true for the sheep, because in 
the current experiment cortisol levels increased significantly. Although, 
suppression of the sympathomedullary system by the elevated /?-endorphin 
levels cannot be discounted in the present work, as neither circulating 
adrenaline nor noradrenaline levels increased during either anaesthesia or
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surgery. Of relevance to this study could be the finding that the acute 
administration of opioids improves immune competence by increasing the 
activity of NK (natural killer) lymphocytes (Morley et al., 1987). Tonneresen 
and co-workers (1984) have shown an increase in NK cell activity during 
abdominal surgery in both male and female patients. This rise in NK cell 
activity occurred after pre-medication and continued during anaesthetic 
induction and surgery, and thereafter, declining post-operatively. Although 
plasma /?-endorphin levels were not measured in Tonneresen's experiment, 
it would appear that the profile in NK cell activity observed in that report 
resembles both the plasma /?-endorphin profile for the sheep in the current 
experiment, and that for the horse as observed by Robertson et at. 1990. 
However, further studies in the sheep would need to be undertaken to 
determine if any association between NK cell activity and /?-endorphin levels 
existed during anaesthesia and surgery.
6.7. Conclusions
This current experiment has delineated two distinct "stressors" that the 
sheep experiences during surgery, those being anaesthetic stress and 
surgical stress. As in man, anaesthetic stress exerts less influence on 
endocrine function in the sheep than does the stress of surgical trauma. 
This study has shown that in the sheep, the anaesthetic agent halothane 
induced the release of the pituitary hormones ^-endorphin, GH and 
presumably ACTH, because plasma cortisol levels also increased during 
anaesthesia. More importantly, and unlike in man, anaesthetic induction 
with halothane also modulates the release of insulin from the /?-cells of the 
islets of Langerhans. This modified endocrine response to the anaesthetic 
stress in turn alters the metabolic homeostasis of the sheep. A reduction in 
circulating free fatty acid levels was demonstrated in the present study 
indicating lipogenesis or preferential FFA oxidation. This may simply be due 
to a rapid increase in the rate of utilisation of FFA's and a failure in the 
lipolytic mechanism (i.e. no catecholamines) suggesting that glucose is the
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more important energy substrate during surgery.
The similarity in the endocrine and metabolic responses to both 
anaesthetic induction and surgical trauma between man, a monogastric 
animal, and the sheep, a ruminant animal, is of interest in itself. However, 
one major difference between the two species does arise during surgery. 
Unlike man, the sheep does not activate the release of catecholamines in 
response to either anaesthetic stress or surgical stress and therefore relies 
on the stimulation of the hypothalamic-pituitary-adrenal axis and the 
subsequent release of the catabolic steroid cortisol to mobilise energy 
substrates. This experiment demonstrates that in the sheep stimulation of 
the hypothalamic-pituitary-adrenal axis and the resultant elevation in 
cortisol levels during surgery acts to, suppress plasma insulin levels, 
maintain plasma free fatty acid levels and to increase plasma glucose 
concentrations. These metabolic and endocrine changes enable the ewe to 
respond to stress, while the ewes immunised against ACTH 1-24 are not 






The results from the experiments described in this thesis have 
demonstrated the physiological responses which occur when sheep are 
exposed to an acute stress. Details are given of the changes which take 
place following either the activation and integration of the
sympathomedullary axis and the HPA axis or following activation of only 
one of these axes.
All three experiments show clearly that it is the very nature of the stressor 
itself that dictates the way in which the two stress pathways respond. This 
is certainly the case for the HPA axis. The independent responses of the 
HPA axis to exercise or surgery as stressors is clearly demonstrated. These 
two unrelated stressors elicited quite different responses from the HPA axis 
and especially the expression of cortisol. Exercise resulted in a rapid 
increase in peripheral cortisol levels, which was maintained for the duration 
of the exercise and declined once the stressor had ceased. In contrast, 
anaesthesia and surgery or anaesthesia alone produced both a greater and 
more sustained increase in cortisol levels. In this experiment, cortisol 
concentrations slowly increased in response to the stressor and remained 
elevated after the stress was removed. These results suggest that there 
could be a difference in the way in which individual stressors are received 
and processed by the central nervous system. It appears from the nature of 
the cortisol release that anaesthesia and surgery produces a more 
pronounced release of CRF and AVP into the hypophysial-portal circulation 
than does exercise. As exercise produces a rapid increase and decrease in 
cortisol levels it is possible that one or more peripheral humoral factors are 
augmenting CRF and AVP to stimulate ACTH release from the pituitary.
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One such peripheral humoral agent is adrenaline, and it should certainly be 
considered in light of the fact that it is secreted from the adrenal medulla 
during exercise. In addition, adrenaline has also been reported to act on 
anterior pituitary a- and ^-adrenergic receptors to stimulate the release of 
ACTH (Giguere et al., 1981). The results from this thesis also indicate that 
of the two catecholamines studied, adrenaline (but not noradrenaline) may 
function as a peripheral humoral agent. Support for this comes from the 
results in chapter 5 which demonstrated that cortisol levels are not 
influenced by tyramine HCI stimulated noradrenaline release.
The interrelationship between the two stress pathways which was first 
proposed by Long (1952) and then by Axelrod and Reisine (1984) was also 
demonstrated during exercise in chapter 4. It appears from these data that 
the HPA-axis may be influenced by catecholaminergic input, specifically the 
tonic regulation of cortisol. The cortisol basal level increased in response to 
or-adrenergic receptor blockade with phentolamine and conversely 
decreased slightly during ^-adrenergic receptor blockade with propranolol 
HCI. Support for possible catecholaminergic regulation of cortisol secretion 
comes from studies which have identified adrenergic receptors within 
bovine adrenocortical cells (Kawamura et a!., 1984) as well as within the 
rat anterior pituitary (Giguere et a!., 1981). It is possible therefore that 
adrenergic receptors may also be present in the ovine pituitary and adrenal 
cortex. Evidence of this interrelationship between the two stress axes may 
be manifested when one axis is prevented from functioning as it was during 
surgery in chapter 6
The major objective of this thesis was to determine the physiological role 
of the sympathomedullary and the HPA axis in response to acute stress. 
The fact that the type of stressor appears to affect the nature of the stress 
response has made the task difficult. Consequently it is only possible to 
comment on the effects of the two stressors studied, exercise and surgery.
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Exercise as a stressor, (chapter 4) produced the "classical" stress 
response in which both the sympathomedullary and HPA axes are 
stimulated. From the results, I postulated that activation of the 
sympathomedullary axis is the primary stress pathway which is initiated in 
the sheep as a consequence of exercise. The catecholamines, released 
during activation of this axis and stimulation of their associated receptors, 
provides a potent combination which alters the physiological state of the 
animal and prepares it for either "fight or flight". The stimulation of both 
adrenaline and noradrenaline during exercise induced the rapid mobilisation 
of FFA's, glucose and lactate from their storage sites while inhibiting insulin 
release.
The capacity of the catecholamines and their ability to mediate metabolic 
and haemodynamic changes in response to stress was more closely defined 
in chapter 5 when only the sympathetic nervous system (SNS) was 
stimulated without the confounding effects of either adrenaline and or 
cortisol. The results from this experiment demonstrate that the 
noradrenaline released in response to activation of this nervous system 
facilitates plasma FFA release and stimulates blood glucose levels. More 
importantly, this experiment also demonstrated that in the sheep the 
inhibition of insulin secretion from the pancreatic /?-cells is not attributed to 
noradrenaline released from the SNS, but instead presumably to circulating 
adrenaline levels.
The role of the HPA axis during exercise and in particular that of cortisol 
appears to be a secondary response which has a major affect on energy 
substrate metabolism, in particular the lipolytic mechanism. One of the 
interesting findings revealed from this experiment was the result that low 
cortisol levels appear to constrain the animals lipolytic mechanisms 
resulting in a reduced rate of lipolysis. A working hypothesis is that plasma 
levels of cortisol regulate the lipolytic mechanism by influencing the status 
of the /7-adrenergic receptor. Support for this comes from studies which
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have shown that the glucocorticoids can increase the number of /?- 
adrenergic receptors in rat adipose tissue (Giudicelli et a/., 1989).
The influence that cortisol levels may have on lipolysis was also observed 
during the infusion experiment in chapter 5. In this experiment it was found 
that the treatment with propranolol HCI before tyramine failed to prevent 
the tyramine-induced rise in plasma FFA levels in one of the four treated 
ewes. This occurred even though all the ewes were given the same mass- 
specific dose of propranolol HCI. The plasma FFA levels for this ewe were 
significantly higher from the onset of the study when compared to the other 
three ewes and as were her cortisol levels.
The similarity of the metabolic responses between species especially 
between man, a monogastric animal, and sheep, a ruminant animal, were 
clearly shown during exercise. Not only were the metabolic responses 
similar but the adrenergic receptor type which the physiological response is 
mediated was, on the whole, the same across a large range of species 
including man. This consistency of this stress response between species 
demonstrates the intimacy of the "evolutionary blueprint" of both stress 
axes and their subsequent effects on physiological responses.
Surgical stress (chapter 6) demonstrates the synergistic nature of the two 
stress pathways. One of the major findings from this work is that when the 
sympathomedullary pathway is denied, as it is during surgery, the HPA axis 
can facilitate catecholamine-like effects in which the metabolic status of the 
sheep is altered to accommodate for the stressor. The increased cortisol 
levels had profound effects on the mobilisation of FFA's and the elevation 
in blood glucose levels. More importantly, this experiment also 
demonstrated for the first time in the sheep, that cortisol per se can acutely 
modulate insulin secretion. The key feature of this experiment however, 
demonstrates again the interrelationship between the two stress axes by 
the animals ability to switch from one pathway to another when one is
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denied. Thus, the capacity of the animal's homeostatic mechanism to 
maintain internal order is maintained.
A problem which could be perceived from the studies described in this 
thesis is the low number of animals which were used in all three 
experiments. The low number of animals used for these experiments was 
both a function of cost and logistics. However, even though there is a 
biological variability, inherent in the use of small animal numbers, the 
results have produced clearly defined trends. These defined trends would 
surely result in statistically significant outcomes if a greater sample size 
were used.
Future Research and Possible industry Application
The finding that low cortisol levels impinge on the animals lipolytic 
mechanism and that this effect may be the result of an altered /?-adrenergic 
receptor status needs to be clarified. It is possible that cortisol not only 
influences lipolysis but may alter other physiological responses that are also 
mediated by this receptor. The results from this thesis also suggest that 
low cortisol levels may modulate glycogenolysis in the non-exercising 
muscle. It could be that physiological levels of cortisol are required to 
maintain "normal" ^-adrenergic receptor function and that by lowering 
cortisol levels the affinity of the /?-adrenergic receptor to agonist coupling is 
impaired. It is conceivable that cortisol levels may have a direct influence 
on the status of all /?-adrenergic receptor sub-types. If this is so, then the 
manipulation of the cortisol levels may influence the physiological response 
of the stress axes. This could be especially pertinent to the animal meat 
production industries where problems such as dark cutting meat and 
ecchymosis (blood splash) are a result of acute stress and as a result have 
a deleterious effect on meat quality.
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